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ABSTRACT 
Schizophrenia is a devastating mental illness characterized by a broad range of 
clinical manifestations including hallucinations, social cognitive impairments, and 
disordered thinking and behavior, all of which impair daily functioning. The immune 
molecule complement component 4 (C4), located in the major histocompatibility locus 
(MHC) on chromosome 6 in humans, is highly associated with schizophrenia such that 
specific structural variants and regulatory regions increase the expression of C4 and 
confer greater risk for this brain disorder. Besides their established role in brain immune 
defense, complement proteins play a role in various stages of brain development 
including neurogenesis, migration and synaptic development. However, C4 has never 
been experimentally upregulated to determine the impact of increased expression of this 
immune gene on brain development.  Here, I study the role of C4 in layer 2/3 pyramidal 
neurons in the medial prefrontal cortex of mice to study the hypothesis that C4 




synapses. Specifically, neuronal connectivity was assayed by measuring dendritic spine 
density using confocal microscopy and functional connectivity through whole-cell 
electrophysiology recordings. Additionally, the role of microglia in altering the 
developmental wiring of the brain was examined by quantifying microglia engulfment in 
the medial prefrontal cortex. Lastly, complement-induced changes to the prefrontal cortex 
were accompanied by deficits in social behavior in both juvenile and adult mice. Overall, 
these studies show that C4 affects brain connectivity by reducing dendritic spine density 
and excitatory drive through enhanced microglia-engulfment of synaptic material which 
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Introduction to the pathology and etiology of schizophrenia 
 
1.1 Clinical features and neuropathology in schizophrenia 
Schizophrenia (SCZ) is a chronic developmental disorder that affects more than 
21 million people worldwide (Kessler et al. 2010). SCZ is usually diagnosed in 
adolescence or early adulthood when prefrontal cortex (PFC) networks mature and 
individuals experience their first episode of psychosis. Almost all cases of this disorder 
are both chronic and progressive yielding a grim prognosis for diagnosed individuals 
(Zhang et al. 2005). Ten years after initial diagnosis, fifty percent of affected individuals 
are unable to live independently, fifteen percent are hospitalized and ten percent die of 
suicide (World Health Organization 2017). It is clear that this disease is genetic- a 
monozygotic twin of an affected individual has a 50% chance of developing SCZ, 
compared to an occurence of only 1-2% in the general population (Gottesman & Shields 
1976). Scientists have focused on understanding deletions of larger sections of DNA that 
have been found to be disrupted or deleted in a subset of SCZ cases, yet these sort of 
studies yield limited success in identifying specific genetic links to SCZ (Kim et al. 2011, 
Sigurdsson et al. 2010). A limited understanding of the pathogenesis of SCZ has stunted 
the development of more effective treatments, leaving many affected individuals 
chronically hospitalized or homeless. More basic research of the underlying pathogenesis 




Individuals afflicted with SCZ experience symptoms that can be categorized 
into three clusters: positive, negative and cognitive symptoms. Positive symptoms 
include psychosis, paranoia, and disordered thought (American Psychiatric 
Association 2013). Negative symptoms include depression, anhedonia, suppressed 
speech and social withdraw (Lieberman et al. 2005). Cognitive symptoms include a 
wide range of deficits in social cognition, working memory, attention, and executive 
function that together leads to a decreased ability to comprehend and manage 
information to guide thought and decision making (Elvevåg & Goldberg 2000, 
Piskulic et al. 2007). Treatment of SCZ usually relies on symptom management, 
such as antipsychotic medication to treat psychosis. However, treating symptoms 
does nothing to help cure the underlying disease, and patients are frequently not 
compliant with medication regiments (American Psychiatric Association 2013, 
Green 2006). Cognitive impairments, including social deficits, are the most common 
predictor of prognosis, including employment status, relapse and living dependence, 
but there are currently no available treatments that effectively target cognitive 
symptoms (Elvevåg & Goldberg 2000, Green 2006). 
Among the many clinical traits of SCZ are deficits in social cognition such as 
social cue perception and emotion regulation, which suggest dysfunction of the PFC 
(Green 2006). Moreover, patients with SCZ exhibit abnormal activity in the PFC 
during affective face perception and cognitive reappraisal (Morris et al. 2012, Taylor 
et al. 2012, Delvecchio et al. 2013).  These results are not surprising given the well-




et al. 2012). Although the mechanisms that cause social deficits in SCZ are unclear, 
evidence suggests that dysfunction in the PFC correlates with symptom onset and 
severity (Vita et al. 2012). In fact, a neurological hallmark of SCZ is a reduction of 
gray matter in the PFC due to a loss of neuronal processes and synapses (Glantz & 
Lewis 2000, Thompson et al. 2001). Therefore, it has been hypothesized that 
pathology in SCZ arises in part due to deficits in the pruning of cortical synapses, 
thus producing aberrant circuitry (Glantz & Lewis 2000, Thompson et al. 2001). 
In line with this, current research suggests that deficits in neuronal 
connectivity and plasticity, present across multiple brain areas, underlies the diverse 
disruptions in information processing and cognition (Glausier & Lewis 2013, Glants 
& Lewis 2000). Individuals diagnosed with SCZ have decreased cortical volumes 
prior to, during and after the first episode of psychosis when compared to age and 
sex-matched healthy samples (Lawrie & Abukmeil 1998, Steen et al. 2006, Levitt et 
al. 2010). This loss in brain matter is progressive with the most significant losses 
found in gray matter neuropil, consisting of dendrites and spines, of the prefrontal 
and temporal cortices (Dazzan et al. 2012, Giedd & Rapoport 2010, McIntosh et al. 
2011). Interestingly, the density of cortical neurons is unchanged in these brain 
regions despite the loss of gray matter (Thune et al. 2001), suggesting a decrease in 
synaptic density and/or dendritic branching (Glausier & Lewis 2013, Selemon & 
Goldman-Rakic 1999, Glantz & Lewis 1997). Importantly, these changes in brain 
structure can be detected in humans before the first episode of psychosis, before 




brain connectivity (Anticevic et al. 2015).  
The over pruning of synapses has been suggested to alter multiple 
neurotransmitters including glutamate and dopamine, with suspected links to a 
disrupted immune system. The loss of gray matter observed in human SCZ post 
mortem tissue correlates with a loss of excitatory synapses therefore leading to a 
decrease in glutamatergic transmission (Bustillo et al. 2014, Glantz and Lewis 
1997). Moreover, glutamate levels in the PFC negatively correlated with psychotic 
symptoms such that greater decreases in glutamate levels were found in SCZ cases 
with more severe psychotic symptoms (Bustillo et al. 2014). Additionally, 
inflammatory abnormalities, such as increased expression of SERPINA3, TNFα, 
IL1β, IL6, and IL6ST, have been observed in the ventral midbrain in post mortem 
SCZ tissue, and these results were also replicated in a maternal immune activation 
(MIA) mouse model (Purves-Tyson et al. 2019). Importantly, these differences in 
immune markers from SCZ tissue could be accounted for by a subset of cases, 
including about 45% of high inflammatory cases. The ventral midbrain houses the 
majority of dopamine-releasing neurons in the brain, therefore MIA might 
contribute to SCZ pathology by disrupting immune-mediated wiring of 
dopaminergic circuits (Purves-Tyson et al. 2019).  These findings are important 
because they link SCZ-associated neuroinflammation to dopaminergic 
abnormalities, which is a hallmark of this disorder. 
Alterations in the brain structure of individuals diagnosed with SCZ are 




magnetic resonance imaging and electroencephalogram recordings (Volk & Lewis 
2010, Cho et al. 2006). Although antipsychotics do help 25% of diagnosed patients 
(Kessler et al. 2010), current clinical options are limited. Sadly, the majority of 
individuals diagnosed with SCZ are not able to function as independent members of 
society with currently available treatments. Thus, there is a tremendous need to 
develop new treatments. To do this, we must understand how these diverse 
neurological hallmarks arise based on genetic and environmental risk factors. 
 
1.2 Major histocompatibility molecules genetically associate with schizophrenia 
Recent genetic studies have provided insight that enable a greater understanding 
of the underlying pathology in SCZ and could ultimately lead to novel, more effective 
therapeutic interventions. Genetic studies conducted using human tissue show that the 
strongest genetic association to SCZ is contained in a region on chromosome 6 known as 
the major histocompatibility complex, or MHC locus (Shi et al. 2009, International 
Schizophrenia Consortium 2009, Ripke et al. 2013, Stefansson et al. 2009, Schizophrenia 
working group of the Psychiatric Genomics Consortium 2014). The MHC locus encodes 
genes that are involved in the recognition and elimination of pathogens. However, the 
MHC locus contains megabases of DNA, including over 200 genes, complicating the 
identification of candidate genes that could be important in the pathogenesis of SCZ 
(Carroll et al. 1984, Horton et al. 2004). 
A recent study focused on a single gene from the MHC locus, called complement 




and regulatory regions (Sekar et al. 2016). C4 is a member of a larger family of proteins 
called the complement cascade family, which are important in the recognition and 
destruction of pathogens using nonspecific yet rapid defense mechanisms, referred to as 
innate immunity (Carroll et al. 1984). Human C4 contains two distinct genes, or isotypes, 
C4A and C4B (Carroll et al. 1984).  C4A has been shown to strongly bind protein-
antigen complexes, whereas C4B more effectively binds antibody-coated red blood cells 
to tag pathogens for destruction by macrophages (Law et al. 1984). Importantly, alleles 
for C4 that generate greater protein expression correlate with increased risk of developing 
SCZ; C4A expression correlates with 1.4 times the odds risk for SCZ (Sekar et al. 2016). 
Since complement proteins have previously been studied in the context of immunity, new 
research has been aimed at understanding alternative roles for this protein in the brain to 
understand its implication in SCZ. 
 
1.3 The complement cascade 
The complement cascade protein family is an intricate network of over 50 
membrane-bound and circulating proteins that serve as the first-line of defense against 
pathogens in innate immune responses. The complement system is divided into 3 
proteolytic pathways: the classical pathway, the lectin pathway and the alternative 
pathway (Morgan & Gasque 1997). When initiated, one or more of these pathways are 
activated via a series of proteolytic cleavages that stimulates either engulfment of the 




cell-killing complex called the membrane attack complex (Morgan & Gasque 1997). In 
the classical pathway, complement component 1q (C1q) initiates the classical cascade by 
recognizing and binding to a pathogen which causes a proteolytic cascade that activates 
the cleavage of complement component 3 (C3) (Morgan & Gasque 1997). Cleaved C3 
(C3b) is then recognized by C3 receptors (CR3) on macrophages, which initiate 
phagocytosis (Figure 1.1). 
 
 
Figure 1.1: The complement cascade in pathogen recognition and phagocytosis. 
C1q, C1r and C1s form a complex. When C1q recognizes a pathogen, a conformation 
change allows C1s to dissociate. C1s then initiates a proteolytic cascade that leads to 
the cleavage of C3 into C3a and C3b. C3b is able to bind the pathogen and is then 
bound by C3Rs contained on macrophages. The recognition of C3b by macrophages 
initiates phagocytosis of the pathogen. Note: Figure made by Ashley Comer. Figure 





The liver produces most of the complement proteins in the body (Morgan & 
Gasque 1997). After being synthesized in the liver, complement proteins are then 
released to freely circulate in the blood, ready to respond to an immune insult. 
Complement proteins, similar to many immune defense molecules, cannot pass the 
blood-brain barrier (Veerhuis et al. 1998). However, complement proteins are present in 
the brain, so they must be produced locally (Gasque et al. 1995). Neurons and glial cells, 
including microglia and astrocytes, have been found to synthesize a wide range of 
complement proteins including C1q, C3, and C4, among others (Stephan et al. 2013, 
Veerhuis et al. 1998, Lévi-Strauss & Mallat 1987, Gasque et al. 1995, Walker et al. 1995, 
Shen et al. 1997, Comer et al, 2020). Additionally, microglia express complement 
receptors C1qR, C2R, C3R, C4R and C5aR and astrocytes express C1qR (Woodruff et al. 
2010). The finding that glia produce much of the brain’s complement proteins is 
consistent with their well-described role in immune defense (Nimmerjahn et al. 2005, 
Dong & Benveniste 2010, Yang et al. 2010). Microglia play an important role in immune 
defense since they are the brain’s resident macrophage; they physically survey the brain 
as scavengers that phagocytose both foreign material, such as infectious particles, and 
neural material such as apoptotic cells and synaptic material (Nimmerjahn et al. 2005, 
Schfaer et al. 2012). Additionally, when microglia or astrocytes are activated, they 
produce and secrete complement proteins (Veerhuis et al. 1999). The function of 
neuronal-derived complement proteins is not as well-defined, and it is unknown if 
complement derived from different cell-types have slightly different functions. However, 




phenotype in the visual system thalamic nucleus, the lateral geniculate nucleus (Bialas et 
al. 2013).   
Recent work shows that complement proteins are implicated in various processes 
besides immune defense in the brain (Sekar et al. 2016, Stevens et al. 2007, Schafer et al. 
2012). Complement proteins play a role in the developmental wiring of the brain. 
Specifically, microglia engulf synaptic material in the developing brain, but mice 
deficient in either C3 or the microglial receptor CR3 lose this ability, which leads to 
aberrant circuit formation in retinogeniculate synapses (Schafer et al. 2012). Further, C3 
plays a role in neuronal migration through the lectin pathway C4 (Gorelik et al. 2007). 
C1q also modulates neurite outgrowth both in vitro and in vivo in spinal cord 
regeneration after injury (Peterson et al. 2015). Interestingly, the effect of complement 
proteins on synaptic pruning might be circuit specific, as there is evidence that certain 
brain regions, including the visual and barrel cortex, do not depend on complement 
proteins for proper synaptic pruning (Welsh et al 2020, Gunner et al. 2019). Although 
there is evidence for microglia-mediated synapse loss in multiple neurological diseases, 
there is evidence that complement proteins aren’t always involved in this process and 
alternative pathways are being studied such as STAT1 and CCL2 signaling (Lobsinger et 
al, 2013, Di Liberto et al. 2018). This suggests that complement-dependent wiring might 
exert differential effects on different brain regions. Together, these studies suggest novel 
roles of complement signaling in wiring the central nervous system, however little is 





1 .4 The inflamed brain in schizophrenia: the convergence of genetic and 
environmental risk factors that lead to uncontrolled neuroinflammation 
1.4.1 Introduction 
Schizophrenia (SCZ) is a prevalent mental illness without satisfactory treatment 
options. Approximately 20 million people worldwide are afflicted by this chronic and 
debilitating mental disorder (American Psychiatric Association. 2013, Whiteford et al. 
2013). SCZ is characterized by a broad range of clinical manifestations including 
hallucinations, social and cognitive impairments, as well as disordered thinking and 
behavior that impair daily functioning (American Psychiatric Association. 2013). Current 
treatment options do not improve cognitive or negative symptoms, both of which 
contribute more significantly to the long-term prognosis of SCZ than positive symptoms 
(Lieberman et al. 2005, Green 2006). More effective therapies for SCZ have lagged due 
to a lack of understanding of its underlying mechanisms.  
Genome-wide association studies (GWAS) have identified novel susceptibility 
loci that confer greater risk for SCZ (Ripke et al. 2013, Li et al. 2017). These 
breakthroughs have enabled the characterization of genes that may shed light on the 
pathophysiology of SCZ. In addition, much progress has been made in preclinical studies 
focusing on environmental risk factors for SCZ and other neurodevelopmental disorders 
(NDD) that alter brain development such as psychosocial stress, maternal immune 
activation (MIA), and exposure to pollution (Gomes, Zhu and Grace 2019, Bergdolt and 




environmental factors conferring increased risk for SCZ, recent work suggests that these 
factors converge by altering immune processes, which are known to play an essential role 
in shaping brain development (Müller and Schwarz 2010, Kroken et al. 2018, Stephan, 
Barres and Stevens 2012). Indeed, elevated immune function is found in SCZ and 
therapeutics that target immune function have shown some success in symptom reduction 
(Sommer et al. 2014, Kroken et al. 2018). Nevertheless, it is still unclear how immune 
molecules regulate synaptic wiring during normal brain development and contribute to 
synaptic pathology in neuropsychiatric disorders. Causal links between specific immune 
molecules and altered synaptic connectivity within circuits implicated in neuropsychiatric 
disorders are currently lacking (Elmer and McAllister 2012). 
Microglia are central nervous system (CNS) phagocytes that, among their other 
roles, orchestrate innate immunity in the brain. Microglia have well-described roles in 
rapidly responding to inflammatory insults through dynamic surveillance of the CNS 
parenchyma (Nimmerjahn, Kirchhoff and Helmchen 2005, Liu et al. 2019b) and clearing 
debris and apoptotic cells through phagocytosis (Galloway et al. 2019, Ayata et al. 2018). 
Recent studies have begun to uncover the diversity of microglia, which can have 
significantly different gene expression patterns across brain regions, in health and in 
pathological states, and at different developmental time points (Tan, Yuan and Tian 2020, 
Hammond et al. 2019, Sankowski et al. 2019, Tay et al. 2017a). These complex cells 
contribute to normal brain development and function by supporting the neuronal circuitry 
through synapse addition, elimination, maintenance, and plasticity (Hammond, Robinton 




studies, there is evidence of microglial dysfunction in SCZ (Bayer et al. 1999, Hercher, 
Chopra and Beasley 2014, Uranova et al. 2020, Bloomfield et al. 2016, Sellgren et al. 
2019, Trépanier et al. 2016, De Picker et al. 2017). A key element to understand the 
pathogenesis of SCZ is to discern how genetic and environmental risk factors intersect to 
alter microglial function. Furthermore, outstanding questions that remain to be answered 
are at what stage(s) of disease progression microglial function ameliorates or contributes 
to the pathology of SCZ, and what are the particular subtypes or phenotypes of microglia 
that could be targeted for therapeutic intervention.  
In this chapter, I discuss the genetic and environmental risk factors for SCZ and 
how they converge to alter microglial function in response to systemic and central 
inflammation. Additionally, we highlight how these risk factors alter the indispensable 
functions of microglia during development, adolescence and adulthood. Limitations of 
the current knowledge are also addressed, and key future experiments are proposed. 
Understanding how the heterogeneous genetic and environmental risk factors for SCZ 
interact to reach a disease threshold and determine its progression is necessary for the 
development of more effective therapeutics. 
 
1.4.2 Genetic risk factors for schizophrenia that interplay with immunological responses 
SCZ is driven by genetic factors, as the risk for developing this disorder increases 
from 1% in the general population to 50% in individuals with a diagnosed twin (Cardno 




association studies (GWAS) have made progress in discovering loci throughout the 
genome that are associated with SCZ (Dennison et al. 2019, Li et al. 2017, Ripke et al. 
2013, Consortium 2011, Schizophrenia Working Group of the Psychiatric Genomics 
Consortium 2014). These studies reveal that SCZ has a heterogeneous etiology, with 
genes likely conferring risk across the entire genome. This heterogeneity, in combination 
with environmental factors, has made it difficult to pinpoint which genes contribute to the 
disease pathology. Although the genetic determinants for SCZ are not well understood, 
evidence suggests that immune dysfunction and inflammation contribute to its 
pathophysiology (van Kesteren et al. 2017, Trépanier et al. 2016). 
The major histocompatibility (MHC) locus is located on chromosome 6 and has 
the highest association to SCZ compared to any other loci across the genome 
(Schizophrenia Working Group of the Psychiatric Genomics Consortium 2014, Shi et al. 
2009, Stefansson et al. 2009). This region encodes genes that are involved in innate 
immunity. For instance, complement component 4A (C4A), located in the MHC locus, is 
highly associated with SCZ: specific structural variants and regulatory regions that 
increase the expression of C4A confer a greater risk for SCZ (Sekar et al. 2016). The 
complement cascade is part of the innate immune system that recognizes foreign 
pathogens and apoptotic cells, and tags them for destruction, such as through 
phagocytosis by macrophages (Veerhuis, Nielsen and Tenner 2011). Besides their 
established role in immune defense, complement proteins play a role in various stages of 
brain development including neurogenesis, cellular migration and synaptic development 




last 5-10 years have linked complement proteins to microglia-mediated pruning of 
synapses, suggesting that C4A could directly contribute to SCZ pathology (Hong et al. 
2016, Schafer et al. 2012, Stevens et al. 2007). 
In line with this, it was recently shown that increased expression of the mouse 
homologue of human C4A, called C4b in mice, in medial prefrontal cortex (mPFC) layer 
(L) 2/3 pyramidal neurons led to a marked reduction in connectivity and decreased 
sociability in juvenile and adult mice, both of which mirrored the deficits seen in SCZ 
(Comer et al. 2020). These results suggest that C4A might contribute directly to 
pathology in SCZ. Although, the molecular mechanisms that link increased C4 
expression to synaptic loss remain unclear, overexpressing this neuroimmune gene led to 
increased localization of the postsynaptic protein PSD-95 to microglial lysosomes, 
suggesting upregulated microglia-dependent synaptic engulfment (Comer et al. 2020). 
Additionally, variation in C4 structural alleles increases risk for autoimmune diseases and 
indicate that sex-differences in the C4 gene might explain greater vulnerability to SCZ in 
males (Kamitaki et al. 2020). In another study, C4 serum levels were assessed at baseline 
and in a 1-year follow-up in a cohort of twenty-five patients with first episode psychosis 
that were taking either olanzapine or risperidone (Mondelli et al. 2020). Compared with 
responders to antipsychotic medication, non-responders showed significantly higher 
baseline C4 levels, suggesting that baseline expression of this immune gene can predict 
clinical outcome (Mondelli et al. 2020). Since this study focused on a limited number of 
markers, it is not clear how psychosis progression correlates with levels of other immune 




important regulator of C4 that is expressed during early postnatal development (Kraus et 
al. 2006). Genetic variants located in the CSMD1 and CSMD2 genes have been linked to 
SCZ (Håvik et al. 2011) and their dysregulation led to deficits in general cognitive ability 
and executive function (Athanasiu et al. 2017), both of which are affected in SCZ. 
Conversely, a recent study showed that CSMD1 levels in the blood are decreased in SCZ, 
while antipsychotic treatment resulted in up-regulation of CSMD1 and improved 
cognitive symptoms (Liu et al. 2019a). 
 Transcriptomic and genomic studies have implicated alterations in key cytokines 
with SCZ, including increases in interferon regulatory factor 3 (IRF3) (Li et al. 2015), 
which is a major transcription factor in viral infection, and interferon gamma (IFN-γ), an 
important regulator of viral propagation (Paul-Samojedny et al. 2011). In support of 
neuroimmune genes altered in SCZ, other studies have found changes in pro-
inflammatory interleukin 1 (IL)-1α (Katila, Hänninen and Hurme 1999), IL-1β 
(Sasayama et al. 2011, Katila et al. 1999), IL-6 (Frydecka et al. 2015, Kalmady et al. 
2014) and anti-inflammatory IL-10 (reviewed in (Gao et al. 2014)). Several studies also 
investigated circulating C-reactive protein (CRP), IL-6, IL-1β, TNF-β and TGF-β, which 
are also elevated at the mRNA level in people with SCZ, to determine their reliability as 
peripheral biomarkers (Kroken et al. 2018). However, other studies reported limited 
immune gene enrichment in SCZ (Pouget et al. 2016), highlighting the genetic 
complexity of the disease, in addition to possible variability between cohorts and 




Several GWAS have revealed that multiple immune receptors are associated with 
SCZ including the MHC receptors and Toll-like receptors (TLRs) (Stefansson et al. 2009, 
Shi et al. 2009, Schizophrenia Working Group of the Psychiatric Genomics Consortium 
2014, Purcell et al. 2009, Consortium 2011). TLRs play a role in the recognition of 
microbe-derived molecular signals by innate immune cells including microglia (reviewed 
in (Wright et al. 2001, Lehner 2012)). In addition to their established role in innate 
immunity, TLRs regulate early brain development (Chen et al. 2019, Mallard 2012) via 
their effects on synaptic plasticity and neurogenesis (Barak, Feldman and Okun 2014). 
Other groups have shown alterations in TLR2 (Kang et al. 2013) and TLR4 (García-
Bueno et al. 2016, MacDowell et al. 2017) in either the blood or post-mortem brain tissue 
of people with SCZ. Overall, these data have linked MHC signaling and other immune 
receptors pathway with the pathology of SCZ, However, the molecular underpinnings of 
their contribution to SCZ are not yet clear. It is also still not understood how disruption in 
particular immune pathways contributes to specific cellular and behavioral hallmarks of 
this disorder, such as decreased gray matter volume. 
To identify robust peripheral biomarkers that can predict SCZ pathology, 
researchers have compiled an architecture of genes observed in patients from multiple 
GWAS. A subset of overlapping genes from these studies identified candidates including 
CD14, Clusterin, Dipeptidyl peptidase 4, Early Growth Response 1, Heat Shock Protein 
Family D Member 1, C4 and MHC genes (Pouget et al. 2016). Despite the identification 
of these candidate biomarkers, other studies highlight that the current literature does not 




(Kroken et al. 2018). Some studies have identified markers that are related to antigen 
presentation and immune activity (Pouget et al. 2016), whereas others have revealed 
changes in inflammatory cytokines (Kroken et al. 2018, Hudson and Miller 2018). These 
studies together indicate that some cases or stages of SCZ may involve the innate and/or 
adaptive immune system. However, genetics only explains part of the susceptibility and 
pathophysiology of SCZ, which provides further support that environmental risk factors 
are also required to trigger the disease in most cases (Knuesel et al. 2014). 
Lastly, SCZ-associated genes with diverse functions in the brain have also been 
implicated in inflammation (Brandon et al. 2009). For example, the gene Disrupted-in-
Schizophrenia 1 (DISC1) was first found in a Scottish family with SCZ (St Clair et al. 
1990) and subsequently in other populations worldwide (Chubb et al. 2008). 
Interestingly, the disruption of DISC1 protein in mice led to dysregulation of an immune-
related network of genes that are perturbed in SCZ (Trossbach et al. 2019), suggesting 
that non-immune genes can modulate the expression of inflammatory gene networks. In 
support of this, in a dual-hit genetic-environmental mouse model of SCZ, where Disc1 
mutation was combined with MIA, transient administration of minocycline, an anti-
inflammatory antibiotic drug, rescued electrophysiological and structural deficits during 
early postnatal development, as well as cognitive abilities in juvenile mice (Chini et al. 
2020). It is clear that the expression of hundreds of genes is altered in SCZ, although it 
remains to be determined how the interaction between immune and non-immune 




gene dysfunction and inflammation both contribute to the pathophysiology of SCZ (van 
Kesteren et al. 2017, Trépanier et al. 2016). 
 
1.4.3 Exposure to pollution increases risk for schizophrenia by enhancing inflammatory 
responses 
The environment is becoming increasingly polluted from multiple sources and has 
been found to correlate with increased prevalence of SCZ (Horsdal et al. 2019). Traffic-
related air pollution (TRAP), such as diesel exhaust (Bolton et al. 2017, Inoue et al. 2006, 
Hartz et al. 2008, Block and Calderón-Garcidueñas 2009), is the result of the combustion 
of fossil fuels and can be modeled in the lab using elemental carbon (Newman et al. 
2013) (Newman et al. 2013) or by taking the finest particles (<200 nm) from TRAP and 
re-aerosolizing them into nanoparticulate matter (nPM). nPM is the most toxic 
component of TRAP, in terms of its impact on the brain (Davis et al. 2013). By-products 
of TRAP, such as ozone (O3), which can be generated from nitrogen oxide, can also be 
changed photochemically after their release from motor vehicles (Mumaw et al. 2016). 
Altogether, multiple paradigms are currently used in animal models to study the effects of 
air pollution on brain development (Davis et al. 2013, Newman et al. 2013, Woodward et 
al. 2017). This work is particularly relevant when considering the epidemiological studies 
that link air pollution to SCZ pathogenesis (Horsdal et al. 2019). Indeed, many of the 




(Figure 1.2). Interestingly, immune genes, including those expressed by microglia, are at 
the center of this interaction (Peters et al. 2006, Genc et al. 2012).  
 
 
While the mechanisms involved in SCZ pathogenesis are still unclear, exposure to 
air pollution has been found to increase the expression of multiple inflammatory genes in 
Figure 1.2: Overview of the overlap between immune-signaling genes that are 
altered from pollution and in schizophrenia. 
Of the immune genes that are associated with SCZ, many are also found to be altered 
either in humans or animals exposed to pollutants, offering a novel hypothesis for the 
cause of cytokine-induced neuroinflammation observed in people with SCZ. The 
inflammatory genes including TLR2, TNF-α, MHC, CRP, TLR4, IRF3, complement 
pathway, IL-6, IFN-y, CD14, IL-10, TGF-β are altered in SCZ, while TNF-α, TLR4, 
IL-6, CD14 and IL-1 are altered in SCZ and after exposure to air pollution. Note: Figure 






humans and mouse models. Children exposed to TRAP have elevated circulating levels 
of pro-inflammatory cytokines, including IL-6, IL-1ß, CD14 and TNF-α, compared to 
children living in less-polluted cities (Gruzieva et al. 2017, Calderón-Garcidueñas et al. 
2008, Calderón-Garcidueñas et al. 2015). Additionally, nPM from air pollution induced a 
similar inflammatory cytokine signature in the circulation of healthy young adults, 
characterized by an elevation of IL-6, together with an increased density of inflammatory 
cells and microparticles, suggesting the occurrence of endothelial injury (Pope et al. 
2016). In line with this, TRAP exposure in rodents increased IL-1α, IL-6 and TLR4 
expression in the brain (Bolton et al. 2017, Bos et al. 2012). Pollution exposure especially 
impacted microglial TLR4 signaling in multiple mouse models involving TRAP 
(Woodward et al. 2017, Woodward et al. 2018), O3 (Mumaw et al. 2016), or diesel 
exhaust particle (Bolton et al. 2017, Bai et al. 2019) exposure, by upregulating TLR4 in a 
MyD88-dependent pathway (Woodward et al. 2017). Male offspring were especially 
susceptible to these deleterious effects, showing greater changes in microglial TLR4 
signaling that were accompanied by behavioral deficits in anxiety-like behavior, 
contextual and auditory cue fear conditioning and the forced swim test (Bolton et al. 
2012, Bolton et al. 2013, Bolton et al. 2017). Prolonged exposure to inflammatory 
molecules, such as IL-6, additionally led to neuroadaptive effects such as altered synaptic 
plasticity (Gruol 2015). Therefore, exposure to pollution could alter brain development 
and function by causing increased expression of pro-inflammatory markers, a feature on 




TRAP alters brain development and increases the risk for SCZ (Woodward, Finch 
and Morgan 2015, Pedersen et al. 2004), however it is unclear if pollution-mediated 
changes in brain development or inflammatory signaling directly contribute to pathology. 
Recent work has studied the effects of chronic nPM exposure using a double-hit model 
where cortical neuronal cultures from exposed mice were re-exposed in culture. A double 
exposure to nPM reduced neurite outgrowth (Davis et al. 2013) while resulting in an 
inflammatory transcriptomic profile (Solaimani et al. 2017) in neuronal cultures. Another 
group showed that TRAP can reduce hippocampal neurogenesis by 70% in rats, which 
correlated with behavior deficits in object recognition, food-seeking behavior, and in the 
forced swim test (Woodward et al. 2018). These phenotypes were reproduced in mice 
using elemental carbon exposure (Morris-Schaffer et al. 2019). In the mouse brain, nPM 
exposure induced neuroinflammation evident through a microglia-mediated increase in 
TNF-α (Cheng et al. 2016). Furthermore, exposure to nPM led to altered microglia 
morphology and elevated levels of C5, C5a and CD68 proteins, indicative of increased 
phagocytic activity, in the corpus callosum (Babadjouni et al. 2018) a region that is 
particularly reduced in volume in SCZ patients (Kubicki et al. 2005). Other work has 
highlighted the neurotoxicity of ultrafine particles (UFP), which induced pro-
inflammatory signaling and lead to a long-lasting reduction of corpus callosum volume 
(Allen et al. 2017). Overall, neuroinflammation induced by pollution appears to have a 
substantial impact on the brain by altering axonal myelination (Cole et al. 2016). 
However, it is still unclear to what extent pollution-driven inflammation, compared to 




state caused by exposure to air pollution has been shown to alter microglial function and 
neuronal development, as well as axonal myelination, thus affecting several processes of 
neurodevelopment that have been linked to SCZ pathogenesis. 
 
1.4.4 The gut-brain axis in schizophrenia 
The CNS communicates bi-directionally with the gastrointestinal (GI) system to 
maintain homeostasis, for instance by regulating hunger and digestion processes at steady 
state (Konturek et al. 2004). There has been extensive study of the reciprocal gut and 
CNS interactions, which communicate through the enteric nervous system and vagus 
nerve, and via alternative pathways involving the immune and neuroendocrine systems 
(Sampson et al. 2016, Singh et al. 2016, Sudo et al. 2004) or through direct secretion by 
gut microbes of neurotransmitters (Yano et al. 2015) and metabolites (De Vadder et al. 
2014, Sherwin et al. 2019). However, the importance of the gut in mediating brain 
function and behavior was ignited by the discovery that germ-free mice, which are devoid 
of microorganisms, have heightened stress responses (Sudo et al. 2004). In more recent 
work, the microbiota has been shown to influence complex behaviors such as social 
behavior, depression, and anxiety which are directly relevant to SCZ and other 
neuropsychiatric disorders (Sherwin et al. 2019, Desbonnet et al. 2014). Additionally, 
19% of people with SCZ are comorbid for irritable bowel syndrome, which has a known 
inflammatory etiology (Gupta et al. 1997) compared to an occurrence rate of only 2.5% 




challenging since it is highly sensitive to environmental changes. Therefore, most of the 
environmental risk factors for SCZ also impact the microbiota (Franklin and Ericsson 
2017), making it difficult to determine causation. However, recent work suggests a 
causative role for the microbiota in neuropsychiatric disorders and highlights the role of 
the immune system in linking the brain and gut in pathological conditions (Castro-Nallar 
et al. 2015, Yolken et al. 2015, Schwarz et al. 2018, Zheng et al. 2019, Zhu et al. 2019).  
The microbiota not only plays a key role in regulating host metabolism but also 
modulates inflammatory responses and neural function. Germ-free mice have multiple 
deficits in nervous system function including heightened hypothalamic-pituitary-adrenal 
(HPA) axis responses (Sudo et al. 2004), altered anxiety-like behaviors (Neufeld et al. 
2011), increased motor activity (Diaz Heijtz et al. 2011), and impaired memory (Gareau 
et al. 2011), and social behaviors (Desbonnet et al. 2014). The microbiota of people with 
SCZ has been found to contain more of the bacterial species Lactobacillus compared to 
healthy controls, and levels of this bacterium correlate with psychosis severity (Castro-
Nallar et al. 2015, Yolken et al. 2015, Schwarz et al. 2018). In a recent study, gut 
microbiota from SCZ patients was transferred into germ-free mice to test whether SCZ-
relevant behavioral phenotypes were transmissible via their gut microbiome. Germ-free 
mice receiving fecal transplants from these patients had lower levels of glutamate and 
higher levels of glutamine and GABA in the hippocampus, and these mice exhibited 
locomotor hyperactivity and decreased anxiety-like and depressive-like behaviors, as well 
as increased startle responses relative to control mice that received fecal transplants from 




from drug-free individuals with SCZ into antibiotic-treated mice caused SCZ-related 
phenotypes such as impaired learning and memory as well as increased psychomotor 
behaviors, while also leading to increased PFC dopamine and hippocampal serotonin 
levels compared to mice receiving microbiota transplants from healthy controls (Zhu et 
al. 2019). Microbes are able to produce or aid in the production of multiple 
neurotransmitters, including serotonin, dopamine and GABA, but it is still unclear how 
the gut production of these neurotransmitters affects CNS function (Yano et al. 2015, 
Strandwitz 2018). Additionally, gut microbiome transplantation or treatment with 
probiotics has been shown to, at least partially, reverse MIA-associated phenotypes in 
rodents, including deficits in anxiety-like, stereotypic and sensorimotor behaviors (Hsiao 
et al. 2013). The reversal of these phenotypes seems to be mediated through the 
normalization of gut permeability and microbe dysbiosis (Hsiao et al. 2013), suggesting 
that the gut microbiota can directly modulate immune responses even between a dam and 
its embryo. This is not surprising given that the microbiota has a well-studied role in 
inducing and maintaining the function of the host immune system.  
The gut-brain axis links multiple environmental risk factors for SCZ, specifically 
through immune signaling. MIA is a risk factor for SCZ that depends on maternal 
immune signaling relayed to the fetal brain through the placenta. Maternal gut 
microorganisms have been found to play an important role in MIA-mediated deficits. A 
ground-breaking study showed that MIA phenotypes in exposed offspring are dependent 
on the presence of segmented filamentous bacteria in the maternal gut which promote 




phenotypes, including deficits in cortical development and behavioral abnormalities, 
depend on gut microbiome-mediated increases in IL-17, as these phenotypes were 
diminished in mice deficient for IL-17 (Kim et al. 2017, Shin Yim et al. 2017). These 
data show that maternal microbe-induced immune signaling impacts fetal brain 
development with long-term consequences. Intriguingly, adult mice that have been 
exposed to lipopolysaccharides (LPS) in utero display improvement of their social 
deficits in later life upon re-exposure to LPS, which promotes gut microbiome production 
of IL-17a (Reed et al. 2020). Together, these findings suggest that prenatal inflammatory 
insults can prime the gut-immune-brain axis, thus leading to altered CNS responses to 
immune challenges later in life. 
The gut microbiome can affect the integrity of the blood-brain barrier (BBB), 
which facilitates increased neuroinflammation. The presence of gut microbes is necessary 
for the proper formation of the BBB during early development. Mice from germ-free 
dams have disrupted BBB maturation, which is evident by decreased tight junction 
expression both prenatally and postnatally. The hyperpermeability of the BBB in germ-
free mice persists into adulthood, but can be rescued by microbiota transplantation from 
controls or through the administration of bacteria that produce short chain fatty acids 
(SCFAs) (Braniste et al. 2014), which are known to have anti-inflammatory effects and 
promote BBB integrity (Hoyles et al. 2018). As mentioned previously, the gut plays an 
important role in the differentiation of Th17 cells. Interestingly, the gut also promotes the 
infiltration of Th17 cells into the brain through the meninges where these cells secrete IL-




BBB endothelial cells express TLRs and therefore are able to respond to gut microbe 
components such as LPS, which can alter tight junction expression and promote immune 
cell infiltration into the CNS (Tang et al. 2017). The BBB and microbiome are both 
disrupted in SCZ; this works thus highlights the potential for crosstalk between these 
systems that might act synergistically to further contribute to neuroinflammation in SCZ. 
Gut microbes produce metabolites that can cross the BBB and inhibit the function 
of mitochondria in the CNS (Hulme et al. 2020). A decrease in mitochondria density and 
altered structure has been observed in post-mortem SCZ brain tissue across multiple 
regions including the anterior cingulate cortex (Flippo and Strack 2017, Roberts 2017). 
This finding raises the intriguing possibility that gut microbe metabolites can contribute 
to SCZ pathology. While the identity of the CNS cell(s) affected by gut metabolites 
remains unclear, the dysfunction of mitochondria in microglia has been shown to alter 
cytokine production and inflammatory responses in the brain (reviewed in (Culmsee et al. 
2018)). MIA, which increases the risk for SCZ, has been shown in mice to alter the 
structure of mitochondria in a disease-associated microglial subtype known as dark 
microglia, among the hippocampus (Hui et al. 2018). Taken together, these studies 
suggest that there is extensive interplay between risk factors for SCZ, such that signaling 
from the gut-brain axis and exposure to an early immune insult can alter the function of 
microglia and CNS mitochondria. Future studies could aim to target the gut microbiome 
to dually control BBB integrity and reduce neuroinflammation. 
Gut microbiota dysbiosis can alter the maturation and function of microglia in the 




free mice have microglia with an immature morphology and gene expression profile in 
adulthood (Erny et al. 2015), suggesting that the microbiota impacts the maturation of 
microglia. The absence of microbes was found to not only affect microglial function but 
also impair innate immune responses, which were partially recovered by colonization 
with a more complex microbiome or by supplementation with SCFAs, which are a 
byproduct of certain gut microbes (Erny et al. 2015). SCFAs might affect CNS function 
through their interactions with BBB endothelial cells (Braniste et al. 2014) or directly 
with the CNS considering that they do not require receptors to bypass the BBB (Frost et 
al. 2014). The lack of SCFAs could additionally lead to increased peripheral and central 
inflammation considering their well-known anti-inflammatory functions (Li et al. 2018a, 
Vinolo et al. 2011). 
Microglia also show sex-dependent differences in response to gut microbe 
sterility. Microglia from germ-free male mice displayed altered expression of immune 
genes and a more immature phenotype at juvenile stages whereas microglia from female 
mice were more affected in adulthood (Thion et al. 2018). These findings suggest that the 
maternal microbiome can regulate microglial function in the offspring brain (Thion et al. 
2018), notably in the context of MIA exposure (Kim et al. 2017, Shin Yim et al. 2017), in 
a sexually dimorphic manner. Sex differences in microglial response to microbiome 
challenges are intriguing as they could partially explain the earlier onset of SCZ in males 
compared to females (Ochoa et al. 2012). MIA models also display sexual dimorphism in 
microglial properties and behavioral outcomes (Hui et al. 2018).  However, much work is 




Without a doubt, the gut microbiome influences the development and 
maintenance of the immune and nervous systems, with significant crosstalk. In the 
context of SCZ, the metabolites and diversity of gut microbes may impact multiple 
disease symptoms. The microbiome links multiple risk factors for SCZ, including stress 
responses, by promoting immune activation and BBB disruption (Figure 1.3). Innate 
immunity of the brain, including microglial function, is sensitive to gut dysbiosis, making 
the gut microbiota an interesting target in SCZ. Probiotics and microbiome transplants 
should be further explored to improve symptom severity in people with SCZ. 
Additionally, precautionary steps could be taken in pregnant mothers to improve diversity 
of gut microflora, considering its profound impact on brain development. Future work 
should further explore the role of SCFA-producing microbes, considering that they exert 
anti-inflammatory effects and improve brain function and behavior. Taken together, gut 
microbes are positioned to alter immune responses to environmental challenges by 
regulating neuronal function, behavior, and microglial responses, all of which are altered 
in SCZ. 
 
1.4.5 Maternal immune activation enhances risk for schizophrenia by altering microglial 
function 
It has become increasingly clear that immune challenges occurring during 
pregnancy increases offspring risk for varied neurodevelopmental and neuropsychiatric 




(Sørensen et al. 2009) or viral infections such as influenza, rubella or herpes (Brown and 
Derkits 2010, Pearce 2001) leads to lasting changes in offspring brain function and 
behavior (Estes and McAllister 2016). Maternal infection has been extensively studied 
using animal models of maternal immune activation (MIA), which have provided a 
substantial amount of causative evidence for how early immune insults disrupt brain 
development and function (Knuesel et al. 2014, Estes and McAllister 2016). MIA can be 
induced by exposing pregnant dams to immunogens that mimic an infection. The most 
common immunogens used to model MIA include polyinosinic:polycytidylic acid 
(poly(I:C)) and lipopolysaccharide (LPS) which mimic viral or bacterial infections, 
respectively. These agents elicit immune responses that enable cytokines to pass through 
the placental barrier, activating placental and embryo macrophages, and leading to 
increased inflammation in the developing offspring (Wu et al. 2017). Although work is 
needed to normalize MIA protocols, particularly on the temporal level, and to understand 
the variability in reported results (Kentner et al. 2019), this animal model has provided 
insight into how maternal infection enhances the risk for various disorders. Here, we 
focus on progress that has been made in understanding prenatal immune challenges in 
mice and humans. 
 MIA impacts brain function in a circuit-specific manner and interacts with other 
risk factors for SCZ. These early immune insults can elicit a vast array of phenotypes in 
mice that are relevant to SCZ and autism spectrum disorder (ASD), including 
abnormalities in ultrasonic vocalization and sociability, increased repetitive behaviors, 




working memory (Fernández de Cossío et al. 2017, Pendyala et al. 2017, Shin Yim et al. 
2017, Knuesel et al. 2014). Some of these behavioral effects are sex-dependent (Haida et 
al. 2019). MIA-induced behaviors were accompanied by changes in specific brain areas 
such as altered hippocampal volume and cortical thickness, and changes in synaptic 
density and proteins (Fernández de Cossío et al. 2017, Estes and McAllister 2016), which 
are also observed in SCZ (Glantz and Lewis 2000, Onwordi et al. 2020, Hui et al. 2018). 
Alterations in amygdala-cortical circuitry have been implicated in SCZ (Benes 2010) and 
a recent study showed that MIA enhances glutamatergic neurotransmission between these 
circuits by increasing synaptic strength in the exposed offspring (Li et al. 2018b). An 
exciting development in this field showed that MIA-induced deficits in 
neurodevelopment depend on inflammatory signaling through the maternal microbiome 
(Kim et al. 2017). MIA via LPS also disrupts BBB function by increasing its 
permeability, thus promoting neuroinflammation (Simões et al. 2018, Estes and 
McAllister 2014). However, there is also evidence for no change in BBB permeability 
after MIA induced via poly(I:C) in mice (Garay et al. 2013), suggesting immunogen-
dependent effects. These differences also emphasize the variability of MIA animal 
models and the need for experimental standardization.  
Given that microglia are the primary innate immune cells of the brain, they 
provide rapid responses to immune insults and are greatly affected by systemic 
inflammation. MIA exerts its effects on neurodevelopment largely by disrupting 
microglial function and by priming them for altered responses later in life. Changes in the 




subcortical regions including the anterior cingulate cortex, striatum and hippocampus 
(Zhang et al. 2018). Microglial involvement in MIA effects is evident through an increase 
in cytokine and chemokine signaling, in mouse hippocampus and basal forebrain, during 
late fetal development in response to either LPS (Schaafsma et al. 2017) or poly(I:C) 
(Pratt et al. 2013). A recent study showed that an MIA mouse model induced at 
embryonic day 9.5 with poly(I:C) led to an increased density of a pathological microglial 
subtype, called dark microglia, in the hippocampus of male versus female offspring (Hui 
et al. 2018). Dark microglia are almost exclusively observed in disease states or in aged 
animals, and exhibit greater levels of oxidative stress and hyper-ramified processes in 
closer proximity to synapses than typical microglia (Bisht et al. 2016). These studies 
highlight the ability of MIA to alter microglial state and function. 
Moreover, MIA in mice alters the transcriptome and phagocytic activity of 
microglia in offspring (Mattei et al. 2017). Specifically, hippocampal microglia from 
male poly(I:C) mice displayed a downregulation of genes that encode cell surface 
receptors associated with phagocytosis (P2ry6, Sirpa, Siglece, Cx3cr1, Fcgr1, Itgav) 
(Mattei et al. 2017). These receptors are important components of the microglial 
‘sensome’, which contribute to the regulation of microglia-neuron interactions and are 
important for the engulfment of neuronal material (Mattei et al. 2017). Inflammatory 
abnormalities, such as increased levels of Serpin Family A Member 3, TNFα, IL-1β, IL-
6, and IL-6ST, have been observed in the ventral midbrain in post-mortem SCZ tissue, 
and these results were also replicated in an MIA mouse model (Purves-Tyson et al. 




accounted for by a subset of cases, including about 45% of high inflammatory cases. The 
ventral midbrain houses the majority of dopamine-releasing neurons in the brain, 
therefore MIA might contribute to SCZ pathology by disrupting immune-mediated wiring 
of dopaminergic circuits (Purves-Tyson et al. 2019). These findings are important 
because they link SCZ-associated neuroinflammation to dopaminergic abnormalities, 
which is a hallmark of this disorder. 
Multiple studies targeting microglial signaling pathways were able to reverse 
MIA-associated neuropathology, suggesting that microglia are the main culprit in 
inducing neurological dysfunction in response to immune challenges. For example, a 
study that targeted colony stimulating factor 1 receptor (CSF-1R), which plays a role in 
microglial proliferation, was successful in reversing some MIA-induced phenotypes 
(Ikezu et al. 2020). Depleting and repopulating microglia by inhibiting CSF-1R was 
protective in mice exposed to poly(I:C) prenatally (Ikezu et al. 2020). Specifically, once 
the microglial population was renewed, not only were the deficits in repetitive and social 
behaviors reversed, but normal neuronal connectivity and microglia-neuron interactions 
were also restored (Ikezu et al. 2020). Another successful approach to restore typical 
microglial function targeted the peroxisome proliferator-activated receptor gamma 
(PPARγ) signaling pathway. PPARγ signaling is activated by fatty acids and reduces 
myeloid cell-induced inflammation via suppressing their production and/or secretion of 
inflammatory molecules (Bernardo and Minghetti 2006). Agonists of PPARγ have been 
found to be protective in the context of MIA by inhibiting microglial expression of pro-




that targeting microglial PPARγ signaling could be beneficial in offspring exposed to 
MIA (Zhao et al. 2019). In support of this, a recent study showed lower serum levels of 
PPARγ in patients with SCZ while levels of this biomarker decreased further with disease 
progression (Yüksel et al. 2019). Treatment with minocycline, a broad-spectrum anti-
inflammatory and antibiotic drug that generally restores microglial functions, also 
reversed changes in microglial transcriptome and phagocytic activity in mouse offspring 
exposed to MIA (Mattei et al. 2017). Lastly, there is evidence that deep brain stimulation 
in rats can prevent some of the behavioral deficits associated with MIA specifically by 
reducing microglial pro-inflammatory responses (Hadar et al. 2017). Taken together, 
these data suggest that microglia play a critical role in MIA-induced brain dysfunction 
and that targeting microglia is a potential therapeutic approach to reverse MIA-induced 
phenotypes.  
MIA is an important model that has increased our understanding of how immune 
insults occurring during embryonic development can alter brain development. Although 
there is variability in data obtained using mouse models of MIA, notably due to 
differences in immunogen manufacture (molecular weight, endotoxin contamination, 
etc.), timing of immunogen administration, dosage, route of administration, housing 
conditions, timing of cage cages and mouse strain used (Kowash et al. 2019, Careaga et 
al. 2018, Kentner et al. 2019), understanding what causes these differences could aid in 
understanding the mechanisms underlying vulnerability versus resiliency to MIA (Meyer 
2019). In humans, only a subset of pregnant mothers who are exposed to a viral or 




expected since immune activation is only one of the many risk factors for SCZ. 
Therefore, the variability in mouse models of MIA might be exploited to elucidate why 
certain sub-populations of individuals are at greater risk for SCZ.  Since some mouse 
strains are resilient to MIA, the genetic differences between mouse strains could be used 
to identify protective versus susceptibility genes (Schwartzer et al. 2013). Overall, future 
work aimed at understanding such variability will likely be valuable in discovering how 
only a subset of subjects is vulnerable to MIA.  
It is interesting that MIA is a risk factor for both SCZ and ASD, since some of the 
neurological deficits observed in these disorders appear to be opposing. For example, 
SCZ is characterized by a significant loss of gray matter resulting in hypoconnectivity 
between the anterior hippocampus and PFC (Vita et al. 2012, Blessing et al. 2019), on 
which the neonatal ventral hippocampal lesion rodent model of SCZ is based (Joseph, 
Bhardwaj and Srivastava 2018), whereas ASD is associated with hyperconnectivity 
(Supekar et al. 2013). How could the same risk factor play a role in such opposing 
phenotypes? We propose that the underlying genetic background and the time of 
exposure are important factors that determine the effects that MIA exerts on brain 
development. For example, SCZ is associated with genetic variation in the C4 gene that 
led to enhanced C4 expression (Sekar et al. 2016) whereas C4, C3 and C1q were found to 
be downregulated in ASD (Fagan et al. 2017). Differences in certain genes, such as 
complement genes, which have an established role in synaptic pruning (Schafer et al. 
2012, Sekar et al. 2016, Stevens et al. 2007, Comer et al. 2020), could explain how MIA 




TLR4, which directly respond to poly(I:C) and LPS (Zhou et al. 2013, Lu, Yeh and 
Ohashi 2008), respectively, could differ between mouse strains with varying 
susceptibility to MIA and in humans predisposed to different NDDs. Lastly, it is not clear 
how recently emerging viruses, such as the coronaviruses that cause “Severe Acute 
Respiratory Syndrome” and “Middle East Respiratory Syndrome”, might contribute to 
NDDs (Gretebeck and Subbarao 2015, Fauci, Lane and Redfield 2020). It is also 
unknown whether the severe acute respiratory syndrome coronavirus 2, which caused the 
COVID-19 pandemic, leads to lasting consequences on brain development and behavior 
while preliminary data suggest that passive transfer of antibodies from mother to embryo 
is possible (Zeng et al. 2020). 
 
1.4.6 Stress-induced inflammation  
Exposure to psychological stress or traumatic life events prenatally and during 
childhood or adolescence results in an increased risk for SCZ (Holtzman et al. 2013, 
Read, Bentall and Fosse 2009, Kessler et al. 2010, Weinstock 2008). Specifically, during 
critical periods of development, certain stressors, such as physical or mental abuse, 
socioeconomic disadvantage, living in an urban environment and neglect, all confer 
greater risk for SCZ (Popovic et al. 2019, Quidé et al. 2017, McGrath et al. 2004). 
Additionally, people with SCZ have altered physiological responses and increased 
vulnerability to stressful stimuli (Schifani et al. 2018). Thus, increased exposure and 




development, represents a significant challenge. However, cellular and molecular 
mechanisms that link early life stress (ELS) with increased risk for SCZ are still unclear. 
Nevertheless, evidence suggest that psychosocial stressors contribute to SCZ pathology 
by in part increasing neuroinflammation. 
Individuals with SCZ have altered physiological stress responses (van Leeuwen et 
al. 2018, Schifani et al. 2018, van Venrooij et al. 2012). Exposure to stress stimulates the 
sympathetic nervous system causing the secretion of epinephrine and norepinephrine, and 
increased HPA axis function which leads to the release of stress hormones, such as 
cortisol, into the blood (reviewed by (Chrousos 2009)). These stress hormones alter an 
organism’s physiology to promote activities that combat the stressor, such as increased 
cardiac function and glucose availability, while decreasing less urgent processes 
including digestion, reproduction, and immune function (Chrousos 2009). In healthy 
individuals, cortisol led to the suppression of adaptive immunity and an increase in innate 
immunity due to the effects of glucocorticoids on inflammation (Barnes 1998). Although 
cortisol has some anti-inflammatory effects, its ability to regulate inflammatory responses 
is altered in SCZ. In healthy individuals, an acute stressor led to increased salivary levels 
of cortisol and a decrease in IL-6; however, in individuals with SCZ, an increase in 
cortisol was shown to be accompanied by an increase in IL-6 (Chiappelli et al. 2016). 
Additionally, chronic and ELS, which are risk factors for SCZ, are linked to increased 
immune activation (Chiappelli et al. 2016), as well as abnormal sensitivity and levels of 
glucocorticoids and their receptors (do Prado et al. 2017, Webster et al. 2002, Sinclair et 




2010). In this sense, stress-induced release of cortisol might increase inflammatory 
responses in people with SCZ instead of having anti-inflammatory effects such as seen in 
healthy individuals.  
Although multiple studies have found an increase in HPA axis function in people 
with SCZ (Chiappelli et al. 2016, Mondelli et al. 2010a, Walder, Walker and Lewine 
2000), others have reported a decrease in cortisol levels compared to controls in response 
to a stressor (Glassman et al. 2018, Ciufolini et al. 2014, Lange et al. 2017). The 
inconsistencies between these findings could be due variation including differences in 
stressor intensity, duration, time point of exposure (Lange et al. 2017), or administration 
of antipsychotics, which have been shown to alter cortisol stress responses (Houtepen et 
al. 2015). Despite these discrepancies, HPA axis dysfunction has been observed in first-
episode psychosis prior to antipsychotic treatment (Mondelli et al. 2010a, Mondelli et al. 
2010b, Ryan et al. 2004). Additionally, recent work has shown that regardless of 
differences in cortisol responses to acute stressors among people with SCZ, those with 
decreased cortisol responses to social stress had lower measures of social functioning 
(Tas et al. 2018). Therefore, understanding differences in cortisol responses and its 
relationship to immune function in SCZ could provide insight into the role of 
psychosocial stress on disease progression.  
Prenatal psychological stress is associated with an increased risk of SCZ (Pugliese 
et al. 2019, Weinstock 2008, Kofman 2002). In mice, prenatal stress increased placental 
expression of several pro-inflammatory genes including IL-6, IL-1B, and TNFα 




administration of a nonsteroidal anti-inflammatory drug (Bronson and Bale 2014). 
Additionally, studies in mice have shown that male offspring exposed to prenatal stress 
displayed behavioral deficits including anhedonia and changes in stress responses that 
coincided with altered placental gene expression in males but not females, affecting 
PPARα, the growth factor IGFBP-1, hypoxia-inducible factor 3a (HIF3α), and glucose 
transporter GLUT4, all of which have been implicated in immune system function 
(Mueller and Bale 2008). Importantly, the placenta is a regulator of maternal-fetal 
immune initiation in offspring (reviewed in (Hsiao and Patterson 2012)) and this 
interaction appears to be crucial given that prenatal dysregulation of the immune system 
can lead to altered immune responses postnatally (Pedersen et al. 2018, Bilbo and 
Schwarz 2009). Maternal restraint stress resulted in offspring with altered microglial 
morphology and density in the cortical plate at embryonic stages and in neocortex at 
adulthood, and these prenatal-induced changes were reversed by blocking IL-6 
(Gumusoglu et al. 2017), confirming that increased maternal expression of IL-6 can cause 
neuroinflammation in embryos by crossing the placenta (Dahlgren et al. 2006). 
Nevertheless, the role of maternal stress-induced inflammation and the specific 
involvement of the placenta in mediating its consequences are not fully understood.  
 Early life stress (ELS), such as childhood abuse or neglect, is a major risk factor 
for SCZ, however the mechanisms by which ELS induces changes in neuronal circuitry is 
not clear. Mounting evidence suggests that dysfunction of the immune system and 
microglia, especially, can contribute to brain miswiring and behavioral deficits after ELS 




increases multiple blood pro-inflammatory markers including CRP, IL-1β, IL-6, IL-8, 
TNF-α (Hepgul et al. 2012, Marsland et al. 2017, Réus et al. 2017) while suppressing the 
anti-inflammatory cytokine IL-10, leading to depressive-like behaviors in mice (Réus et 
al. 2017). In line with these findings, ELS resulted in altered microglial gene expression, 
density, morphology and phagocytic activity during maturation in particular brain regions 
including the mPFC, striatum, anterior cingulate cortex and hippocampus (Banqueri et al. 
2019, Réus et al. 2019, Bollinger et al. 2017, Wang et al. 2017, Cohen et al. 2016, 
Delpech et al. 2016). Chronic stress also altered microglial function by activating the 
P2X7 receptor, which induced the NLRP3 inflammasome thus increasing levels of 
mature IL-1β within the brain (Pan et al. 2014, Yue et al. 2017). 
Since microglia play vital roles in brain development and homeostasis including 
neurogenesis, synaptic formation and elimination (Tay et al. 2017b, Salter and Beggs 
2014, Hong et al. 2016), their dysfunction could explain some of the neurological deficits 
observed after exposure to stress. Studies using RT-PCR from isolated microglia show 
that steroid hormone receptors, such as the glucocorticoid receptor, are abundant in 
microglia (Sierra et al. 2008), suggesting the possibility that stress could directly impact 
microglial function through glucocorticoid signaling. Indeed, a line of evidence suggests 
that stress can impact microglial proliferation, while blocking corticosterone synthesis or 
glucocorticoid receptor activity restored normal microglia density in mice (Nair and 
Bonneau 2006, Duque and Munhoz 2016). There is evidence that stress later in life can 
also induce changes in microglia, especially when these cells are primed by an 




2020). For instance, mice that were susceptible to repeated social defeat had microglial 
transcriptomes that were enriched for markers of phagocytosis, pro-inflammatory 
responses and reactive oxygen species compared to mice that were either resistant or not 
exposed to stress (Lehmann et al. 2018). Additionally, mice that were sensitive to 
repeated social defeat showed an increase in markers for extracellular matrix remodeling 
and BBB leakage, which coincided with an enhanced permeability of the BBB to a 
fluorescent tracer, and correlated with increased microglial phagocytosis of neuronal 
material (Lehmann et al. 2018, Stankiewicz et al. 2015). Additionally, microglial 
depletion by the CSF1R antagonist PLX5622 in a repeated social defeat mouse model 
protected against the behavioral abnormalities and prevented an increase in reactive 
oxygen species in the mPFC, nucleus accumbens and paraventricular nucleus (Lehmann 
et al. 2019). Together, these data support that microglia play a vital role in stress-induced 
neuropathology by becoming more phagocytic, inducing the inflammasome and 
engulfing neuronal material.  
Psychosocial stress might be more preventable than the other risk factors for SCZ. 
Reducing psychosocial stress in expecting mothers and young children or combating 
stress with exercise, nature exposure, yoga, or therapy could be used in individuals at risk 
for or diagnosed with SCZ (Vancampfort et al. 2011, Brannigan et al. 2019, Entringer et 
al. 2009). Some lines of evidence show that environmental enrichment can protect against 
or reverse many effects of stress, including ELS, by rescuing behavioral phenotypes, 
inflammatory responses, microglial function, and oxidative stress, notably in the mPFC 




2016), a region implicated in SCZ (Glantz and Lewis 2000, Barch et al. 2001). However, 
there is conflicting evidence concerning the ability of environmental enrichment to rescue 
these phenotypes in severe cases of ELS (Mackes et al. 2020). Alternatively, future 
studies could determine if treatment with anti-inflammatory medications can protect 
against stress-induced neuroinflammation since microglial depletion has been shown to 
be protective (Lehmann et al. 2019). 
 
1.4.7 How the peripheral immune system gains access to the CNS in schizophrenia 
The link between BBB dysfunction and SCZ was first established when 
epidemiological studies revealed that about two-thirds of SCZ cases are diagnosed with 
comorbid conditions associated with deficits in endothelial cell function, such as 
metabolic syndrome and cardiovascular disease (Burghardt, Grove and Ellingrod 2014, 
Israel et al. 2011). Capillary wall endothelial cells form tight junctions with one another 
and are an integral component of the BBB along with pericytes, astrocytic endfeet, 
microglia, and the extracellular matrix that forms the basement membrane (Abbott et al. 
2010, Lassmann et al. 1991, Joost et al. 2019, Bisht et al. 2016). The BBB restricts the 
passage of molecules between the blood and the brain to protect sensitive neural tissue 
from pathogens and immune molecules while allowing the passage of vital molecules 
such as glucose (Abbott et al. 2010). This allows the BBB to isolate the brain from 




pathological states the ability of the BBB to isolate the CNS from harmful immunological 
responses is disrupted (Najjar et al. 2017, Bechter et al. 2010).  
Claudin-5, expressed in brain endothelial cells, forms a major component of the 
BBB barrier-forming tight junctions (Greene, Hanley and Campbell 2019, Morita et al. 
1999). Claudin-5 maps to a region on chromosome 22 where small deletions cause the 
22q11 deletion syndrome, which is found in 30% of SCZ cases (Murphy 2002, Motahari 
et al. 2019). People with this syndrome are haploinsufficient for claudin-5 and have 
increased odds of developing SCZ (Fiksinski et al. 2018, Greene et al. 2018). A recent 
study showed that during acute versus chronic inflammation, levels of claudin-5 are 
differentially expressed (Haruwaka et al. 2019). It is still unknown if microglial 
phagocytosis of tight junctions is also involved in SCZ, although this finding suggests 
that BBB dysfunction could be mediated through a decrease of molecules involved in 
tight junctions or BBB permeability.  
Indeed, post-mortem mPFC tissue from SCZ individuals show changes in the 
endothelial cell gene expression of molecules involved in tight junctions and BBB 
permeability. People with SCZ can be divided into subgroups based on their extent of 
brain and serum inflammatory markers (Fillman et al. 2016). Cases of SCZ that have 
higher serum pro-inflammatory markers, which include about 40% of affected people 
(Fillman et al. 2016), also have greater gray matter loss in the mPFC, which is thought to 
underlie multiple symptoms of SCZ (Zhang et al. 2016). Compared to healthy controls, 
SCZ cases, especially high-inflammatory cases, have increased expression of the 




(Kavzoglu and Hariri 2013, Nguyen et al. 2018, Cai et al. 2018). ICAM-1 and VCAM-1 
interact with receptors on leucocytes to allow monocyte infiltration into the brain 
(Hermand et al. 2000). In endothelial cell cultures, ICAM-1 expression can be induced in 
a dose-dependent manner by the pro-inflammatory cytokine IL-1β (Cai et al. 2018). 
ICAM-1 expression has also been found to correlate with the expression of the 
macrophage marker CD163, and CD163-positive macrophages were found in close 
association with neurons in the frontal cortex of high-inflammatory SCZ cases (Cai et al. 
2018). In this study, proteins that form endothelial cell tight junctions, including 
cadherin-5 (CDH5) and occluding (OCLN), were also upregulated in the frontal cortex 
(Cai et al. 2018), which highlights a compensatory mechanism to regain BBB integrity. 
Conversely, multiple studies have a found a decreased expression of CDH5 in the PFC of 
SCZ individuals, while genetic knockdown of CDH5 in mouse PFC led to BBB 
disruption and changes in behavior including deficits in learning, memory, sensorimotor 
gating, and anxiety-like behavior (Greene et al. 2018, Nishiura et al. 2017). The 
expression of tight junction genes could differ depending on the time point during SCZ 
progression, such that compensatory mechanisms could be elicited in later disease stages. 
In addition, the conflicting evidence for a leaky BBB in SCZ suggest that the BBB is 
compromised in only a subset of SCZ cases. The finding of subgroups of people with 
SCZ showing variable levels of systemic inflammation support this hypothesis. Together, 
these findings reveal the importance of studying subgroups of SCZ patients, based on 





In addition to endothelial cells, pericytes and astrocytes have also been implicated 
in BBB dysfunction during systemic inflammation (Nishioku et al. 2009, Fabry et al. 
1993, Banks, Kovac and Morofuji 2018, Chen et al. 2017). There is some evidence that 
pericytes can exit the perivascular space in response to LPS-induced inflammation in 
mice, while the extent of pericyte detachment correlated with microglial reactivity 
(Nishioku et al. 2009). Pericytes secrete cytokines, including IL-1 and IL-6, which are 
capable of disrupting endothelial cell tight junctions (Fabry et al. 1993). Disruption of the 
BBB in several mouse models of neuropsychiatric or inflammatory diseases has been 
shown to affect microglial function, while dynamic neuroimmune interactions were 
described at the BBB in both health and diseased sates (Borjini et al. 2019, Merlini, 
Davalos and Akassoglou 2012, Haruwaka et al. 2019). Although causal evidence is 
needed, multiple studies have found that microglial reactivity worsens BBB integrity in 
pathological states and that administration of the anti-inflammatory drug minocycline can 
improve BBB function (Shigemoto-Mogami, Hoshikawa and Sato 2018, Yenari et al. 
2006, da Fonseca et al. 2014). More work is still needed to understand whether or how 
the interplay between BBB dysfunction and microglia abnormalities contribute to the 
pathogenesis of SCZ. Complex cytokine signaling between the pericytes, endothelial 
cells, astrocytes and microglia is crucial for the development and maintenance of BBB 
integrity (Banks et al. 2018, Chen et al. 2017). Lastly, it was suggested that PFC 
hypoconnectivity in SCZ might result from altered blood flow regulated by pericytes, 
together with abnormalities in the structures of capillaries and astrocytic end feet 




types of the neurovascular unit and how they might be altered in response to 
inflammation in SCZ will likely be important.  
Abnormal activity in multiple brain networks and regions are observed in SCZ 
(Uhlhaas 2013). There is clear evidence that excitatory circuits are altered in SCZ 
(Uhlhaas 2013, Glantz and Lewis 1997, Glantz and Lewis 2000). Blockade of N-methyl-
D-aspartate receptors (NMDARs) in healthy subjects leads to psychotic symptoms and 
cognitive deficits that resemble those observed in SCZ (Balu 2016). Additionally, both 
mRNA and protein levels of the NMDA subunits NR1 and NR2C are decreased in post-
mortem SCZ brain tissue (Weickert et al. 2013). Recent evidence suggests that NMDAR 
function might be inhibited in SCZ by autoantibodies, which are produced against an 
organism’s own tissue and are implicated in autoimmune disorders such as lupus (Becker 
et al. 2019). Circulating autoantibodies against glutamate and NMDARs were found to be 
present in approximately 20% of psychotic SCZ patients (Jézéquel et al. 2017). An 
increased BBB permeability might alter neuronal function by allowing the entry of 
autoantibodies against NMDARs into the brain, which have been shown in mouse models 
and neuronal culture experiments to suppress glutamatergic activity by altering the 
organization of NMDARs and their anchoring molecule ephrin-B2 (Jézéquel et al. 2017, 
Kannan et al. 2017, Kayser and Dalmau 2016). Studies that interrogate specific cell-type 
and neural circuit responses will allow greater understanding of the impact of BBB 





Beyond the BBB, peripheral inflammatory responses can gain access to the CNS 
via the meninges, the multi-layered protective tissue that surrounds the brain and spinal 
cord (reviewed in (Rustenhoven and Kipnis 2019). Cytokines can accumulate in the dural 
CSF and cross into the brain, passing between endothelial cells that lack tight junctions 
(Louveau et al. 2015). Additionally, cytokine signaling specifically within the meninges 
has been shown to alter neuronal function by binding directly with receptors on neurons 
in frontal cortical regions and altering cognitive and social behaviors in mice (Derecki et 
al. 2010, Filiano et al. 2016). Meningeal T-cell production of multiple inflammatory 
molecules, including IL-17, IL-4, and INF-γ, have been shown to alter both excitatory 
and inhibitory circuitry and modulate cognitive function and social behavior (Ribeiro et 
al. 2019, Derecki et al. 2010, Filiano et al. 2016). Lastly, the CNS meningeal lymphatic 
system also offers a route for peripheral-central immune crosstalk. Since the brain does 
not contain a resident lymphatic system, waste removal is facilitated by cerebrospinal 
fluid draining through the meninges into the deep cervical lymph nodes, where 
interactions between CNS immune molecules and peripheral immune cells can occur 
(Louveau et al. 2015, Louveau et al. 2018). In this manner, the peripheral immune system 
can gauge central immune status. In the aging brain, dysfunction of the meningeal 
lymphatic vessels leads to accumulation of harmful amyloid beta-protein toxicity and 
increase Alzheimer’s pathology (Da Mesquita et al. 2018). Longitudinal imaging studies 
have shown that progressive brain matter loss is consistent with accelerated aging in 
patients with SCZ (Schnack et al. 2016). It remains to be determined whether therapeutic 




vessels or cerebral spinal fluid drainage (Da Mesquita et al. 2018) could improve the 
cognitive and social deficits observed in SCZ. 
 
1.4.8 Future directions for understanding and targeting the immune system in 
schizophrenia 
There is growing evidence from both human and animal studies that many of the 
risk factors for SCZ converge on their ability to promote neuroinflammation, and that 
these effects are mediated in part by microglia. However, is there a pro-inflammatory 
phenotype in SCZ? Post-mortem and clinical studies show an increase in pro-
inflammatory markers in people with SCZ compared to controls (Sekar et al. 2016, 
Fillman et al. 2016, Boerrigter et al. 2017, Goldsmith and Rapaport 2020, Pedraz-
Petrozzi et al. 2020, Lesh et al. 2018). Moreover, there is evidence for elevated levels of 
cytokines in blood samples from people with SCZ, whether they are medication-naive or 
receiving antipsychotic treatment, during episodes of psychosis (Mondelli et al. 2020, 
McKernan et al. 2011, De Picker et al. 2019, Steiner et al. 2020). Thus, such studies 
suggest that inflammation might contribute to the development of SCZ and also drive its 
progression and cyclic nature.  
SCZ cases can be sub-divided using either serum or post-mortem brain tissue 
levels of pro-inflammatory cytokines, which reveal that about 40% of SCZ cases have a 
high inflammatory expression signature (Boerrigter et al. 2017, Fillman et al. 2016, Cai et 




provide information on their inflammatory states earlier in the disease development nor 
do they assay inflammation in the brain, which could differ from blood or CSF 
biomarkers of inflammation. There has been some success in longitudinal PET imaging 
studies that measure expression of translocator protein (TSPO), a non-specific marker of 
pro-inflammatory microglia, in the brain (Selvaraj et al. 2018). These studies show that 
SCZ is characterized by increased TSPO expression, which correlated with greater gray 
matter loss (Selvaraj et al. 2018). However, there have been mixed results concerning 
PET measurements of TSPO with some studies showing increased TSPO binding in SCZ 
(Doorduin et al. 2009, Bloomfield et al. 2016) and others showing no correlation (Di 
Biase et al. 2017, Notter et al. 2018). Additionally, recent work revealed that neuronal 
activity can also drive the expression of TSPO (Notter et al. 2020). It is thus not clear if 
TSPO is a reliable marker for neuroinflammation (Sneeboer et al. 2020). The 
identification of more specific in vivo markers for neuroinflammation would be useful. 
Ideally, additional work should be done to specifically interrogate the extent of 
neuroinflammation in SCZ, in addition to peripheral inflammation, to determine if 
increased inflammation correlates with all or only a percentage of SCZ cases.  
Given that SCZ is a highly heterogeneous disease, it is not surprising that there 
are different disease subtypes. Studies that have divided individuals with SCZ based on 
inflammatory markers have found more severe symptomology in those with higher levels 
of pro-inflammatory markers. Specifically, there is evidence for greater gray matter loss 
and poorer performance in language tasks (Fillman et al. 2016) and increased depressive 




Consistent with this, therapeutics that reduce inflammation provide the greatest symptom 
improvement in neuropsychiatric cases associated with high inflammation. For example, 
inhibition of TNF was shown to improve symptoms in people with major depression, but 
only in those with heightened immune biomarkers (Weinberger et al. 2015, Raison et al. 
2013). Additionally, various anti-inflammatory agents including aspirin, estrogen, N-
acetylcysteine, COX-2 inhibitors, minocycline and fatty acids (Sommer et al. 2014) have 
been shown to improve symptom severity in SCZ, but there are some mixed findings of 
the efficacy of these therapeutics. Minocycline has been shown to reduce microglia and 
complement-dependent synapse removal in an in vitro model from patient-derived 
neuronal cultures while decreasing the risk for SCZ when administered to young adults 
(Sellgren et al. 2019), suggesting that targeting synaptic pruning via neuroinflammation 
would be therapeutic for SCZ and might directly target the disease process. Nevertheless, 
it is possible that there are discrepancies concerning the ability of some of these drugs to 
improve symptoms in SCZ because they might only be effective in high-inflammatory 
cases. Future work aiming to elucidate the differences between subtypes of SCZ could 
potentially allow for the development of more effective and targeted therapeutics. 
Although people with SCZ can be divided based on extent of inflammation, there is no 
denying the role of the immune system in this complex disease. 
In line with this, microglia are significantly altered in SCZ and contribute to 
neural dysfunction by responding and contributing to neuroinflammatory signaling. In 
SCZ post-mortem tissue, microglia have been noted to have altered morphologies and 




engulfment of synaptic material is essential for the normal wiring of the brain and can 
contribute to pathological states when mis-regulated (Filipello et al. 2018, Vainchtein et 
al. 2018, Weinhard et al. 2018, Tremblay, Lowery and Majewska 2010, Wake et al. 2009, 
Paolicelli et al. 2011, Schafer et al. 2012, Comer et al. 2020, Dejanovic et al. 2018). 
There is also evidence that microglia contribute to synapse formation during 
development, adolescence and into adulthood (Akiyoshi et al. 2018, Weinhard et al. 
2018, Miyamoto et al. 2016, Parkhurst et al. 2013). Additionally, a two-photon in vivo 
imaging study in awake mice has shown that microglial contacts with synapses increase 
synaptic activity thus enhancing neuronal network synchronization (Akiyoshi et al. 
2018). In this study, when MIA was induced with poly(I:C), microglia became reactive 
while neuronal synchronization decreased (Akiyoshi et al. 2018), suggesting that 
microglia contribute to network function and that their role in this process can be easily 











Although there is evidence that microglia contribute to excessive synaptic pruning 
in SCZ, it is not clear if microglia-dependent synapse formation is also altered. Since 
much of the data collected from individuals with SCZ is from post-mortem samples, it is 
difficult to discern what is occurring on the synaptic level earlier in development. Recent 
studies suggest that more immature spine types can be differentially targeted in SCZ 
(Comer et al. 2020, MacDonald et al. 2017), therefore, it is possible that synapse 
formation mediated by microglia is also altered in SCZ. In a prenatal ventral 
hippocampus lesion model for SCZ, microglia displayed altered density, morphology and 
ultrastructure, together with increased expression of multiple complement genes 
including C1q and C3 (Hui et al. 2019). This increase in microglial expression of 
complement proteins coincided with an increase of synaptic pruning in the PFC and 
behavioral deficits in rats, but was reversed by administration of minocycline (Hui et al. 
2019). These studies highlight the necessary role exerted by microglia in normal brain 
Figure 1.3: Summary of the pathogenic mechanisms of schizophrenia covered in 
this chapter, which involve microglial alteration induced by neuroinflammation 
Risk factors for SCZ that enhance neuroinflammation include pollution, nutrition 
induced gut-brain axis dysbiosis, viral infection, maternal immune activation, genetic 
predisposition and cytokine secretion. The increase in neuroinflammation leads to 
changes in microglial function. In their homeostatic state, microglia perform their 
immune sentinel role by interacting with neurons to guide circuit wiring during 
development. In an increase inflammatory milieu, there is a loss of microglial 
homeostasis where microglia-neuron interactions are disturbed, causing altered 
plasticity, as well as synaptic formation, synaptic stripping, and pruning. In turn, 
therapeutic approaches that reduce neuroinflammation via anti-inflammatory drugs, 
microglial inhibition and repopulation, improved nutrition, environmental enrichment 
and/or prevention of psychological stress, which promote the return of microglia to their 
homeostatic roles, could be potentially exploited to limit SCZ-associated exacerbations. 
Note: Figure made by Ashley Comer as part of Comer et al., Frontiers in Cellular 





development but also show their ability to drive neuroinflammation and contribute to 
pathology in disease states.  
Indeed, there are multiple disease-associated microglial subtypes such as those 
seen in neurodegenerative disorders (Deczkowska et al. 2018) and dark microglia which 
were recently observed in SCZ post-mortem brain samples (Uranova et al. 2018). More 
work is needed to fully understand microglial subtypes that are more prevalent in disease 
states and how they contribute together to pathology, however data suggest they partially 
contribute to disease by enhancing synaptic pruning (Stratoulias et al. 2019). Future 
studies should also aim to develop more translational animal models so that in vivo 
studies can be performed to gain greater understanding into how microglia functionally 
impact synaptic development and circuit function in pathological states. 
Although there is no doubt that the immune system plays a critical role in shaping 
brain development and contributes to disease states when dysregulated, there is a need to 
understand which specific circuits and neuromodulatory systems in particular are most 
impacted by abnormal immune signaling. It is clear that complement proteins facilitate 
the removal of synapses (Stevens et al. 2007) and that the upregulation of complement 
proteins contributes to circuit miswiring (Comer et al. 2020). However, SCZ is also 
characterized by alterations in inhibitory circuits (Dienel and Lewis 2019), 
neuromodulatory systems such as dopamine (Howes et al. 2017) and glutamate (Uno and 
Coyle 2019), and changes in the connectivity between brain regions such as the 
hippocampus and PFC (Sigurdsson and Duvarci 2015). Do inflammatory responses alter 




 There is evidence that inflammatory responses target specific neuromodulatory 
systems and brain circuits. For example, changes to the gut microbiome driven by 
inflammation can alter the production of serotonin (Rogers et al. 2016), which is known 
to be disrupted in SCZ. Interestingly, MIA in rats has been found to increase the levels of 
dopamine in both the nucleus accumbens and mPFC (Luchicchi et al. 2016) of offspring, 
which is well-known to play a role in the positive symptoms of SCZ (Kesby et al. 2018). 
Additionally, MIA initially triggers hyperinhibition and neuronal miswiring, before 
leading to a reduced inhibitory drive (Thion et al. 2019). ELS in mice was shown to alter 
HPA circuity development, in addition to hippocampal and PFC function (Brenhouse, 
Danese and Grassi-Oliveira 2019). In addition, ELS is known to have an impact on 
inhibitory connectivity (Ohta et al. 2020, Goodwill et al. 2018), and previous work 
suggests that oxidative stress and/or neuroinflammation might underlie the changes in 
parvalbumin interneurons in response to ELS (Brenhouse et al. 2019, Holland et al. 
2014). There is evidence for parvalbumin interneuron dysfunction in SCZ, as they have 
altered density in the frontal cortex of individuals with SCZ (Kaar et al. 2019). 
Interestingly, the meninges modulate cortical interneuron migration during development 
(Borrell and Marín 2006); future work could interrogate whether changes in meningeal 
signaling, such as immune molecule signaling, could contribute to alterations in 
interneuron migration in SCZ. Although these studies suggest that risk factors for SCZ 
can exert specific effects on different CNS circuits, more work is needed to fully 
understand the mechanisms by which inflammation alters specific neuromodulatory 




whole-brain or mesoscopic imaging could shed light into how specific neuronal networks 
are impaired in SCZ (Grandjean et al. 2020, Boido et al. 2019, Sofroniew et al. 2016).  
It is well-established that spine dysfunction is present in SCZ and is at least 
partially mediated by reductions in excitatory synaptic connectivity and plasticity 
(Berdenis van Berlekom et al. 2020, Glantz and Lewis 2000, Glausier and Lewis 2013). 
However, most of the work in this field has relied on human post-mortem tissue, so there 
is limited knowledge of what could be occurring earlier in development to drive these 
synaptic alterations. Recent work has highlighted the fact that the immune system works 
closely with the CNS to establish and refine neural circuits in healthy states as a part of 
normal development (Tay et al. 2017b, Hammond et al. 2018, Paolicelli et al. 2011). 
However, when this process is dysregulated, it can lead to pathology and the miswiring of 
the brain through synaptic loss (Schafer et al. 2012, Comer et al. 2020), which occurs in 
SCZ.  
How are certain synapses selectively removed while others are protected? In the 
developing brain, there is a period of intense synaptogenesis followed by critical 
developmental periods characterized by experience-dependent refinement of synapses 
(Trachtenberg et al. 2002, Holtmaat and Svoboda 2009). Synaptic elimination driven by 
sensory experience refines brain circuitry by optimizing connections between neurons. In 
SCZ, this process is thought to be dysregulated, thus leading to a loss of both excessive 
and necessary synapses, causing aberrant brain connectivity. Recent data suggest that 
more immature spine types, such as filopodia and thin spines (Cruz-Martín, Crespo and 




SCZ (MacDonald et al. 2017). A similar phenotype was seen in mice overexpressing the 
mouse homologue of the SCZ-associated gene C4. In this in vivo model, synaptic loss 
observed in the PFC was specifically due to a loss of smaller spine-types while 
mushrooms spines were unaffected (Comer et al. 2020). This evidence is in line with 
previous work showing that complement-dependent synapse removal is activity-
dependent and that connections with less activity are more likely to be eliminated 
(Schafer et al. 2012). Small spines were also shown to be preferentially contacted and 
eliminated upon microglial contact in vivo (Tremblay et al. 2010). Additionally, it has 
been suggested that immune signaling is able to protect more mature spines. There is 
increased expression of the “don’t eat me” signal CD47 at synaptic inputs that are more 
active (Lehrman et al. 2018). In this way, the immune system would guide synaptic 
wiring by tagging synapses for removal while protecting other connections that are 
essential to the function of a circuit. However, more work is needed to support this idea 
and understand the mechanisms by which the immune system contributes to synapse-
specific elimination versus stabilization.  
It is also possible that in SCZ, spine loss is driven by the inability of circuits to 
produce “appropriate” connections. Therefore, the subsequent excessive pruning that 
occurs in SCZ could be due to the fact that neurons fail to produce adequate connections 
in the first place. This is relevant in the context of microglia since they regulate 
synaptogenesis (Miyamoto et al. 2016). Since most of the data obtained from people with 
SCZ is limited to post-mortem tissue, our information about what is happening on the 




models to understand the role of microglia and immune signaling in synapse formation 
during the first weeks of postnatal development, when most synaptogenesis occurs (Cruz-
Martín, Crespo and Portera-Cailliau 2010), is key. Future advances in the resolution and 
capabilities of in vivo human imaging studies notably through specific markers could 
help answer this question. It is encouraging that previous studies show a similar 
phenotype in mice that is seen in humans in terms of weaker synapses preferentially 
being eliminated (MacDonald et al. 2017, Comer et al. 2020). This could allow for 
studies in mice that more readily translate to humans. Understanding the mechanisms of 
complement-mediated circuit wiring is a worthwhile area of future study given it is both a 
mechanism of normal brain development and is implicated in multiple 
neurodevelopmental and neurodegenerative diseases. Lastly, enthusiasm has grown over 
the last decade to study marmosets in neuroscience research and an increase in the 
feasibility of genetic manipulations could provide a more relevant model to study how 
abnormal neuroimmune signaling contributes to SCZ (Okano et al. 2016, Servick 2018). 
Here, I have highlighted the diverse risk factors for SCZ and how they impact the 
CNS by altering immune signaling. Likely, these risk factors act additively on certain 
signaling pathways to push vulnerable individuals past a certain threshold into a disease 
state. This field would benefit from future studies that aim to elucidate how the immune 
system regulates specific circuits and neuromodulatory systems to drive the diverse 
phenotypes observed in SCZ. Additionally, an in-depth understanding of the specific 




driven neurodevelopment after exposure to the various genetic and environmental risk 
factors described in this section. 
 
1.5 Linking complement proteins to aberrant circuit development in schizophrenia 
 
Despite significant progress in this field, it is still not clear how reciprocal 
interactions between neurons and microglia contribute to the maturation and 
refinement of developing cortical circuits (Tremblay et al. 2010, Hoshiko et al. 2012, 
Miyamoto et al. 2016). Mouse studies investigating the role of C4 and other 
complement proteins in synaptic refinement have relied on loss-of-function 
manipulations (Sekar et al. 2016, Stevens et al. 2007, Schafer et al. 2012, Martinelli 
et al 2016), whereas SCZ is linked to increased C4 expression (Sekar et al. 2016). 
Additionally, previous studies have focused on the role of complement proteins in 
the visual system (Sekar et al. 2016, Stevens et al. 2007, Schafer et al. 2012) rather 
than interrogating their role in more SCZ-relevant brain regions, such as the PFC. 
Thus, overall, it is not known how increased C4 expression impacts the development 
of cortical microcircuits, which are commonly altered in neurodevelopmental 
disorders (Meredith 2015, Del Pino et al. 2018). 
 Herein, the role of the immune system in the pathophysiology of SCZ is 
deatailed, describing how environmental and genetic risk factors converge to cause 
uncontrolled neuroinflammation in this neurodevelopmental disease. To 




development, I investigated the effects of C4 overexpression on developing networks 
in layer (L) 2/3 of the mouse medial prefrontal cortex (mPFC), a cortical region 
where gray-matter loss is most prominent in SCZ (Glantz & Lewis 2000, Thompson 
et al. 2001). I show that C4 overexpression induced transient structural and 
functional changes to L2/3 excitatory neurons in the mPFC. Additionally, I 
interrogated the role of microglia in complement-induced wiring deficits in the 
mPFC by measuring microglia engulfment of synaptic material. The relationship 
between C4-induced PFC circuit dysfunction and abnormalities in rodent social 
behavior was examined. Lastly, a technical pipeline is described to enable the study 
of novel disease-associated genes in rodents without the reliance on genetic animal 
lines, which can be costly and time-consuming to create.  Taken together, these 
results link C4 overexpression to neural and behavioral deficits relevant to SCZ and 
identify a critical window in which the trajectory of brain development might be able 













Materials and methods 
 
2.1 Ethics statement 
All experimental protocols were conducted according to the National Institutes of 
Health (NIH) guidelines for animal research and were approved by the Boston University 
Institutional Animal Care and Use Committee (IACUC; protocol #17–031). 
 
2.2 Animals 
All mice were group housed on a 12-hr light and dark cycle with the lights on at 7 
AM and off at 7 PM and with food and water ad libitum. Offspring were housed with 
dams until weaning at postnatal day 21 (P21). For spine density and morphology, 
microglia engulfment, electrophysiology, and behavior experiments, wild-type CD-1 
mice of both sexes from age 7 to 70 d were used (CD-1 IGS; Charles River; strain code: 
022). For in situ hybridization, C4b knockout (KO) mice in a C57BL/6 genetic 
background (The Jackson Laboratory, stock number: 003643) and wild-type C57BL/6 
mice of both sexes at age P30 were used (Charles River; strain code: 027). Males and 
females were used for all experiments, and no differences were found between sexes. 
 




For control conditions, we used a plasmid containing EGFP under the CAG 
promoter (pCAG-EGFP, Addgene plasmid #11150) (Matsuda & Cepko 2004). DNA 
sequences containing mC4b (NM_009780.2, synthesized by Genescript) and hC4A 
(RC235329, Origene) were subcloned (InFusion Kit, Clonetech) into the pCAG backbone 
to produce pCAG-mC4 and pCAG-hC4A, respectively (See Table 2.2 for primers used to 
subclone). Endogenous PSD-95 was fluorescently labeled in vivo using PSD95-FingR 
(EF1a-PSD95.FingR-RFP) which tags endogenous PSD-95 protein using a Fibronectin 
scaffold with mRNA display which acts as an antibody-like protein to tag a specified 
target (Gross et al. 2013). For electroporations with RFP and fusion C4-GFP, pCAG-
mRFP was obtained from Addgene (Addgene plasmid #28311) (Manent et al. 2009), and 
C4-GFP was made by inserting GFP from the pCAG-GFP plasmid C terminus to C4 
using a GSSGSS linker (subcloned by Genescript). All plasmid DNA was purified using 
the ZymoPureII (Zymo Research) plasmid preparation kit and were resuspended in 
molecular biology grade water. 
 
2.4 Antibodies and histology 
Mice were administered a lethal dose of sodium pentobarbital (250 mg/kg; IP) 
before being transcardially perfused with PBS and then 4% paraformaldehyde (PFA) 
solution. After brains were dissected and postfixed for 24 hr in 4% PFA solution, they 
were transferred to a 30% (w/v) sucrose solution and stored at 4°C. Coronal sections 




each experiment (see specific methods). For immunostaining, tissue was blocked and 
permeabilized in 10% donkey serum with 0.25% TritonX100. Sections were incubated 
with primary antibodies (see antibody table for dilutions) overnight at 4°C on a shaker 
and with secondary antibodies for 2 hr at room temperature. After incubation periods and 
between each step, sections were rinsed three times with PBS for 10 min. Depending on 
the experiment, the following primary antibodies were used: guinea pig anti-Iba1 
(Synaptic Systems, 234004), rat anti-CD68 (Bio-Rad, MCA1957GA), rabbit anti-RFP 
(Rockland, 600-401-379), mouse anti-PSD95 (BioLegend, clone K28/43), guinea pig 
anti-Synaptophysin 1 (Synaptic Systems), rabbit anti-C4 (Biogen, 931–946), and Beta-
Actin HRP-conjugate (Sigma, clone AC-15). The following secondary antibodies (see 
antibody table) were used: donkey anti–guinea pig Alexa Fluor 594 (Jackson 
Laboratories, 706-545-148), donkey anti–guinea pig Alexa Fluor 488 (Jackson 
Laboratories, 706-585-148), donkey anti-rabbit Alexa Fluor 647 (Jackson Laboratories, 
711-605-152), llama anti–guinea pig Atto 647 (Progen: 80308), donkey anti-rat 488 
(Invitrogen: A21208), donkey anti-rabbit 594 (Jackson Laboratories, 711-585-152), and 
donkey anti–guinea pig 647 (Jackson Laboratories, 711-605-152). Brain sections were 
subsequently mounted onto microscope slides (Globe Scientific) using Fluoromount-G 
mounting medium with DAPI (Thermo Fisher Scientific). 
Table 2.1: Antibody table 
Antibody Supplier Dilution 
guinea pig anti-Iba1 Synaptic Systems: 234-004 1:500 
rat anti-CD68 Bio-Rad: MCA1957GA 1:500 
rabbit anti-RFP Rockland: 600-401-379 1:1000 
mouse anti-PSD95 BioLegend: K28/43 1:1000 






Synaptic Systems: 101-004 1:500-1:1000 
Beta-Actin HRP-conjugate Sigma: AC-15 1:1000 
donkey anti–guinea pig 
Alexa Fluor 594 
 
Jackson Laboratories: 706-545-148 1:1000 
donkey anti–guinea pig 
Alexa Fluor 488 
Jackson Laboratories: 706-585-148 1:1000 
donkey anti-rabbit Alexa 
Fluor 647 
Jackson Laboratories: 711-605-152 1:1000 
llama anti–guinea pig Atto 
647 
Progen: 80308 1:1000 
donkey anti-rat 488 Invitrogen: A21208 1:1000 
donkey anti-rabbit 594 Jackson Laboratories: 711-585-152 1:1000 
donkey anti–guinea pig 
647 
Jackson Laboratories: 711-605-152 1:1000 
 
2.5 In utero electroporation 
L2/3 progenitor cells in the mPFC were transfected via in utero electroporation 
(IUE) (Szczurkowska et al. 2016). pCAG-EGFP was electroporated in the control 
condition, and pCAG-EGFP plasmid was co-electroporated with either pCAG-mC4 or 
pCAG-hC4A plasmids for the mC4 or hC4 groups, respectively. Prior to surgery, all tools 
were sterilized by autoclaving. Aseptic techniques were maintained throughout the 
procedure, and a sterile field was prepared prior to surgery using sterile cloth drapes. 
Animals were weighed, and a combination of buprenorphine (3.25 mg/kg; SC) and 
meloxicam (1–5 mg/kg; SC) was administered as a preoperative analgesic. Timed-
pregnant female CD-1 mice at E16 were anesthetized by inhalation of 4% isoflurane and 
maintained with 1%–1.5% isoflurane via mask inhalation. The abdomen was sterilized 




incision was made in the skin and then in the abdominal wall. The uterine horn was then 
exposed to allow injection of 0.5–1.0 μl of DNA solution (containing 1 μg/μl plasmid and 
0.1% Fast Green) into the lateral ventricles using a pressure-injector (Picospritzer III, 
Parker Hannifin) with pulled-glass pipettes (Sutter Instrument, BF150-117-10). To target 
L2/3 progenitor cells in PFC for imaging and electrophysiological experiments, a custom-
built triple electrode probe (Szczurkowska et al. 2016) was placed by the head of the 
embryo, with the negative electrodes placed near the lateral ventricles and the positive 
electrode placed just rostral of the developing PFC. For bilateral IUEs used in behavioral 
experiments, plasmid DNA (1 μg/μL) was injected into both lateral ventricles by 
positioning the glass pipette at a 90° angle relative to the midline of the embryo’s head 
and injecting 2–4 μl of DNA solution. These modifications ensured that the DNA 
solution would travel to the lateral ventricle contralateral to the injection site. Next, four 
square pulses (pulse duration: 50 ms, pulse amplitude: 36 V, interpulse interval: 500 ms) 
were delivered to the head of the embryo using a custom-built electroporator (Bullmann 
et al. 2015). Embryos were regularly moistened with warmed sterile PBS during the 
surgical procedure. After electroporation, the embryos and uterine horn were gently 
placed back in the dam's abdominal cavity and the muscle and skin were sutured (using 
absorbable and nonabsorbable sutures, respectively). Finally, the dams were allowed to 






Fluorescence images were collected using an inverted laser scanning confocal 
microscope (Nikon Instruments, Nikon Eclipse Ti with C2Si+ confocal) controlled by 
NisElements (Nikon Instruments, 4.51) including four laser lines (405, 488, 561, and 640 
nm). For M-FISH and microglia experiments, confocal images were taken with a 60X 
Plan Apo objective (Nikon Instruments; Plan Apo, NA 1.4, WD: 0.14 mm, oil objective) 
using 1,024 × 1,024 pixel scans (pixel size = 0.27 × 0.27 μm). For dendritic spine 
imaging, images from P7–9, P14–16, P21–23, and P55–60 brain tissue were taken using 
a 40X Plan Apo λs objective (Nikon Instruments; Plan Apo, NA 1.3, WD: 0.2 mm, water 
objective) using 1,024 × 1,024 pixel scans (pixel resolution = 0.12). We imaged apical 
dendritic tufts in L1 and basal dendrites in L2/3. For dendritic spine imaging and 
neuronal reconstructions, we collected ROIs that consisted of stacks of images 
(approximately 20–40 optical sections, z-step = 0.3 μm and 1 μm, respectively). The area 
and diameter of neurons were analyzed in 40X images from the brightest z-plane of the 
soma. Brain sections from behavior mice were imaged using an upright wide-field 
microscope (Nikon Instruments, Nikon Eclipse Ni) controlled by NisElements (Nikon 
Instruments, 4.20) using a 10X objective (NA: 0.3, WD: 16 mm). DAPI and GFP-
transfected cells in behavior brains were imaged using fluorescence filters for BFP 
(excitation: 370–401, dichroic: 420) and GFP HC (excitation: 470/40, dichroic: 495). 
Images in all conditions were collected using the same imaging conditions and exposure 
settings. Imaged stacks were imported in TIFF format into ImageJ (NIH). For confocal 




prelimbic, infralimbic, and medial orbital divisions of the mPFC. For behavior brain 
analysis, all GFP-positive cells were counted to quantify the extent of electroporation. 
 
2.7 Multiples fluorescence in situ hybridization 
For M-FISH experiments, P21 and P30 brains were collected and immediately fresh-
frozen on dry ice in O.C.T. compound (Fisher HealthCare, 23-730-571). Tissue was cut 
on a cryostat (Leica CM 1800) at 15-μm thickness, and M-FISH experiments were 
completed by using a commercial assay (RNAscope, Advanced Cell Diagnostics). In situ 
fluorescent probes were used to detect mC4 (#445161-C1), EGFP (#400281-C2), and 
CaMKIIα (#445231-C3). M-FISH assay and all reagents were obtained from Advanced 
Cell Diagnostics. All M-FISH experiments had N = 3 mice per condition. For in situ 
analysis, we quantified fluorescent signal from L2/3 CaMKIIα+ cell bodies of transfected 
GFP+ cells and their untransfected neighbors in mC4 conditions from single z-planes of 
60X confocal images. This approach allowed us to control for variability of transcript 
expression between mice. We use the DAPI signal to identify the cell’s nucleus, and all 
quantification of in situ signals was performed in the soma’s brightest focal plane. 
CaMKIIα signal was used to delineate the perimeter of the cell body of L2/3 excitatory 
neurons in the mPFC and this ROI was used for analysis. Transfected cells were 
identified by presence of GFP mRNA, and nontransfected cells were GFP (−). Next, 
fluorescent signals from GFP and C4 transcripts were thresholded and binarized. The 




or C4 mRNA. We used the same binarization threshold and analysis procedure for both 
conditions. 
 
2.8 Quantitative polymerase chain reaction 
Animals at P21 or P60 were anesthetized with 4% isoflurane/oxygen (v/v). Brains were 
rapidly extracted following transcardiac perfusion using NMDG slicing solution: 92 mM 
NMDG, 2.5 mM KCl, 1.25 mM NaH2PO4, 30 mM NaHCO3, 20 mM HEPES, 25 mM 
glucose, 2 mM thiourea, 5 mM Na-ascorbate, 3 mM Na-pyruvate, 0.5 mM CaCl2·2H2O, 
and 10 mM MgSO4·7H2O. Sections (200 μm) were cut on a vibratome (LEICA VT1000 
S) and kept in the NMDG slicing solution bubbled with 95% O2/5% CO2 (295–305 
mOsm). The sections were trimmed under a wide-field microscope to isolate the 
transfected region (containing GFP+ cells) of the tissue. Each trimmed piece was flash 
frozen in dry ice. RNA was extracted from these tissue using Zymo Microprep kit 
(R1050), and cDNA was synthesized with Azuraquant cDNA synthesis kit (AZ-1997). 
RNA and cDNA were quantified using a Thermo Fisher Scientific NanoDrop One 
Spectrophotometer. Primer sets for qPCR were designed using NCBI primer blast (NIH) 
and were synthesized by Integrated DNA Technologies. Primer sets (Table 3.1) were 
verified to produce a single product following PCR amplification using Apex Taq RED 
Master Mix, 2.0X (Genesee Scientific 42–138) on a Bio-Rad T100 thermocycler. qPCR 
was carried out on an Applied Biosystems ABI 7900 Real Time PCR machine using 




to three biologically diverse internal reference genes (GAPDH, beta-Actin, and HPRT). 
These references were amplified in parallel with the target genes of interest and all 
samples were performed in triplicates. Dissociation curves were verified for every 
reaction, and only dissociation curves yielding single products were used in subsequent 
analysis. 
Table 2.2: Primers used in cloning and PCR experiments 
Gene Primer Sequence Purpose 
GAPDH Forward  5'-CCACCCAGAAGACTGTGGAT-3' Internal Control 
qPCR 
 Reverse 5'-CACATTGGGGGTAGGAACAC-3'  
Beta 
Actin 
Forward  5'-CCTTCC TCTTGGGTATGGA-3' Internal Control 
qPCR 
 Reverse 5'-TGCTAGGAGCCAGAGCAGTA-3'  
HPRT Forward  5'-GGCCAGACTTTGTTGGATTT-3' Internal Control 
qPCR 
 Reverse 5'-CAGATTCAACTTGCGCTCAT-3'  




hC4  Forward  5’-
CCCGGGATCCACCGGTGATCCGGTA
CCGAG GAGATCTG-3’ 







mC4  Forward  5’-
CGGGCCCGGGATCCACAGCCATGCG
GCTCCT CTG-3 








2.9 Cell culture 
HEK293T cells were maintained in complete media: DMEM (HyClone) 




(100 μg/ml). Cells were maintained at 37°C and 5% CO2 in a Thermo Scientific 
HERAcell 150i incubator. Either pCAG-GFP, pCAG-mC4, pCAG-hC4, or pCAG-mC4-
GFP (5 μg each) was transfected into HEK293T cells (approximately 70%–80% 
confluent) grown in 10-cm culture dishes using 2.5 μL of GeneGlide (BioVision, Cat#: 
M1081) using serum-free media. After 4–6 hr, the transfection media was removed and 
replaced with complete media. Forty-eight hours after transfection, cells were imaged 
live in phenol red–free DMEM at room temperature using an Olympus BX51WI upright 
microscope with a 10X UPlanFL N (NA = 0.30) objective. 
 
2.10 Isolation of post-synaptic densities 
 Post-synaptic density (PSD) fractions were isolated as described (Dejanovic et al. 
2018, Wu et al. 2019) with minor modifications. Briefly, the electroporated region of the 
PFC was dissected and snap frozen and kept at −80°C until further processing. Pieces of 
brain tissue were homogenized using a Teflon homogenizer. After 1,400g, 10-min 
centrifugation, the supernatant was transferred to a new tube and the pellet was 
rehomogenized and pelleted at 1,400g, 10 min. Supernatants were combined and 
centrifugated at 13,800g, 10 min. The pellet was resuspended in 0.32 M Tris-buffered 
sucrose and ultracentrifuged into 1.2, 1.0, 0.85 M sucrose gradient at 82,500g for 2 hr. 
The synaptosome fraction was collected, solubilized with 0.5% Triton X-100, and then 
centrifuged at 32,800g for 20 min to yield the PSD fraction. Samples from individual 






 Immunoblotting was performed as previously described (Dejanovic et al. 2018) 
with minor modifications. Briefly, transfected HEK293 cells were directly lysed in the 
dish with 0.5% SDS in PBS, supplemented with complete protease inhibitor cocktail 
(Roche) and Benzonase Nuclease (Sigma). All protein samples were boiled in reducing 
SDS loading buffer and separated on Bolt Bis-Tris Plus gels (Thermo Fisher). After 
transfer to nitrocellulose membranes (Thermo Fisher), membranes were incubated with 
the following primary antibodies overnight: mouse anti-PSD-95 (clone K28/43, 
BioLegend), guinea pig anti-Synaptophysin 1 (Synaptic Systems), rabbit anti-C4 (in 
house, Biogen 931–946), Beta-Actin HRP-conjugate (clone AC-15, Sigma). HRP-
conjugated secondary antibodies were from GE Healthcare. Immunoreactivity was 
detected on ChemiDoc XRS+ (Bio-Rad) and analyzed with Image Lab software. mC4 
levels were quantified by normalizing to the loading control, vinculin. 
 
2.12 Dendritic spine analysis 
 For the dendritic spine developmental time-course experiments in control, mC4, 
and hC4 conditions, we analyzed dendritic spines at multiple postnatal days (P7–9, P14–
16, P21–23, P55–60). For all groups, we analyzed 20 dendrites from 7 mice (from 
multiple litters). Confocal image z-stacks (40X) were background subtracted and median 




visually inspecting the entire z-stack of images. Dendrites were selected if the entire 
length to be analyzed was constricted within about 15 μm in the z-plane; this typically 
included from the tip of the branch to the bifurcation (for apical tufts). Brightest dendrites 
were selected from each image to ensure that dim protrusions, such as filopodia, were 
reliably identified. To reliably identify spines of a given dendrite, we analyzed GFP+ 
dendrites that were not occluded by other nearby cell processes. Dendrite selection and 
all following spine analysis were conducted blindly. For a dendritic protrusion to be 
counted, it had to clearly protrude out of the shaft by at least 3 pixels (approximately 0.36 
μm). Dendritic protrusions were quantified from either apical dendritic tufts in L1 or 
secondary/tertiary basal dendrites in L2/3. Spine density was calculated by dividing the 
number of counted spines by the total dendritic length analyzed (50–80 μm long shafts). 
Since GFP brightness is monotonically related to the volume in each protrusion 
(Holtmaat et al. 2005), we quantified the fluorescent intensity (TIB [a.u.]) of dendritic 
spines in apical tufts. To obtain a TIB value, the mean gray value of the dendritic spine 
was measured at the brightest focal plane and was divided by the mean fluorescence 
intensity of the adjacent dendritic shaft to normalize for varying imaging conditions. We 
sorted dendritic spine types into large mushroom/stubby (TIB > 75%), medium-size 
spines (25% ≤ TIB ≤ 75%), and thin-spine/filopodia (TIB < 25%) intensity groups based 
on percentile cutoffs determined from TIB distribution values of dendritic spines. We 
previously showed that this is a reliable, unbiased approach for classifying dendritic spine 





2.13 Electrophysiological recordings and analysis 
 Mice (P18–25) were anesthetized with 4% isoflurane-oxygen mixture (v/v) and 
perfused intracardially with ice-cold external solution containing the following: 73 mM 
sucrose, 83 mM NaCl, 26.2 mM NaHCO3, 1 mM NaH2PO4, 22 mM glucose, 2.5 mM 
KCl, 3.3 mM MgSO4, 0.5 mM CaCl2 and were bubbled with 95% O2/5% CO2 (295–305 
mOsm). Coronal slices (300-μm thickness) were cut on a VS1200 vibratome (Leica) in 
ice-cold external solution before being transferred to ACSF containing the following: 119 
mM NaCl, 26 mM NaHCO3, 1.3 mM NaH2PO4, 20 mM glucose, 2.5 mM KCl, 2.5 mM 
CaCl2, 1.3 mM MgCl2, bubbled with 95% O2/5% CO2 (295–305 mOsm). Slices were 
kept at 35°C for 30 min before being allowed to recover for 30 min at room temperature. 
All recordings were performed at 30–32°C. We only recorded from transfected neurons 
in the anterior cingulate cortex and prelimbic, infralimbic, and medial orbital divisions of 
the mPFC. Signals were recorded with a 5X gain, low-pass filtered at 6 kHz, and 
digitized at 10 kHz using a patch-clamp amplifier (Multiclamp 700B, Molecular 
Devices). 
Whole-cell voltage-clamp recordings were made using 3–5 MΩ pipettes filled 
with an internal solution that contained 125 mM Cs-gluconate, 3 mM NaCl, 8 mM CsCl, 
4 mM EGTA, 4 mM MgATP, 0.3 mM NaGTP, and 10 mM HEPES (pH 7.3) with CsOH 
(280–290 mOsm). Series resistance (Rs) and input resistance (Rin) were monitored 
throughout the experiment by measuring the capacitive transient and steady-state 
deflection in response to a −5 mV test pulse, respectively. For mEPSC recordings, cells 




(Tocris). For mIPSC recordings, cells were voltage clamped at Erev Glu (+5 mV) in the 
presence of 1 μM Tetrodotoxin (Tocris). For all groups, we analyzed 10–12 cells from 4 
mice (from multiple litters). mPSCs were detected by fitting to mPSC amplitude template 
using pClamp10 analysis software (Molecular Devices). The peak current of each mPSC 
was calculated. Next, average mPSC amplitude and IEI was calculated for each cell and 
then averaged across each condition to determine the population mean and SEM. Bath 
application of 100 μM GABAA inhibitor picrotoxin at Erev Glu and 20 mM CNQX and 
50 mM DL-AP5 at Erev GABAA eliminated mPSCs, thus confirming the identity of the 
recorded currents. Cells were excluded if Rs varied by more than 20% during a recording. 
For all recordings, series resistance was close to 10 MΩ (control, 9.39 ± 0.53 MΩ, n = 
12; mC4, 9.74 ± 0.44 MΩ, n = 10; p > 0.05) and was not compensated. 
In current-clamp recordings, CNQX (20 mM), 50 mM DL-AP5, and picrotoxin 
(100 μm) were routinely added to the extracellular solution to block ionotropic synaptic 
transmission mediated by glutamate and GABAA receptors, respectively, to assess 
persistent firing. Neuronal excitability was assessed using the input–output curve 
measured from the changes in membrane potential (presence of APs) evoked by current 
steps (from Vrest, start = −200 pA, step duration: 300 ms), increasing in increments of 
10–15 pA in current-clamp mode. Cm and Rm were calculated in seal-test configuration 
from the decay and steady-state current of a transient generated in response to a −5 mV 





2.14 Neuronal morphology analysis 
 Confocal images of L2/3 GFP-positive neurons in mPFC (P21 and P60) were 
collected using a 40X objective. z-Stacks for images with a large field of view were taken 
at z-step of 1 μm through the entire section (about 200-μm thickness), taking care to 
include the entirety of the dendritic tree. Image stacks of dendritic trees and soma were 
imported in TIFF format into ImageJ (NIH). Cell somas and dendrites were traced 
manually to ensure accurate reconstruction. Dendritic arbors that could not be confidently 
and completely reconstructed were not used in the analysis. Dendritic reconstructions 
were confirmed by comparing independent reconstructions from two investigators (N = 
10 neurons per condition). The dendritic parameters analyzed included the total dendritic 
length (of all dendrite branches), number of dendritic branches, number of branch points, 
number of dendritic end tips. Branch order for each dendritic branch was assigned 
starting at the cell body and increased after each branch point and the maximum branch 
order quantified. Sholl analysis was performed using Simple Neurite Tracer (SNT, 
ImageJ plugin, Longair MH, 2011). Each reconstructed neuron was thresholded and 
binarized, and the skeletons were imported to SNT. Sholl analysis was performed by 
calculating the number of dendrites that intersected concentric spheres that radiated from 
the soma in 10-μm radius increments. On some occasions, the dendritic arbor could not 
be reconstructed for several reasons: dendritic processes extended outside of the acquired 
field of view (or z-stack); the field of view became too dense with GFP-positive 
processes from neighboring cells, preventing unambiguous reconstruction; and some 




reconstruction. Thus, our reconstructions are an underestimate of the entire dendritic 
arbor. Neuronal soma area and diameter were measured from a single z-plane for each 
neuron. Soma diameter was measured perpendicular to the apical axis. Analysis was 
performed at P21 in the mPFC and 315 neurons were analyzed for control (6 ROIs from 3 
mice) and 216 cells were analyzed for the mC4 condition (7 ROIs from 3 mice). 
 
2.15 Microglial assays 
 GFP colocalization with microglia (Iba1) was quantified at P21. Confocal images 
of mPFC (60X objective) were collected using the same exposure settings between 
conditions including channels for DAPI, GFP (transfected neurons), and Iba1 (microglia). 
All images were background subtracted and binarized using the same settings between 
experimental groups. Analysis was completed for single z-planes. To quantify microglia 
proximity to GFP+ neurons, we first defined the electroporated region (ROI) to be 
analyzed. We created an ROI for a single z-plane in the mPFC where transfected neurons 
were located. There were 26 ROIs for each condition. The ROIs of electroporated regions 
were, on average, 98,000 μm2 (approximately 280 μm × 350 μm) and contained, on 
average, 13.6 microglia per ROI. We then identified microglia by tracing around the 
perimeter of the cell (using Iba1 signal), including the cell body and any proximal 
processes in the single analyzed z-plane. Microglia cell bodies were confirmed by the 
presence of DAPI. Colocalized GFP and Iba1 signal was isolated and quantified within 




mask was only included in the analysis if it was equal to or larger than 1.23 μm 
(approximately 3 pixels). GFP-positive puncta within microglia were visually inspected 
in three-dimensional space by examining multiple z-planes to confirm the containment of 
the puncta to the microglia cytoplasm. The percentage of colocalized signal was 
quantified by dividing the area of the mask by the total area of the microglia (GFP/Iba1 
colocalization [%] = microglia area colocalized with GFP / total microglia area). Using 
this analysis, we also calculated the percentage of microglia that were positive for GFP 
(GFP-positive microglia [%] = total number of GFP-positive microglia / total number of 
microglia), N = 26 ROIs (ROIs of electroporated regions from 3 mice per condition 
including 373 control and 334 mC4 microglia). 
 To quantify engulfment of synaptic material in nonexpanded tissue, we 
electroporated (E16) a plasmid that labels endogenous PSD-95 (EF1a-PSD95.FingR-
RFP) for control and mC4 conditions. Analysis was completed for single z-planes using 
DAPI, PSD-95-FingR-RFP, Iba1, and CD68 (a lysosomal marker). ROIs of 
electroporated regions were defined as described in the previous section (Colocalization 
of GFP and Iba1). Analysis was completed using the same method as in the GFP and 
Iba1 colocalization analysis, except synaptic material was only counted if it was within 
the lysosome of the microglia (PSD-95-postive puncta that colocalized with both Iba1 
and CD68 signals). For each thresholded mask, the total colocalized area (microglia 
engulfment area [%] = microglia area colocalized with PSD-95 and CD68 / total 
microglia area) was quantified. We also quantified the percentage of microglia positive 




/total number of microglia). We also quantified the colocalization of fluorescent signals 
from PSD-95, Iba1, and CD68 in confocal images that were pixel shifted randomly by 12 
μm in four possible directions for each channel, independently. The percent area of each 
microglia colocalized with CD68 signal was calculated as a measure of microglia 
reactivity (area of CD68 / microglia area). In a separate analysis, the cortical depth of 
each engulfment-positive microglia was determined by measuring the distance from the 
center of the cell body (using DAPI) to the adjacent pia mater. We restricted cortical 
depth analysis to L1 and L2/3 of the mPFC, where the dendritic spines of L2/3 cortical 
neurons are localized (depth ≤ 300 μm). Microglia that did not contain triple-stained 
puncta (PSD-95/Iba1/CD68) were excluded from correlation analysis. Control: N = 26 
ROIs (from 5 mice; 345 microglia); mC4: N = 26 ROIs (from 5 mice; 319 microglia). 
 Microglia density analysis (P21) was completed using 50-μm z-stack images 
using DAPI and Iba1 signals. Microglia density was independently calculated for L1 
(cortical depth: 0–120 μm) and L2/3 (cortical depth: >120–300 μm) of the mPFC. 
Density was calculated per ROI (electroporated region) by dividing the number of 
microglia in the ROI by the total volume of tissue for each ROI. Microglia density was 
measured in 19 control ROIs (from 5 mice, 2,146 microglia) and 17 mC4 ROIs (from 5 
mice, 1,640 microglia) in the superficial layers of cortex, and in each ROI the density was 






2.16 Expansion microscopy 
 Coronal mouse brain sections (50 μm) were permeabilized as previously 
described and stained at 4°C for 24 hr with primary antibodies (rat anti-CD68, rabbit anti-
RFP, guinea pig anti-Iba1) at a dilution of 1:500 for each. Tissue was subsequently 
washed three times for 10 min in 1X PBS with 0.025% Triton-100X. The tissue was then 
incubated with secondary antibodies (anti-rat 488, anti-rabbit Alexa 546, anti-rabbit 594, 
anti–guinea pig Atto 647, anti–guinea pig Alexa 647) at 4°C for 24 hr. Tissue sections 
were again washed three times with PBS for 10 min. Sections were then anchored in 0.1 
mg/ml Acryloyl-X SE in 1X PBS for 12 hr and polymerized within a polyacrylamide and 
sodium acrylate gel (Tillberg et al. 2016). The gels were trimmed and subsequently 
digested with proteinase k (8 units/ml) for 8–10 hr. Following digestion, the sections 
were transferred into a #1.5 glass-bottom dish, washed three times with 1X PBS, and 
expanded with milliQ purified water for 15 min twice. Fluorescence images of the 
expanded tissue were acquired with a Nikon C2Si inverted laser scanning confocal 
microscope (Nikon Instruments, Nikon Eclipse Ti with C2Si+ confocal) with a 40X Plan 
Apo λs objective (Nikon Instruments; Plan Apo, NA 1.3, WD: 0.2 mm, water objective). 
Images of microglia near apical dendrites of L2/3 FingR-PSD95-RFP(+) neurons were 
acquired with a pixel sampling of (0.155 μm/pixel) and 1-μm z-axis step interval. 
The scaling factor for each expanded microglia was determined by comparing 
pre-expansion measurements of the long and short cross sections of the microglial cell 
body in a maximum-intensity projection image, and these values were compared to 




based on pre-expansion images. This scaling factor was applied to any measurements 
made within that expanded image (e,g., lysosomes area) to calculate the original size of 
the organelles. To determine the number and size of lysosomes, ROIs were manually 
drawn following the perimeter of the lysosome using the z-axis plane with the brightest 
CD68 signal. This z-plane was determined first qualitatively and confirmed by a line scan 
through the approximate center of the lysosome signal, which yielded the largest slope of 
intensity versus distance. The lysosome ROIs were counted and the cross-sectional areas 
measured and compared between experimental groups. CD68-positive signals were 
scored as a lysosome if they were 3 × 3 pixels, or 7–9 clustered pixels (0.216 μm2 
expanded), in size with an average signal intensity of at least two times above local 
background levels and were present in two consecutive z-planes. 
Additionally, each lysosomal ROI was verified for FingR-PSD95-RFP signal 
using a z-axis profile plot for both CD68 and RFP signal. ROIs that show overlapping 
peaks between RFP and CD68 were verified for signal within the ROI in comparison to 
the surrounding local background. Local background was determined by calculating the 
mean background signal of RFP in a region surrounding each ROI. We considered 
lysosomes positive for synaptic engulfment if the ROI signal increased by two standard 
deviations over the local background signal. PSD95-FIngR-RFP-positive signal was 
scored as a PSD-95 internalized puncta if they were 2 × 2 pixels, or 4–5 clustered pixels 
(0.0961 μm2 expanded), in size with an average signal intensity of at least two times 
above local background levels. The data were derived from 5 and 4 mice each for control 




and mC4 conditions, respectively. We analyzed a total of 1,987 and 2,531 lysosomes 
from control and mC4 conditions, respectively. 
 
2.17 Maternal interaction task 
 For all juvenile behavior tasks, we used control (N = 15) and mC4 (N = 21) mice 
that were electroporated bilaterally at E16. Prior to the maternal homing test, dams were 
acclimated to the behavioral task by placing them in the mesh cup for 5-min periods, for 
3 d consecutively. Mice were separated from their dams for 1 hr immediately before 
testing. The MI task consisted of two phases. In phase 1 (MI1), mice were placed in an 
OF with home bedding and fresh bedding, and in phase 2 (MI2) mice were placed in an 
OF with home bedding, and their dam was restrained in a small wire mesh cup and an 
empty wire mesh cup. Both phases of the behavioral task were run on P18. 
For MI1, individual pups were transferred to a homemade acrylic arena (50 × 50 
× 30 cm length-width-height) and placed in a “starting corner.” The arena contained fresh 
bedding in two neutral corners and nest bedding in the corner opposite from the starting 
corner. Mice explored for 3 min, and the total time spent in the starting, nest, and fresh 
corners was measured using a homemade video tracking system written in MATLAB 
(MathWorks). Grooming occurrences and time spent grooming were annotated by a 
trained experimenter blind to experimental conditions. 
For MI2, two wire mesh cups were placed in opposite corners of a homemade 




the other empty, and the start corner contained soiled home bedding. Mice spent 5 min 
exploring the MI2 environment, and we video-recorded behavior using a Logitech C270 
Webcam at 30 fps. Time spent near each cup and other areas was measured using our 
homemade video tracking system that tracked the centroid of the mouse. Behaviors were 
recorded under a dim light (approximately 20 lux) positioned over the center zone of the 
arena. Between trials and mice, the arena was cleaned with 70% ethanol. 
 
2.18 Adult behavior 
 For all adult behavior tasks, we used control (N = 22) and mC4 (N = 20) mice that 
were electroporated bilaterally at E16. The same cohort of adult mice was run in all adult 
behavioral tasks between the ages of P60–70. All behavior was recorded using a Logitech 
C270 Webcam at 20 fps. All mice were handled for 3 d consecutively prior to any 
behavioral testing to ensure familiarity to the experimenter. For all behavioral tasks, 
experiments were recorded under a dim light (approximately 20 lux) positioned over the 
center zone of the arena. For the open field task (OF), mice were placed in a homemade 
acrylic arena (50 × 50 × 30 cm length-width-height) and were free to explore for 5 min. 
For EZM, mice were placed in the closed arm of a homemade elevated-zero maze (EZM) 
(track diameter = 50 cm, track width = 5 cm, wall height for closed arms = 40 cm, height 
of track = 61 cm) and were free to explore for 5 min. For OF and EZM, mice were not 
exposed to the arenas until testing day, since the initial response to the environment is 




the OF arena for 3 d prior to behavioral testing (5 min each day). For the novel-object 
interaction task, mice were placed in the center of the arena that contained a novel object 
(small plastic toy with smooth, cleanable surfaces) in one corner (corner alternated 
between mice). Mice were free to explore the arena for 5 min. For novel-object 
recognition, the arena contained a familiar object (object exposed in novel-object task) in 
one corner and a novel object in the opposite corner (corners alternated between mice), 
and mice were free to explore for 5 min. For the sociability task, the arena contained a 
novel mouse (age, sex, and strain matched) under a mesh wire cup in one corner and an 
empty mesh wire cup in the opposing corner, and mice were free to explore for 5 min. 
For all behavioral tasks, the arena was cleaned with 70% ethanol between all trials. 
All adult behavior was analyzed using DeepLabCut (Mathis et al. 2018), an open-
source software package that uses deep neural networks to automatically track body parts 
from videos. We confirmed accurate tracking of mice based on this software by close 
inspection of videos once they had been annotated by DeepLabCut. For all adult behavior 
position tracking, we used the centroid of the mouse and compared amount of time spent 
in ROIs. For OF, we calculated the maximum and average velocity and the total distance 
traveled. For EZM, we compared the time spent in the open arms of the maze. For both 
novel-object and sociability tasks, we quantified amount of time spent in the corners of 
interest in the arena (time spent with novel object for novel-object interaction, time spent 
with novel versus familiar object for novel-object recognition, time spent with novel 





2.19 Quantification of transfected cells in behavior brains 
We counted the number of GFP-positive cells and assessed the extent of cell 
transfection in brains of animals that were tested in behavioral tasks. Experimental 
groups included mice from at least two litters (N = 15 mice for control and N = 21 for 
mC4 condition for juvenile behaviors; N = 22 mice for control and N = 20 for mC4 
condition for adult behaviors). Somas were counted by multiple trained, independent 
experimenters. Coronal sections (50-μm thickness) from the entire brain were carefully 
inspected, and the DAPI signal was used to corroborate the presence of cell nuclei. We 
used a brain atlas (Paxinos & Franklin 2001) to confirm the location of GFP+ cell bodies 
and to delineate the boundaries of each brain region. Most transfected cells were located 
in frontal cortical regions, between Bregma +3.0 mm and 1.6 mm. We did not observe 
transfected cells in caudal cortical regions or subcortical areas. 
To estimate the total amount of cells transfected in each brain, cells were counted 
from 50-μm sections, including every other section. Since transfections were 
homogenous across neighboring brain sections, once we obtained the total number of 
cells per section, we plotted cell counts against their respective Bregma coordinates. We 
then used a linear interpolation to estimate the cell counts from missing brain sections. In 
a small number of brains (N = 3), we found no differences in total cell counts when we 
compared values obtained from counting GFP-positive cells in all transfected brain 
sections to estimated values obtained using the interpolation approach. In total, including 
juvenile and adult brains, we counted 174,041 neurons from 78 brains. All control and 




patterns of transfected neurons. We did not find any differences in total cell counts 
between groups for juvenile or adult conditions. 
 
2.20 Statistical analysis 
 For confocal image analysis and electrophysiological recordings, we focused on 
neurons in the anterior cingulate cortex and prelimbic, infralimbic, and medial orbital 
divisions of the mPFC. All statistical analysis was completed in GraphPad Prism 8.0, and 
threshold for significance for all tests was set to 0.05 (α = 0.05). M-FISH and qPCR data 
sets were analyzed with an unpaired t test. Spine developmental data were analyzed using 
a one- or two-way ANOVA followed by Tukey’s posttest. Dendritic spine fluorescent 
intensity values were sorted based off of percentile cutoffs determined from TIB 
distribution values of dendritic spines in control conditions, and differences in the density 
of spine types between groups were tested with a one-way ANOVA followed by Tukey’s 
posttest. Electrophysiological data were analyzed with an unpaired t test, and cumulative 
distributions were analyzed with a Kolmogorov-Smirnov (KS) test. Microglia data were 
analyzed using either an unpaired t test or a one-way ANOVA followed by Tukey’s 
posttest. Behavioral data were analyzed with a two-way ANOVA followed by Sidak’s 
posttest and a t test with Welch’s correction. Dendrite and soma morphology 
measurements were analyzed using a t test. Both male and female mice were used, and 
we did not observe any differences between the sexes among groups. Correlations were 




blind to condition. Soma area/diameter and dendrite measurements were analyzed using 
GraphPad Prism 8.0 (GraphPad Software). Figures were prepared using CorelDRAW 
Graphics Suite X8 (Corel Corporation) and ImageJ (NIH). Custom-written routines for 
behavioral tracking and analysis are available upon request. Data are presented as the 





Overexpression of C4 and its impact on prefrontal cortex development 
 
3.1 Introduction 
It is not clear which cells types or brain regions produce C4 in the mouse brain. 
Additionally, since C4 has not yet, to our knowledge, been experimentally overexpressed, 
it is not known how its expression impacts developing cortical networks.  Here, we 
characterize the endogenous expression of C4 in L2/3 neurons using M-FISH. We 
compare the endogenous expression of C4 between excitatory and inhibitory neurons. A 
modified, bilateral in utero electroporation method is verified in its ability to 
experimentally increase the expression of C4 in the PFC, using both qPCR and western 
blot methods. Lastly, the effects of C4 overexpression on developing mPFC networks are 
characterized by examining both developmental spine density with confocal imaging and 




3.2.1 Endogenous expression of C4 in the mouse prefrontal cortex 
Using multiplex in situ hybridization (M-FISH), we showed that PFC neurons in 




was not present in tissue from C4b knock-out (C4 KO) mice (Figure 3.1). Additionally, 
when comparing the endogenous expression of C4 between excitatory and inhibitory 
cells, labeled with probes for CaMKIIa and GAD, respectively, we find an enrichment of 

















Figure 3.1: IUE increased amount of mouse C4 transcript in neurons. 
(A) Representative 60X confocal images of in situ hybridization showing that C4b 
mRNA is expressed in mPFC superficial layers in P30 WT mice. White dotted line: pia 
mater. White circles: nuclei with C4 mRNA. (B) Representative 60X confocal images 
of in situ hybridization showing that C4b mRNA was not expressed in mPFC superficial 
layers in P30 C4b KO mice. White dotted line: pia mater. (A-B) Confirmed in 3 mice 
per condition. Scale bar = 60 µm. (C) Representative 60X confocal images at P21 of in 
situ hybridization from the same coronal section showing CaMKIIα+ neurons that were 
transfected with GFP and mC4 (C4b) (white arrowhead) and untransfected neighbors 
expressing mC4 (pink arrowhead). Scale bar = 15 µm.  (D) IUE reliably increased C4b 
transcript levels in transfected cells. Percent of soma area positive for C4 transcript in 
transfected and untransfected neurons. N = 100 neurons (3 mice) per condition. t-test.  
****p < 0.0001. Mean ± SEM. (E) Transcript levels of GFP and mC4 positively 
correlated in transfected cells. black line: linear fit. gray lines: 95% confidence intervals. 
blue dotted line: average endogenous C4 expression at P21 in CaMKIIα+ mPFC L2/3 
neurons. N = 100 transfected neurons (3 mice). Pearson’s r correlation and linear 
regression. r = 0.28. ****p < 0.0001. Note: Experiments performed by Ashley Comer 
and Lisa Kretsge, data analyzed and figure made by Ashley Comer. Data and figure 








3.2.2 In utero electroporation is a viable method to increase C4 expression 
To target L2/3 mPFC pyramidal neurons for C4 overexpression, we used in utero 
electroporation (IUE) in mice at embryonic day (E) 16 (Figure 3.3) (Szczurkowska et al. 
2016). To overexpress C4, we performed IUE using plasmids with the CAG promoter to 
coexpress green fluorescent protein (GFP) and mC4b (mC4 condition). Then, we used M-
FISH at P21 to quantify the extent of C4 overexpression achieved. Within the same 
coronal section and cortical layer of the mPFC, we identified excitatory L2/3 neurons that 
were either transfected (GFP+/calcium/calmodulin-dependent protein kinase type II 
Figure 3.2: C4 expression is enriched in excitatory neurons.  
Graph showing the % of each cell body occupied by mC4 transcript expression using 
M-FISH. Orange: control GAD (+) neurons. Magenta: control CaMK11a (+) neurons. 
N = 6 mice (200 neurons). Note: Experiments performed and data analyzed by Ashley 




subunit alpha [CaMKIIα]+) or untransfected (GFP−/CaMKIIα+) and compared the 
percent of C4 mRNA+ cell body areas (Figure 3.1). This allowed us to quantify both 
endogenous expression of mC4 in pyramidal neurons and the extent of mC4 
overexpression in transfected cells at P21. 
IUEs reliably increased expression of mC4 at P21 in excitatory CaMKIIα+ 
neurons of the mPFC relative to their nearby untransfected neighbors (Figure 3.1, t test, 
****p < 0.0001). Furthermore, we found that 99% of cells expressing GFP had higher 
amounts of mC4 mRNA relative to the mean transcript levels of nearby untransfected 
cells (Figure 3.1). To quantify mRNA levels more precisely, we performed quantitative 
PCR (qPCR) in tissue that was dissected to isolate the transfected region of the mPFC 
(Figure 3.3, B, right panel) from control (IUE with pCAG-GFP) and mC4 (IUE with 
pCAG-GFP and pCAG-mC4) animals at P21 and P60. At P21, IUEs reliably increased 
mC4 transcript by approximately 2.8-fold relative to control (Figure 3.3, C). However, 












We tested multiple commercial antibodies in order to detect mC4 protein. 
However, they were either nonspecific and/or not sensitive enough to detect C4 upon 
transient transfection of human epithelial kidney (HEK) cells. Therefore, we generated an 
antibody that detected both mC4 and hC4 in HEK cells that were transfected with C4 
(Figure 3.4). Using this antibody, we found that C4 protein expression was increased in 
the mC4 condition approximately 1.3-fold at P21 and was unchanged at P60 in pooled 
total cell lysates taken from the mPFC (Figure 3.3, E). To test whether C4 is synaptically 
localized, we isolated postsynaptic density (PSD) fractions from PFC tissue (Figure 3.4). 
Indeed, we found that C4 protein was present in the PSD fraction in control conditions 
Figure 3.3: mC4 is expressed in neurons of the medial prefrontal cortex and can 
be overexpressed using in utero electroporation.  
(A) Diagram depicting IUE surgery performed in E16 dams. (B) Representative 20X 
confocal image of IUE with GFP targeted to L2/3 mPFC, the electroporated region. 
Yellow asterisk: L2/3 GFP+ neurons. Left panel scale bar = 250 µm. Right panel scale 
bar = 75 µm. (C) IUE increases mC4 expression by 2.84-fold compared to P21 control. 
N = 18 control mice. N = 15 mC4 mice. t-test with Welch’s correction. p = 0.0392. (D) 
mC4 mRNA expression at P60 for control and mC4 conditions. N = 10 control mice. N 
= 11 mC4 mice. t-test with Welch’s correction. p = 0.2564. (C-D) qPCR performed 
from the dissected electroporated region. Control: blue. mC4: red. Mean ± SEM. (E) 
Immunoblot (top) and quantification (bottom) of relative mC4 levels in total lysates and 
isolated PSD fractions from GFP or mC4 conditions from the electroporated region. 
Since C4 was expressed at relatively low levels, it could only be detected when brains 
were pooled. Lysates and PSDs from the electroporated region were prepared from the 
individual mice and pooled for the Western blot analysis. N = 7 mice per group for P21.  
N = 4 mice per group for P60. Vinculin was used as loading control for lysates and PSD 
fractions. PSD-95 immunoblot served as a control for successful isolation of PSD 
fractions. Note: qPCR data collected and analyzed by Rhushikesh Phadke (tissue 
collection and qPRC), Tushare Jinadasa (tissue collection and qPCR), Yenyu Liu (tissue 
collection and qPCR), Lisa Kretsge (tissue collection), and Ashley Comer (produced 
IUE mice and tissue collection). Western blot data performed and analyzed by Borislav 
Dejanovic. Figure made by Ashley Comer (panels A-D) and Borislav Dejanovic (panel 





and synaptic C4 protein was increased approximately 1.6-fold at P21 and was unchanged 
at P60 in C4-overexpressing tissue compared to controls (Figure 3.3, E). Since we had to 
pool isolated PSDs from multiple mice to have enough synaptic material, we were unable 








We were unable to detect either endogenous or exogenous C4 in histological 
sections using our antibody or other commercially available antibodies. Therefore, we 
created a C4-GFP fusion protein construct (pCAG-C4-GFP) to visualize exogenous C4 
protein expression without the need for antibodies. We confirmed C4-GFP expression in 
HEK cells using western blot (Figure 3.4, A). In both transfected HEK cells and L2/3 
neurons at P21, mC4-GFP protein was expressed (Figure 3.5, A). We found C4-GFP 
localized to cell bodies and dendrites in L2/3 neurons (Figure 3.5, B, yellow arrowhead). 
Overall, these results showed that mPFC L2/3 neurons express endogenous mC4, that a 
subpopulation of C4 is synaptically localized, and that IUE successfully increased mC4 
levels at P21. 
 
Figure 3.4: PSD synaptosome isolation from PFC tissue. 
A) Immunoblot assay showing C4 staining with anti-C4 antibody (clone 931-946). 
Samples were from HEK293 cells transfected with GFP, hC4A, mC4 or mC4-GFP 
constructs. We detected C4 variants as ~250 kDa proteins, which is likely the 
unprocessed protein (predicted molecular weight is 193 kDa) or not fully reduced C4 
protein (C4 has disulfide bonds). (B) Fractionation scheme for the preparation of PSDs 
from mouse PFC region. Fractions that were used for immunoblot analysis are shown 
in bold. (C) Immunoblot of postsynaptic (PSD-95) and presynaptic (Synaptophysin 1) 
marker proteins in PSD isolation steps. Synaptosome fraction contains both PSD-95 and 
synaptophysin 1. Note: Data collected and analyzed and figure made by Borislav 
Dejanovic. IUE mice provided by Ashley Comer. Data and figure published in Comer 








Figure 3.5: mC4-GFP protein is expressed in transfected HEK cells and L2/3 
neurons. 
(A) Representative 10X wide-field images of HEK cells transfected with either GFP 
(top panels) or fusion mC4-GFP (bottom panels). Left panel shows brightfield image. 
Middle and right panels show GFP signal (cyan). Right panel is zoom region of yellow 
square in middle panel. Scale bar left and middle panels = 100 µm. Scale bar right panels 
= 25 µm. (B) Representative 40X confocal image of IUE-transfected L2/3 neurons in 
the mPFC of P21 mice. Neurons co-transfected with pCAG-RFP (magenta) and pCAG-
mC4-GFP (cyan). Bottom panels are zoomed region from the yellow square in the top 
left panel. Yellow arrowheads in bottom panels show C4-GFP signal in the dendrites of 
a neuron. Scale bar top panels = 50 µm. Scale bar bottom panels = 15 µm. Note: Panel 
(A) data collected by Rhushikesh Phadke, Tushare Jinadasa and Yenyu Liu. Panel (B) 
data collected by Ashley Comer. Figure made by Ashley Comer. Data and figure 






3.2.3 C4 overexpression alters developmental synaptic connectivity 
Since we found C4 in PSD fractions, we wondered whether increased expression 
of C4 in developing neurons led to structural alterations in dendritic spines. We used IUE 
to produce control (pCAG-GFP) or C4 overexpression conditions (pCAG-GFP with 
pCAG-mC4b or pCAG-hC4A, for mC4 and hC4 conditions, respectively). Since early 
postnatal development is an important period for synaptic maturation and refinement of 
cortical circuitry (Cohen-Cory 2002), we measured dendritic spine density using confocal 
imaging of GFP in fixed brain sections collected at P7–9, P14–16, P21–23, and P55–60. 
Besides control and mC4 conditions, for comparison we also electroporated hC4A, which 
is highly associated with SCZ (Sekar et al. 2016). 
In control conditions, the density of apical tuft dendritic spines was 
developmentally regulated and increased nearly 8-fold in the 2 wk from P7 to P21 
(Figure 3.6, A, Tukey’s test, ****p < 0.0001). Whereas spine density in mC4- or hC4-
overexpressing neurons was similar to that of control conditions at P7 and P14, apical tuft 
dendritic spine density was approximately 30% lower at P21 (Figure 3.6, A and B). There 
were no differences in apical tuft protrusion density between any groups at P60 (Figure 
3.6, A). These results suggest that overexpression of C4 alters the developmental 
maturation of dendritic spines and that overexpression of either human or mouse 











Closer inspection of protrusion morphology at P21 revealed a significant 
reduction of thin spines/filopodia and medium-sized spines in neurons overexpressing 
either mC4 or hC4, as compared to controls, whereas putative large mushroom spines 
remained intact (Figure 3.6, C and D; spine types sorted by total integrated brightness 
[TIB], see Methods). Since dendritic spine volume positively correlates with PSD size 
and synaptic strength (Arellano et al. 2007, Holtmaat & Svoboda 2009), this result 
suggests that increased expression of mC4 preferentially alters the development of 
weaker synaptic connections. Since overexpression of mC4 and hC4 led to similar 
defects in dendritic spine density at P21, in subsequent experiments we focused on the 
mouse homologue to investigate the role of C4 in cortical circuit function. In contrast to 
Figure 3.6: C4 overexpression led to dendritic spine alterations in apical arbors 
of L2/3 mPFC neurons.  
(A) Developmental time course of spine density in the mPFC revealed a significant 
decrease in spine density in neurons overexpressing C4, as compared to controls, at 
P21-23. **p < 0.01, ***p < 0.001, ****p < 0.0001. N = 240 dendrites from 84 mice (20 
dendrites per each time point; 20 dendrites x 4 time points x 3 conditions). (B) 
Representative 40X confocal images of P21-23 apical dendritic tufts. Scale bar = 5 µm. 
(C) Representative 40X confocal images of P21-23 apical dendritic spine types. Yellow 
asterisk: large mushroom spine (TIB (a.u.) > 75%). Green arrowhead: thin 
spine/filopodia (TIB (a.u.) < 25%). Scale bar = 3 µm. (D) Spine density (spine/µm) 
sorted by spine types reveals a specific reduction of medium-sized and thin/filopodia 
spine types in the mC4 and hC4 condition. *p < 0.05, **p < 0.01, ****p < 0.0001. N = 
60 dendrites from 21 mice (20 dendrites per condition x 3 conditions). (E) 
Representative 40X confocal images of P21-23 basal dendritic spines. Scale bar = 5 µm. 
(F) Analysis of basal dendritic spine density (spine/µm) revealed no difference across 
groups. N = 80 dendrites from 28 mice (20 dendrites per each time point; 20 dendrites 
x 2 time points x 2 conditions). Two-way ANOVA followed by a Tukey’s test for all 
comparisons. Control: blue, mC4: red, hC4: purple. Mean ± SEM. Note: Ashley Comer 
and Thanh Nguyen performed IUEs. Data collected and analyzed by Ashley Comer, 
Thanh Nguyen, Jungjoon Lee, Frances Hausmann, Meaghan Connolly, Thara Venu and 
Alberto Cruz-Martín. Figure made by Ashley Comer. Data and figure published in 





the structural alterations we observed in apical tufts, increased expression of mC4 did not 
significantly alter the density of basal dendritic spines, as compared to control conditions 
(Figure 3.6, E and F). Taken together, these results demonstrate that increased expression 
of C4 in developing cortical neurons caused input-specific dendritic spine pathology and 
that less mature protrusions were preferentially affected, whereas larger mushroom spines 
remained intact. 
3.2.4 C4 overexpression reduces the functional connectivity of cortical neurons 
 To determine whether the morphological spine deficits observed in C4-
overexpressing cells were accompanied by functional connectivity changes, we 
performed electrophysiological whole-cell voltage-clamp recordings in acute brain slices 
prepared from mPFC of P18–25 control and mC4 animals. Voltage-clamp recordings 
demonstrated that overexpression of mC4 caused an approximately 60% decrease in the 
frequency of miniature excitatory postsynaptic currents (mEPSCs) and an increase in the 
interevent interval (IEI) (Figure 3.7, A–C). Increased levels of mC4 also caused an 
approximately 18% reduction in the amplitude of mEPSCs (Figure 3.7, D and E), 
demonstrating that mC4 modifies not only the density of synaptic connections but also 












Further analysis of postsynaptic current kinetics revealed no differences in 
mEPSC Rise10-90 or Decaytau between control and mC4-transfected neurons (Figure 3.7, F 
and G). Although overexpression of mC4 did not alter the frequency or the amplitude of 
miniature inhibitory postsynaptic currents (mIPSCs) (Figure 3.7, H–L), it significantly 
slowed their kinetics (Figure 3.7, M and N, 27% and 19% increase in Rise10–90 and 
Decaytau, respectively), suggesting that there could be mC4-dependent changes in the 
location of inhibitory synapses. Taken together, our data suggest that increased 
Figure 3.7: C4 overexpression reduced functional connectivity in cortical neurons. 
(A) Top: Representative whole-cell voltage clamp recordings showing mEPSCs. Top 
scale bar = 250 ms/10 pA. Bottom: same as top traces but expanded (black rectangle 
region). Bottom scale bar = 125 ms/10 pA. (B) Increased mC4 expression causes a 
reduction in mEPSC frequency. t-test. ****p < 0.0001. (C) Overexpression of mC4 
causes a rightward shift in the distribution of mEPSC interevent interval (IEI). 
Kolmogorov-Smirnov test. ****p < 0.0001. (D) mC4 causes a reduction in mEPSC 
amplitude. t-test. **p < 0.01. (E) mC4 overexpression causes a leftward shift in the 
mEPSC amplitude distribution. Kolmogorov-Smirnov test. **p < 0.01. (F) mEPSC 
Rise10-90 is not altered by mC4 overexpression. t-test. p = 0.715. (G) No changes in 
mEPSC Decaytau with mC4 overexpression. t-test. p = 0.07. (B-G) N = 12 control 
neurons, N = 10 mC4 neurons. Mean ± SEM. Control: blue, mC4: red. (H) Top: 
Representative recordings showing mIPSCs. Top scale bar = 250 ms/20 pA. Bottom 
traces are same as (H) top but expanded (rectangle region). Top scale bar = 125 ms/20 
pA. (I) No difference in mIPSC frequency between control and mC4 conditions. t test. 
p = 0.3726. (J) Distribution of mIPSC IEIs is not changed by increased expression of 
mC4. Kolmogorov-Smirnov test.  p > 0.05. (K) No changes in mIPSC amplitude with 
increased expression of mC4. t test. p = 0.5832. (L) mIPSC amplitude distribution is 
not changed by increased expression of mC4. Kolmogorov-Smirnov test.  p > 0.05. (M) 
mIPSC Rise10-90 is increased in neurons overexpressing mC4. t test. *p = 0.0329. (N) 
mIPSC Decaytau is increased in neurons overexpressing mC4. t test. *p = 0.0225. (I-N) 
N = 10 control neurons, N = 12 mC4 neurons. Control: blue, mC4: red. Mean ± SEM. 
Note: IUEs performed by Ashley Comer and Thanh Nguyen. Data collected and 
analyzed by Tushare Jinadasa. Figure made by Alberto Cruz-Martín. Data and figure 




expression of mC4 alters the developmental wiring of cortical neurons by decreasing 
their excitatory synaptic drive. 
3.2.5 Overexpression of mC4 decreased membrane capacitance without altering overall 
excitability 
We also monitored the electrophysiological properties of L2/3 mPFC neurons to 
determine whether overexpression of mC4 altered neuronal excitability. To do this, we 
injected hyperpolarizing and depolarizing current step injections of different amplitudes 
and recorded the membrane potential (Vm) in control and mC4-overexpressing neurons 
(Figure 3.8, A and B). Overexpression of mC4 did not alter the number of action 
potentials (APs) in response to step current injections of incrementally increasing 
amplitudes (Figure 3.8, C). In agreement with this, we did not see a change in the IEI of 
APs in response to step current injections (Figure 3.8, D) or the minimal current injection 
that resulted in AP generation (Figure 3.8, E) in mC4-overexpressing neurons. Together, 











In contrast, increased levels of mC4 led to an approximately 29% decrease in the 
membrane capacitance relative to controls (Figure 3.8, F). This effect on passive 
membrane properties was specific because increased expression of mC4 did not alter the 
neuron’s resting membrane potential or membrane input resistance (Figure 3.8, G and H). 
Since membrane capacitance is proportional to a cell’s surface area, this result suggests 
that increased expression of mC4 could affect either the gross morphology of cortical 
neurons or plasma membrane properties. Further investigation of neuronal morphology 
showed no difference between conditions in cell body area/diameter or in the width of 
primary dendrites (Figure 3.9, A-C); there was also no change in dendritic complexity 
(Figure 3.10), suggesting that gross neuronal morphology was not affected by mC4 
overexpression. Besides the mC4-dependent changes in membrane capacitance, increased 
expression of mC4 did not have an effect on the morphology or intrinsic properties of 
Figure 3.8: Overexpression of mC4 decreased membrane capacitance without 
altering overall excitability. 
(A-B) Representative current clamp recordings from control (A) and mC4 (B) neurons 
in response to injection of constant-current pulses. Voltage traces (top) shown for 
response to -220 pA (light blue/pink), 185 pA (medium blue/red) and 685 pA (dark 
blue/red) current injections (bottom). Scale bar = 500 pA or 50 mV. Scale bar = 250 ms. 
(C) The number of APs were not different between conditions. Dark blue trace: control 
mean. Light blue trace: control SEM. Dark red trace: mC4 mean. Light red trace: mC4 
SEM. Two-way ANOVA. p = 0.9989. (D) Interevent interval was not different between 
conditions. Dark blue trace: control mean. Light blue trace: control SEM. Dark red 
trace: mC4 mean. Light red trace: mC4 SEM. Two-way ANOVA. p = 0.9838. (E) 
Rheobase was not altered by the overexpression of mC4. t-test. p = 0.8795. (F) mC4 
overexpression led to a dramatic reduction in Cm. t-test. ***p = 0.0007. (G) Vm was not 
changed by mC4 overexpression. t-test. p = 0.2166. (H) Rm was not affected by mC4 
overexpression. t-test. p = 0.5455. (C-H) Control: N =16 cells; mC4: N = 17 cells. blue: 
control. red: mC4. Mean ± SEM. Note: IUEs performed by Ashley Comer and Thanh 
Nguyen. Data collected and analyzed by Tushare Jinadasa. Figure made by Alberto 




transfected cells, thus suggesting that overall neuronal health was not affected by 




Figure 3.9: Overexpression of mC4 did not alter soma size or proximal dendrite 
width. 
(A) Soma area was not different between control and mC4 conditions. t test. p = 0.13. 
(B) mC4 overexpression did not alter the diameter of neurons. T test. p = 0.37. (A-B) 
Only GFP-positive L2/3 mPFC neurons included in analysis. Data points represent 
average measures from ROIs containing many neurons from 3 mice per condition. 
Control: N = 6 ROIs (including 316 neurons). mC4: N = 7 ROIs (including 216 
neurons). (C) Primary dendrite width was not different between conditions. N = 10 
neurons per condition. Data points represent average primary dendrite width per neuron, 
including all primary apical and basal dendrites. T test. p = 0.16. Mean ± SEM. Note: 
IUEs performed by Ashley Comer and Thanh Nguyen. Data collected and analyzed by 
Frances Hausmann, Alberto Cruz-Martín and Ashley Comer. Figure made by Ashley 












3.3 Conclusion and future directions 
In both humans and mice, juvenile and early adulthood time points are an 
important developmental window for PFC development (Marín 2016). Disruption during 
this critical developmental window can leading to lasting changes in brain connectivity, 
cognition and behavior (Marín 2016). Here, we show that C4 contributes to miswiring 
during this critical stage of development. First, we show that mC4 is expressed 
endogenously in the mouse mPFC in both excitatory and inhibitory neurons. However, 
C4 expression is enriched in excitatory cells compared to inhibitory cells, suggesting that 
complement-mediated effects in the brain could be cell-type specific. Using IUE, C4 was 
experimentally overexpressed in pyramidal neurons. Interestingly, in both control and 
mC4 overexpression conditions, mC4 was enriched at the synapse, suggesting that C4 
Figure 3.10: Dendrite morphology was not altered by mC4 overexpression at P21. 
(A) Representative confocal images (40X) of control and mC4 GFP-positive L2/3 
neurons in the mPFC at P21. Images are max z-projections. Scale bar = 50 µm. (B) 
Reconstructions of control and mC4 neurons from (A). Black lines: apical dendrites. 
Gray lines: basal dendrites. Red line: axon. Light blue: cell body. Scale bar = 50 µm. 
(C) There was no difference in total dendritic length (µm) between control and mC4 
neurons. t test. p = 0.59. (D) There was no difference in maximum branch order between 
control and mC4 neurons. t test. p = 0.44. (E) mC4 overexpression did not change the 
total number of branches in PFC L2/3 neurons. t test. p = 0.54. (F) There was no 
difference in the total number of dendritic end tips between control and mC4 neurons. t 
test. p = 0.44. (G) There was no difference in total number of branch points between 
conditions. t test. p = 0.29. (H) No difference found in the sum of Sholl intersections 
between control and mC4 neurons. t test. p = 0.41. (I) Number of intersections as a 
function of Sholl radii (µ m). Dark blue line: control mean. mC4, Dark red line: mC4 
mean. Light blue shade: control SEM. Light red shade: mC4 SEM. (C-I) N = 10 neurons 
per condition. Blue data points: control. Red data points: mC4. Mean ± SEM. Note: 
IUEs performed by Ashley Comer and Thanh Nguyen. Data collected and analyzed by 
Frances Hausmann, Alberto Cruz-Martín, Ashley Comer and Tushare Jinadasa. Figure 





might actively be recruited to the synapse. C4 overexpression led to a developmental 
decrease in spine density at P21, that was then recovered by P60. The recovery of spine 
density could be either due to the lack of significant overexpression of C4 achieved at 
P60 or due to active compensation of spine number, or a combination of both. Future 
studies can answer this question by creating a transgenic mouse model to stably 
overexpress C4 throughout the lifetime of mice.  
 For both overexpression conditions, mC4 and hC4, the loss of spines at P21 was 
due to a loss of filopodia and medium-sized spines, while mushroom spines were intact. 
Future work will interrogate the factors that protect more mature spines while leaving 
more immature spine-type vulnerable to complement-mediated spine removal. It is 
possible that more mature spines express protective factors, such as the protective “don’t 
eat me signal” CD47 which has been found to protect synapses from microglia-mediated 
engulfment (Lehrman et al. 2018). Electrophysiological recordings functionally confirm 
the decrease in excitatory synaptic drive at P21. Interestingly, the excitability of neurons 
overexpressing C4 was not altered, although the capacitance of these cells significantly 
decreased. Future work is required to determine the cause behind decreased capacitance 
which could be due to a change in plasma membrane properties, such as C4-induced 
changes in lipid composition. Since there are known interactions between complement 
proteins and cellular membranes, such as C1q, it is possible that changes in complement 
proteins induce alterations to the plasma membrane (DeLisi & Wiegel 1983). Overall, 
















The role of microglia in C4-induced prefrontal cortical dysfunction 
 
4.1 Introduction 
It has been shown that microglia, the brain’s resident macrophage, engulf 
neuronal and synaptic material dependent on the presence of complement proteins 
(Stevens et al. 2007, Schafer et al. 2012). Microglia are the only cells in the brain that 
express the complement 3 receptor (CR3), which allows microglia to recognize and 
phagocytose material tagged by the complement cascade (Stevens et al. 2007, Schafer et 
al. 2012, Zabel & Kirsch 2013). Microglia-mediated synaptic pruning is necessary for 
normal development of the brain, but can also contribute to abnormal wiring of circuits 
and pathology when mis-regulated (Sekar et al. 2016, Paolicelli et al. 2011, Bohlen et al. 
2019, Hong et al. 2016, Lui et al. 2016). Despite significant progress in this field, it is 
still not clear how reciprocal interactions between neurons and microglia contribute to the 
maturation and refinement of developing cortical circuits (Tremblay et al 2010, Hoshiko 
et al. 2012, Miyamoto et al. 2016). Here, we investigate the role of microglia in 
complement-mediated synaptic loss by observing the colocalization of microglia with 






4.2.1 C4 overexpression enhances microglia-neuron interactions during development 
Several lines of evidence suggest that microglia contribute to circuit maturation 
and synaptic refinement through the secretion of effector molecules and direct 
interactions with neurons (Wu et al. 2015). To determine whether increased expression of 
mC4 led to closer associations of microglia with neurons at P21, we measured the 
colocalization of transfected neuronal GFP with microglia (immunostained for ionized 
calcium binding adaptor molecule 1 [Iba1]) in single z-planes using confocal microscopy 
(Figure 4.1, A). Using this approach, we found instances of microglia colocalized with 
GFP+ neuronal processes in both conditions (Figure 4.1, B; white arrowheads), 
suggesting that microglia were in close proximity with the dendritic processes of 
transfected L2/3 neurons. Increased expression of mC4 led to an approximately 35% 
increase in the number of microglia that colocalized with GFP+ L2/3 neurons (Figure 4.1, 
C) and an approximately 2-fold increase in the area of GFP signal that colocalized with 
the microglia cell body and proximal processes (Figure 4.1, D). These results suggest that 
neuronal overexpression of mC4 led to an increase in the number of microglia in close 
proximity to neurons despite no change in the overall density of microglia in the 























Figure 4.1: Microglia were in closer proximity to neurons overexpressing mC4 at 
P21. 
(A) Representative single z-plane confocal image (60X) showing microglia interacting 
with processes of electroporated neurons in superficial layers of mPFC (left). White 
dotted line: pia. Left scale bar = 50 µm. Higher magnification of insets (left) of L1 and 
L2/3. White arrowhead: microglia (MG). Right scale bar = 10 µm.  (B) Representative 
confocal image (60X) showing microglia (Iba1, magenta) colocalized with neuronal 
GFP signal in P21 histological sections for control (top) and mC4 (bottom) conditions. 
White arrow heads: Iba1/GFP-positive puncta colocalized with microglia soma.  Left: 
max z-projection of entire microglia; scale bar: 7 µm. Right: single z-plane; scale bar = 
3.5 µm. (C) Overexpression of mC4 in L2/3 neurons increased the number of microglia 
that colocalized with GFP+ neuronal material (GFP-positive microglia (%)). t test. 
****p < 0.0001. (D) mC4 overexpression increased the percentage microglia area 
colocalized with neuronal material (MG area (%) = Area of MG GFP+ / Total MG 
Area). t test. ***p = 0.0009. (C-D) N = 26 ROIs (transfected region) from 3 mice per 
condition (including 373 control and 334 mC4 microglia). Mean ± SEM. Note: Data 
collected by Ashley Comer and Thanh Nguyen. Data analyzed and figure made by 








4.2.2 C4 overexpression enhances microglia engulfment of post-synaptic material 
 Since increased expression of mC4 led to a decrease in synaptic connectivity 
(Figure 3.6 and Figure 3.7) and closer association of microglia with transfected neurons 
at P21 (Figure 4.1), we evaluated whether C4 overexpression also enhanced microglia-
dependent phagocytosis of synaptic material. To do this, endogenous PSD-95 was 
fluorescently labeled in vivo using a plasmid containing PSD95-FingR (EF1a-
PSD95.FingR-RFP) (Gross et al. 2013), which labeled only endogenous PSD-95 within 
transfected neurons with red fluorescent protein (RFP) (Figure 4.3; pseudocolored green). 
Figure 4.2: Microglia density and lysosome size were not altered by mC4 
overexpression. 
(A) Microglia density in superficial layers of the mPFC was not affected by mC4 
overexpression. Control: N = 19 ROIs (from 5 mice including 2,146 microglia). mC4: 
N = 17 ROIs (from 5 mice including 1,640 microglia). One-way ANOVA with 
Bonferroni’s multiple comparisons. p = 0.998. (B) Microglia lysosomal area, as 
measured by area of MG positive for CD68, were not different between conditions. 
Area of MG CD68+ (%) = Area of MG CD68+ / Total MG Area. Control: N = 26 ROIs 
(from 5 mice including 345 microglia). mC4: N = 26 ROIs (from 5 mice including 319 
microglia). t test. p = 0.19. Mean ± SEM. Note: Data collected and analyzed and figure 




This approach was preferred instead of using an antibody approach, which would label 
PSD95 of both transfected and non-transfected cells, or using an overexpression method 
with PSD95 tagged with GFP because overexpressing PSD95 can alter synaptic 
properties. Therefore, the advantage of this method is that it allowed endogenous PSD95 
protein to be labeled only in transfected neurons.  Fluorescent signal from PSD95-FingR 
was confined to superficial L1 and L2/3 including transfected cell bodies of L2/3 
neurons, indicating that expression from this electroporated construct mirrored the 













Next, we quantified the colocalization of PSD-95 (identified by PSD95-FingR 
immunofluorescence) with microglia (Iba1) or microglial lysosomes (CD68) (Figure 4.4). 
We observed clear instances of PSD-95 colocalized with Iba1 (Figure 4.4, A and C, white 
arrowheads) and CD68 signal (Figure 4.4, B and D, white arrowheads), suggesting that 
synaptic material was engulfed by microglia and localized to microglia lysosomes. 
Furthermore, using orthogonal views, we confirmed that PSD-95 was localized within 
Figure 4.3: Intrabodies against PSD95 label excitatory synapses of L2/3 pyramidal 
neurons. 
A) Representative confocal image (60X) showing cytoarchitecture (DAPI, blue) and 
labeling of endogenous PSD-95 by FingR (PSD95-FingR-RFP, pseudocolored green) 
in P21 coronal sections. Scale bar = 25 µm. (B) PSD95-FingR labeling pattern was 
consistent with endogenous location of synaptic PSD-95 in L2/3 pyramidal neurons. 
Mean normalized fluorescent intensity (normalized to peak PSD95-FingR signal) as a 
function of distance from pia (µm). Dark blue line: mean. Light blue shade: SEM. Bar 
graph: mean normalized fluorescent intensity (y-axis) is greater in L1 (yellow inset) 
than L4 (red inset).  t-test. p < 0.0001. (C) Zoomed images from image in (A) showing 
boxed regions in L1 (yellow inset) and L4 (red inset). White arrowheads: PSD95-FingR 
puncta. Blue: DAPI (cell nuclei). Scale bar = 5 µm. Note: Data collected and analyzed 
and figure made by Ashley Comer and Alberto Cruz-Martín. Data and figure published 





microglia soma and lysosomal compartments (Figure 4.4, A–D). We quantified the 
colocalization of fluorescent signals from PSD-95-FingR with both Iba1 and CD68 to 
measure postsynaptic puncta within the lysosomes of microglia in control and mC4 
conditions. Overexpression of mC4 led to an approximately 2.3-fold increase in the 
percentage of microglia positive for engulfment (Figure 4.4, E). As a control, we 
analyzed the same images after pixel shifting (see Methods). In the pixel-shifted data, the 
percentage of microglia positive for triple-stained puncta dropped to under 3% in both 
groups (Figure 4.4, E, red dotted line is mean shifted value for both groups), suggesting 
that the colocalization of signals in microglia did not occur by chance. Lastly, we 
observed no change in the area of PSD-95-FingR signal within CD68+ structures (Figure 
4.4, F). Taken together, these data show that C4 overexpression drives microglia 










4.2.3 Microglia phagocytose more material in superficial layers of the cortex 
Since increased expression of mC4 led to specific spine loss in L1 apical tufts 
with no changes in basal dendrites (Figure 3.6), we tested whether microglia engulfment 
of synaptic material was more prominent near the apical dendrites of cortical neurons. 
We measured the distance from the center of each microglia soma to the pia to identify its 
cortical depth, and this measurement was then compared to the area of microglia-
Figure 4.4: mC4 overexpression enhanced microglia engulfment of postsynaptic 
PSD-95. 
(A-D) Representative confocal image (60X) showing PSD-95 located within microglial 
lysosomes in P21 mice for control (A-B) and mC4 conditions (C-D). Single z-plane 
shown.  Scale bar = 5 µm. Magenta: microglia (Iba1).  Red: lysosomes (CD68). Green: 
PSD-95 (PSD95-FingR-RFP, pseudocolored green). White arrowheads: indicate 
colocalization of PSD95 with Iba1 (A and C) or CD68 (B and D). Panels A and C show 
a representative microglia (for control and mC4, respectively) including Iba1 and 
PSD95-FingR-RFP signal. Panels B and D show the same z-plane as panels A and C 
but shows CD68 and PSD95-FingR-RFP signal. Orthogonal views shown. A-D each 
include a graph (bottom right panel) showing a line intensity scan for each signal (A 
and C show Iba1 (magenta) and PSD-95 (green); B and C show CD68 (red) and PSD-
95 (green)). For line intensity graphs, y-axis shows gray intensity value (a.u.) and x-
axis shows length (µm). (E) mC4 overexpression increased the number of microglia 
positive for PSD-95 engulfment (PSD95-FingR-RFP signal colocalized with CD68 and 
Iba1). t test. ****p < 0.0001. red dotted line: average of control and C4 in shuffled pixel 
analysis. (F) There was no difference in area of PSD95 colocalized with microglia 
lysosomes between conditions. (MG engulfment area % = area of microglia occupied 
by PSD95-FingR signal in lysosomes / Total microglia area). t test. p = 0.1927. (E-F) 
Data points represent averages from transfected region ROIs. Control: N = 26 ROIs 
(from 5 mice; 345 microglia). mC4: N = 26 ROIs (from 5 mice; 319 microglia). Mean 
± SEM. (G-H) Microglia engulfment area (%) (from (F)) as a function of cortical depth 
(µm) for control (G) and mC4 (H). Data points represent individual microglia. N = 345 
control and N = 345 microglia. Right graphs are same as left but are zoomed on the y-
axis. blue line: control mean. red line: mC4 mean. gray lines: 95% confidence intervals. 
Pearson’s r correlation. Control: r = 0.12. p > 0.05. mC4: r = -0.21. **p < 0.01. Note: 
Data collected by Ashley Comer and Thanh Nguyen. Data analyzed and figure made by 





engulfed PSD-95 signal. This allowed us to determine whether the connectivity deficits 
in apical tufts were due to altered microglia phagocytosis of synapses in a layer-specific 
manner. In control conditions, there was no correlation between the amount of PSD-95 
colocalized with microglia and cortical depth, suggesting that, during normal 
development, microglia were not biased toward phagocytosis of PSD-95 in specific 
layers (Figure 4.4, G). However, we observed a significant correlation in the mC4 
condition such that microglia closer to L1, where apical tufts are located, engulfed more 
PSD-95 material than their counterparts in deeper layers (Figure 4.4, H). To test whether 
mC4-dependent enhancement of phagocytosis in L1 was due to an increased density of 
microglia, we quantified microglia density in L1 (cortical depth: 0–120 μm) and L2/3 
(cortical depth: >120–300 μm) and found no difference between microglia density 
between layers in either condition (Figure 4.2). There was also no difference in CD68 
area within microglia between control and mC4 conditions (Figure 4.2). In summary, our 
data support the hypothesis that C4 overexpression drives layer-specific circuit 
dysfunction through excessive microglia engulfment of postsynaptic material. 
 
4.2.4 Expansion microscopy confirms that C4 overexpression enhanced microglia-
mediated engulfment of synaptic material 
We used expansion microscopy (ExM), a biological sample–preparation 
procedure that allows for nanoscale imaging with standard confocal microscopes (Wassie 




and CD68 located in microglia. Using ExM, we increased the size of microglia soma by 
approximately 180% (equivalent to approximately 2.8× linear expansion) in control and 
mC4 conditions at P21 (Figure 4.5, D-F). Microglia cell body size increased similarly 
along its long and short axis, supporting previous findings that have shown that ExM 
expands biological tissue linearly (Wassie et al. 2019) (Figure 4.5, D–F). Other than 
increasing their size, expanded microglia had morphologies similar to cells in pre-
expansion conditions (Figure 4.5), suggesting that ExM did not fundamentally alter the 







Using ExM, we observed clear examples of PSD-95 colocalized with Iba1 (Figure 
4.5 A and C, white arrowheads) and CD68 signal (Figure 4.5, B and D), suggesting 
synaptic material was localized to microglia lysosomes. Confocal images obtained after 
ExM show examples of microglia lysosomes that were both negative and positive for 
PSD-95 in control and mC4 conditions (Figure 4.6). Overexpression of mC4 in L2/3 
neurons led to an approximately 3.3-fold increase in lysosomes positive for PSD-95 
(Figure 4.5, E). Additionally, microglia in the mC4 condition contained significantly 
more lysosomes relative to control (Figure 4.5, F, approximately 1.2-fold increase). In 
contrast, previously we found no change in CD68 reactivity using conventional confocal 
Figure 4.5: Expansion microscopy (ExM) expanded microglia by ~2.8x.  
(A) Representative photograph of a coronal PFC brain section before (left) and after 
(right) expansion. Scale bar = 1 cm. (B) Representative confocal image (40X) of a 
lysosome (CD68+) before (left) and after (right) expansion. Scale bar = 1 µm. (C) 
ExM revealed greater detail of lysosome morphology. Mean gray value line intensity 
scan (for dotted lines shown in (B)). Blue line: pre-expansion. Yellow line: post-
expansion. (D) Representative confocal image (40X) of an Iba+ microglia before (left) 
and after (right) expansion. Scale bar = 5 µm.  (E) Graph showing the long diameter of 
each microglia before (blue) and after (red) expansion and after post-scaling (purple). 
One-way ANOVA with Tukey’s. ****p < 0.0001. (F) Graph showing the short 
diameter of each microglia before (blue) and after (red) expansion and after post-
scaling (purple). One-way ANOVA with Tukey’s. ****p < 0.0001. (E-F) The average 
scaling factor was ~2.78 (control: 2.79 = 0.069; mC4: 2.76 = 0.092). N = 86 microglia 
(45 control microglia and 41 mC4 microglia). Post-scaled = post / scaling factor 
(2.78). Inset image of microglia shows the long (E) and short (F) diameter of soma 
(white line with arrows). The coefficient of variation between pre-expansion, post-
expansion and post-expansion scaled microglia sizes was 30.24%, 34.35% and 
29.22%, respectively. The variance between the pre-expansion and post-expansion 
scaled sizes was compared with an F-test and no difference was found between these 
populations (One-way ANOVA with Tukey’s test; p = 0.4212). Mean ± SEM. Note: 
IUEs performed by Ashley Comer. Data collected and analyzed by Rhushikesh 
Phadke, Tushare Jinadasa, Shirley Mai, and Connor Johnson. Figure made by 
Rhushikesh Phadke, Tushare Jinadasa and Ashley Comer. Data and figure published 





microscopy (Figure 4.2, B); this could be due to the enhanced resolution made possible 
by ExM. For both conditions, lysosomes positive for PSD-95 were approximately 1.5-
fold larger than those that were negative for postsynaptic material (Figure 4.5, G). 
Additionally, lysosome size did not differ between conditions for PSD-95(+) lysosomes 
(con[+] versus mC4[+]) or for PSD-95(−) lysosomes (con[−] vs mC4[−]). This suggests 
that lysosomes positive for PSD-95 were morphologically different than lysosomes 






Figure 4.5: Expansion microscopy confirmed C4 overexpression led to enhanced 
microglial engulfment of PSD-95. 
(A-D) Representative confocal images (40X) in expanded tissue showing PSD-95 
within microglial lysosomes in P21 mice for control (A and B) and mC4 (C and D) 
conditions. Panels A and C show a representative microglia (for control and mC4, 
respectively) including Iba1 and PSD95-FingR-RFP (pseudocolored green) signal. 
White arrowheads: indicate colocalization of PSD-95 with Iba1 (A and C). Panels B 
and D show the same z-plane as panels A and C but with CD68 and PSD95-FingR-RFP 
signal. Orthogonal views shown (XY, YZ and XZ). All images are single z-planes. 
Magenta: microglia (Iba1).  Red: lysosomes (CD68). Green: PSD-95 (PSD95-FingR-
tagRFP, pseudocolored green). Yellow box in (A and C) shows zoomed region for 
orthogonal views. A and C: left scale bar = 5 µm, right scale bar (in XY plane) = 2.5 
µm. B and D: scale bar = 1 µm. (E) mC4 overexpression led to an increase of lysosomes 
that were positive for PSD-95 signal. The percent of lysosomes that were PSD95 
positive per each microglia compared between control and mC4. t test. ****p < 0.0001. 
(F) Number of lysosomes in microglia was increased in the mC4 condition relative to 
controls. t-test. **p = 0.0064. (G) Lysosomes that were positive for PSD-95 were larger 
in size compared to PSD-95(-) lysosomes in both control and mC4 conditions. 
Lysosome size (µm2) per microglia for control and mC4 conditions separated into 
lysosomes positive or negative for PSD-95 signal. Control (+) and mC4 (+) are 
lysosome size for lysosomes positive for PSD95. Control (-) and mC4 (-) are lysosome 
size for lysosomes that are negative for PSD95. Two-way ANOVA followed by a 
Tukey’s test for all comparisons. Control (+ vs -): **p = 0.0071. mC4 (+ vs -): *p = 
0.0150. Control (+) vs mC4 (+): p = 0.0868. Control (-) vs mC4 (-): p = 0.2987. (E-G) 
blue: control. red: mC4. N = 86 microglia (45 control (from 5 mice) and 41 mC4 (from 
4 mice) microglia). Mean ± SEM. Note: IUEs performed by Ashley Comer. Data 
collected and analyzed by Rhushikesh Phadke, Tushare Jinadasa, Shirley Mai, and 
Connor Johnson. Figure made by Tushare Jinadasa and Ashley Comer. Data and figure 














4.3 Conclusion and future directions 
In summary, our data support the hypothesis that C4 overexpression drives layer-
specific circuit dysfunction through excessive microglia engulfment of postsynaptic 
material. To follow up on this work, in future studies we would like to gain more 
causative evidence for microglial engulfment of microglia, as opposed to just 
correlational data showing increased microglia engulfment in in mice overexpressing C4. 
To do this, various microglial receptors that are necessary for microglia-mediated 
engulfment can be disrupted to see if the phenotype persists when microglia phagocytosis 
is blocked. For example, CR3 or CX3CR1 could be disrupted using genetic knockout 
mouse lines. The CR3 is necessary for proper synaptic elimination, as mice deficient for 
this receptor have excessive synapses compared to wild type mice in the visual thalamus 
(Schafer et al. 2012). CX3CR1 is a chemokine receptor that is necessary for microglial 
motility, mice deficient for this receptor also show a lack of synaptic pruning that was 
Figure 4.6: ExM revealed that neuronal mC4 overexpression increased the 
number of PSD-95+ lysosomes in microglia. 
(A-B) Representative confocal images (40X) of a single expanded microglia from 
control (A) and mC4 (B) conditions, respectively. The columns in (A) and (B) show 
different z-planes of a single microglia in each of the columns that contain lysosomes 
that were either positive (+) or negative (-) for PSD-95. These images show that mC4 
condition microglia contained a greater number of lysosomes positive for PSD-95. The 
first row shows microglia (Iba1) with a silhouette drawn in white. The second row 
shows lysosomes (CD68) within the microglia shown in the top panel. The bottom two 
rows are a zoomed region (yellow inset from row 2) showing lysosomes (3rd row) and 
PSD-95 (4th row) with a silhouette of the lysosome drawn in white. White arrowheads 
show PSD-95 within lysosomes. Scale bar (A) = 1 µm.  Scale bar (B) = 1.63 µm. Note: 
IUEs performed by Ashley Comer. Data collected and analyzed by Rhushikesh Phadke, 
Tushare Jinadasa, Shirley Mai, and Connor Johnson. Figure made by Rhushikesh 





sufficient to alter behavior in mice (Paolicelli et al. 2011). Alternatively, microglia could 
be depleted using colony stimulating factor 1 receptor antagonists. If the phenotype is 
reversed when microglia function is impaired, this would be causative evidence that 
microglia are necessary for synapse loss when C4 is overexpressed. However, since 
microglia play multiple important roles in development, such as synapse induction, 
instead of depleting the entire population of microglia, it would likely be best to titer the 
dosage of CSF1R antagonists to achieve only partial microglia depletion such as a 20-
40% reduction in the population. This would potentially avoid secondary effects such as 















Effect of C4 overexpression on mouse behavior across development 
 
5.1 Introduction 
In the developing brain, there is a period of intense synaptogenesis followed by 
critical developmental periods characterized by experience-dependent refinement of 
synapses (Trachtenberg et al. 2002, Holtmaat and Svoboda 2009). Synaptic elimination 
driven by sensory experience refines brain circuitry by optimizing connections between 
neurons. In SCZ, this process is thought to be dysregulated, thus leading to the loss of 
both excessive and necessary synapses, thus causing aberrant brain connectivity. If there 
are pathological change to circuits during these critical periods, the effects on the 
developing circuitry can be permanent. Therefore, the purpose of this work was to 
determine if C4 overexpression was sufficient to cause lasting behavioral deficits. 
Here, experiments were run to determine whether bilateral C4 overexpression was 
sufficient to alter behavior in mice. Specifically, we assayed early social behavior in 
juvenile mice using a maternal interaction task. Behavior was also assayed in adults to 
determine whether or not the transient spine phenotype at P21 was able to cause lasting 






5.2.1 Bilateral in utero electroporation reliably transfects L2/3 excitatory neurons in the 
frontal cortex 
To determine whether overexpression of mC4 in the frontal cortex is sufficient to 
cause deficits in early (P18) social behaviors, we administered a task that allowed us to 
measure sensorimotor abilities of mice and maternal–pup social interactions (Zhan et al. 
2014). For these experiments, we used a modified IUE method to target large populations 
of L2/3 neurons in both hemispheres of the frontal cortex. Post hoc analysis of brains 
from these mice showed that most transfected cells were in prefrontal cortical regions, 
confirming that we were able to increase mC4 expression in large populations of PFC 
L2/3 neurons (Figure 5.1). We were able to transfect about 4000 cells per mouse in 











5.2.2 Complement-dependent alterations in frontal cortical circuitry are sufficient to 
alter maternal-pup social interactions 
 To test sensorimotor abilities (maternal interaction 1 [MI1] task), we transferred 
P18 pups to an arena that contained fresh bedding in two neutral corners and nesting 
material from the animal’s home cage in the corner opposite to the starting corner, and 
mice were free to explore the arena for 3 min (Figure 5.2, A). Similar to controls, mC4 
mice spent more time exploring the nest corner relative to the neutral corners, suggesting 
that mC4 mice had normal homing behavior (Figure 5.2, B). Although grooming 
occurrences of mC4 mice were more frequent and about 4.3-fold longer (Figure 5.3) than 
in control mice, there was no interaction between experimental group and corner 
preference (Figure 5.2, B). These results indicate that although mC4 mice engaged in 
Figure 5.1: Targeting large populations of L2/3 frontal cortex neurons using IUE.  
(A) Percentage of GFP+ cells per area in juvenile (P18) mC4 mice. N = 21 mC4 mice. 
(B) Total number of GFP+ positive cells for juvenile mice for control and mC4. N = 36 
mice (15 control and 21 mC4 mice). (C) Percentage of GFP+ cells per area in adult mC4 
mice. N = 20 mC4 mice. (D) Total number of GFP-positive cells per area for adult mice 
(P60) for control and mC4. N = 42 mice (22 control and 20 mC4).  (E) Representative 
sections showing rostro-caudal extent of transfections in the frontal cortex. Images in 
left panels are zoomed areas from the right panels (red square). Frontal association 
cortex: FrA. Supplementary motor cortex: M2. Prelimbic cortex: PL. Infralimbic cortex: 
IL. Anterior cingulate cortex: ACC. Medial orbitofrontal cortex: MO. Ventral 
orbitofrontal cortex: VO. Lateral orbitofrontal cortex: LO. Anterior insular cortex: AI. 
Frontal cortex area 3: Fr3.  Primary motor cortex: M1.  Primary somatosensory cortex: 
S1. Piriform cortex: Pir. Anterior olfactory nucleus: AO. Caudate-putamen: Cpu. Black 
numbers: Bregma coordinates. Left panel scale bar = 0.5 mm. Right panel scale bar = 1 
mm. Mean ± SEM. Note: IUEs performed and data collected by Ashley Comer. Data 
analyzed by Ashley Comer, Frances Hausmann, Eli Spevack, Berta Escude, Charlotte 
Yeung, Thara Venu, Haley Cerretani, Cesar Diaz, and Meaghan Connolly. Figure made 





more repetitive behavior, they were able to explore the arena and interact with their nest 
bedding to the same extent as control animals. Additionally, these results suggest that 
increased levels of mC4 in the frontal cortex did not impair overall sensory abilities or 








 To test maternal–pup social interactions (maternal interaction 2 [MI2] task), we 
placed P18 pups in an arena that contained nest bedding, an empty wire mesh cup, and a 
wire mesh cup containing the pup’s dam, and the behavior of each pup was monitored for 
5 min (Figure 5.2, C). We found that mC4 mice showed an approximately 23% reduction 
in time spent exploring the cup containing the dam as compared to control mice (Figure 
5.2, D). mC4 mice also exhibited an approximately 2.5-fold decrease in the latency to 
first approach the dam’s cup (Figure 5.2, E). The proportion of pups that approached the 
dam’s cup before the empty cup (at start of trial) was approximately 50% (Figure 5.2, F), 
Figure 5.2: C4-dependent alterations in frontal cortical circuitry were sufficient to 
alter maternal-pup social interactions.  
(A) Representative examples of path traveled (black trace) by P18 control and mC4 
pups in MI1 task. Fresh bedding corners (fresh 1 and 2, pink) and nest bedding corner 
(green). (B) Control and mC4 pups spent a similar proportion of time exploring the nest 
and fresh corners in the MI 1 task, suggesting motor and sensory skills were intact. All 
mice spent more time in nest bedding than fresh bedding. **p < 0.01, ***p < 0.001, 
****p < 0.0001. Two-way ANOVA and Sidak's post test. Control vs. mC4 time spent 
in nest: p > 0.9999. Control vs. mC4 time spent in fresh 1: p = 0.3327. Control vs. mC4 
time spent in fresh 2: p = 0.3138. (C) Representative examples of path traveled (black 
trace) by P18 control and mC4 pups in MI 2 task.  Dam’s cup (dam: blue), Empty cup 
(empty cup: yellow), Nest bedding corner (nest: green). (D) mC4 pups spent less time 
interacting with dam and more time near the empty cup compared to controls. Two-way 
ANOVA and Sidak's post test. *p < 0.05. ****p < 0.0001. (E) mC4 mice took longer 
to approach the dam relative to controls (seconds). t-test with Welch's correction. *p < 
0.05. (F) Control and mC4 pups traveled to dam’s cup first ~ 50% of the time, 
suggesting first choice was random. Fisher’s exact test. p = 0.9999. (G) Latency to reach 
first cup (either dam or empty) was not different. t-test with Welch's correction. p = 
0.06. (H) Control and mC4 pups reached the same maximum velocity (m/s). t test. p = 
0.77. (B, D-H) N=15 control mice and N=21 mC4 mice. blue: control. red: mC4. Mean 
± SEM unless otherwise noted. Note: IUEs performed by Ashley Comer. Data collected 
by Elena Newmark and Ashley Comer. Data analyzed by Tushare Jinadasa, William 
Yen and SaraAnn Rosenthal. Figure made by Ashley Comer. Data and figure published 




suggesting that pups in both conditions engaged in similar exploratory behavior of the 
arena before seeking their mother. mC4 and control mice had similar latencies to first 
reach either the empty or dam’s cup (Figure 5.2, G) and similar maximum speeds (Figure 
5.2, H). Taken together, these results indicate that mC4 pups had intact motor and 




5.2.3 Complement-dependent alterations in social behaviors persist into adulthood 
Although we did not observe changes in dendritic spine density at P60 between 
conditions (Figure 4.6, A), it is possible that increased C4 expression in adult mice 
resulted in changes in the function of frontal L2/3 neurons that could not be directly 
assessed by analyzing the mean dendritic spine density (e.g., miswiring of synaptic 
Figure 5.3: mC4 pups had increased grooming occurrences and grooming time 
compared to controls.   
(A) mC4 mice had a greater number of grooming occurrences during the MI 1 task. t 
test with Welch’s correction. *p < 0.05. (B) Average time per each grooming occurrence 
was longer for mC4 mice compared to controls in the MI 1 task. t-test with Welch’s 
correction. **p < 0.01. (A-B) N = 36 mice (15 control and 21 mC4). Mean ± SEM. 
Note: IUEs performed by Ashley Comer. Data collected by Elena Newmark and Ashley 
Comer. Data analyzed by SaraAnn Rosenthal. Figure made by Ashley Comer. Data and 




connections or intrinsic excitability). Therefore, we tested whether bilateral 
overexpression of mC4 in the frontal cortex led to changes in sensorimotor abilities or 
social behavior in adult (P60–70) mice (N = 22 control mice, N = 20 mC4 mice). We first 
tested adult mice in a novel-object task to assess whether interest in a novel object was 
affected by C4 overexpression (Figure 5.4, A). Control and mC4 mice spent similar 
amounts of time exploring the novel object (Figure 5.4, B). Next, a novel-object 
recognition task was performed, in which mice were placed in an arena for 5 min with a 
novel object in one corner and a familiar object in the opposite corner (Figure 5.4, C). 
The discrimination index (DI) for object interaction (DI = [time with novel object − time 
with familiar object] / [time with novel object + time with familiar object]) was positive 
for both control and mC4 mice, indicating that mice in both conditions spent more time 
exploring the novel object relative to the familiar object (Figure 5.4, D). Additionally, the 
DI for control and mC4 mice was not different (Figure 5.4, D), suggesting that 
overexpression of mC4 in the frontal cortex did not alter sensorimotor abilities or general 
motivation. In support of this, mC4 mice traveled at similar speeds and distances in an 










Next, we placed either control or mC4 adult mice in an arena that contained an 
empty wire mesh cup and a wire mesh cup containing a novel mouse (strain, sex, and age 
matched) in opposing corners, and the behavior of each mouse was monitored for 5 min 
(Figure 5.4, E). We found that adult mC4 mice showed a significant reduction in social 
DI, a metric of sociability ([time spent with novel mouse − time spent with empty cup] / 
[time spent with novel mouse + time spent with empty cup]), as compared to control mice 
(Figure 5.4, F). This reduction in sociability was not due to an overall increase in 
Figure 5.4: C4-dependent alterations in frontal cortical circuitry led to behavior 
deficits in sociability that persist into adulthood.  
(A) Representative examples of path traveled (black trace) by P60 control (left) and 
mC4 (right) adult mice in novel object interaction task. pink corner = location of novel 
object. (B) Control and mC4 mice spent a similar amount of time exploring the novel 
object. Percent time spent in corner with novel object shown. p = 0.2127. (C) 
Representative examples of path traveled (black trace) by P60 control (left) and mC4 
(right) adult mice in novel object recognition task. pink corner: location of novel object. 
green corner: location of familiar object. (D) Novel object recognition was intact in the 
mC4 condition. Control and mC4 mice had a similar DI ((time with novel object – time 
with familiar object) / (time with novel object + time with familiar object)). p = 0.1539. 
(E) Representative examples of path traveled (black trace) by P60 control (left) and 
mC4 (right) adult mice in sociability task. pink corner: location of novel mouse under 
mesh wire cup. green corner: location of empty mesh wire cup.  (F) mC4 overexpressing 
mice spent less time exploring a novel mouse and more time with the empty cup relative 
to control. Graph shows DI ((time with novel mouse – time with empty cup) / (time 
with novel mouse + time with empty cup)). *p = 0.029. (G) Control and mC4 mice had 
a similar latency to first approach the novel mouse (sec). p = 0.5416. (H) Control and 
mC4 mice traveled to the novel mouse cup first at a similar proportion. Proportion of 
mice that approached the novel mouse cup first. Fisher’s exact test. p = 0.54. (I) Latency 
to reach first cup (either novel mouse cup or empty cup) was not different (sec) between 
conditions. p = 0.217. (J) Control and mC4 mice reached the same maximum velocity 
(m/s). p = 0.1442. N=22 control and N=20 mC4 mice between P60-70. blue: control. 
red: mC4. t test unless otherwise stated. Mean ± SEM unless otherwise noted. Note: 
IUEs performed by Ashley Comer. Data collected by Ashley Comer and Charlotte 
Yeung. Data analyzed by Balaji Sriram. Figure made by Ashley Comer. Data and figure 




vigilance or anxiety-like behavior in the mC4 condition, because both groups spent 
similar amounts of time in the open arms of the elevated-zero maze (EZM) (Figure 5.5). 
We found no difference between control and mC4 mice in latency to approach either the 
novel mouse or empty cup, or in the proportion of mice choosing the novel mouse first 





Figure 5.5: Adult mice bilaterally expressing mC4 had intact motor abilities. 
(A) Control and mC4 mice (P60) had a similar average velocity in the open field task. 
t-test. p = 0.2141. (B) Control and mC4 mice traveled similar total distances in the OF 
task. t-test. p = 0.1986. (C) Control and mC4 mice spent a similar amount of time 
exploring the open arms of the EZM task. t-test. p = 0.0651 (A-C) N = 42 mice (22 
control and 20 mC4 mice). Mean ± SEM. Note: IUEs performed by Ashley Comer. 
Data collected by Ashley Comer and Charlotte Yeung. Data analyzed by Balaji Sriram. 





5.3 Conclusion and future directions 
Here, we developed a modified, bilateral in utero electroporation method that 
allowed for the transfection of larger populations of L2/3 excitatory PFC neurons. 
Although sensorimotor abilities were intact in both juvenile and adult mice 
overexpressing C4, their ability to engage in normal social behavior was disrupted. 
Overall, these results suggest that increased expression of mC4 in frontal L2/3 neurons 
led to long-lasting alterations in PFC circuitry that were sufficient to cause a reduction in 
social interactions in both juvenile and adult mice. Since it is known that there are many 
other behavior deficits observed in SCZ, future studies could elucidate what other 
behaviors C4 overexpression can impact in mice. For example, the PFC is necessary for 
normal working memory so future studies could assay mice in tasks such as the delayed 
alteration T-maze task. We show here for the first time that the overexpression of C4 
alters the developmental trajectory of cortical circuits which is sufficient to alter SCZ-















Genome-wide association studies (GWAS) have driven the discovery of novel 
candidate genes that are associated with brain pathologies (Yang et al. 2018, 
Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014, Howard 
et al. 2019, Grove et al. 2019). These studies have been particularly beneficial in 
understanding devastating neuropsychiatric disorders such as SCZ, where the 
investigation of novel genes has served as a launching point for new lines of research and 
therapeutic intervention (Comer et al. 2020, Chini et al. 2020). Genes harboring risk for 
SCZ show biased expression in the prefrontal cortex (PFC) during prenatal and early 
postnatal development, a region implicated in the pathology of several neuropsychiatric 
disorders (Clifton et al. 2019). Additionally, mouse models of psychiatric disorders 
exhibit abnormal activity in prefrontal cortical networks (Chini et al. 2020, Oberlander et 
al. 2019, Batista-Brito et al. 2019). These results suggest that SZC-associated genes 
might play a role in the developmental wiring of this region.  Further investigation using 
animal models is required to understand the contribution of these candidate genes to the 
establishment of connections in the PFC and to determine whether these genes have a 




mice that allow for the study of gene expression changes on specific neuronal circuits are 
a promising method to understand the molecular mechanisms that link gene expression 
changes to PFC dysfunction.  
Genetic mouse lines offer a method to study the impact of particular genes on 
brain development and function. However, relying on transgenic mice can be limiting 
since there are not always commercially available lines to examine the effects of specific 
genes on developing neural circuits. Moreover, it can be extremely costly and time 
consuming to develop custom mouse lines. The use of intersectional genetic manipulation 
strategies that combine transgenic mice with viral approaches has revolutionized the 
understanding of the brain (Luo et al. 2018, DeNardo & Luo 2017, Huang & Zeng 2013). 
Despite much progress, viral strategies come with certain limitations dependent on the 
viral vector type, including limits in packaging capacity that can restrict viral expression 
(Wu et al. 2010) and cell toxicity associated with viral expression (Callaway & Luo 
2015). Furthermore, in most experimental conditions, robust gene expression using 
adeno-associated virus (AAVs) requires approximately 2 to 4 weeks (Cruz-Martín et al. 
2014), making routine viral strategies unfeasible to manipulate genes during early 
postnatal development.  
In utero electroporation (IUE) is an alternative approach that allows for rapid and 
inexpensive gene transfer (Saito 2006, Cruz-Martín et al. 2012) that, when coupled with 
fluorescent labeling and pharmacogenetic or optogenetic approaches, provides a powerful 
platform to dissect the function of neuronal circuits. Additionally, with the development 




cell-type specific knock-down or knock-out of specific genes or through the modulation 
of promoters (Zhang et al. 2016, Strecker et al. 2019). Gene manipulation approaches 
using IUE are especially advantageous when the effect of genes on neuronal circuits need 
to be tested during narrow developmental windows (Cruz-Martín et al. 2012). IUE is a 
versatile technique and overexpression can be easily accomplished by inserting a gene 
into an expression vector under a specific promoter. Additional control of gene 
expression can be achieved by driving expression using promoters of different strengths 
or using inducible promoters capable of temporally controlling gene expression (LoTurco 
et al. 2009, Kolk et al. 2011). Additionally, IUE allows for the targeting of cells within 
specific cortical layers, cell types and brain regions, which isn’t always feasible using 
other approaches (Comer et al. 2020, Cruz-Martín et al. 2010). Recent advances in the 
IUE configuration based on the use of three electrodes, which generates a more efficient 
electric-field distribution, have expanded the functional repertoire of this method and 
allowed scientists to target new cell types and increase the efficiency, accuracy, and 
number of cells that can be targeted (Szczurkowska et al. 2016, dal Maschio et al. 2012). 
This technique was recently used to determine the causative role of complement 
component 4A (C4A), a gene linked to SCZ, in PFC function and early cognition (Comer 
et al. 2020). 
Presented here is an experimental pipeline that combines gene transfer approaches 
to target large populations of excitatory neurons in the frontal cortex, including the PFC, 
with behavioral paradigms that not only enables the study of cell and circuit-level 




development and adulthood. First described is a method to bilaterally transfect large 
populations of L2/3 pyramidal neurons in frontal cortical regions. Next, tasks to assay 
social behavior in juvenile and adult mice are outlined. Cell counts can be obtained upon 
the completion of behavioral tasks to quantify the extent and location of cell transfection. 
Furthermore, the number of cells transfected can be correlated with behavioral data to 




6.2.1 Advance preparation for in utero electroporation 
These are the procedures to follow for in utero electroporation.  Purchase a 
commercial plasmid or subclone a gene of interest into plasmid with the desired 
promoter. Determine the desired promoter based off the level of expression needed. In 
general, plasmids under the CAG promoter can be used to achieve high levels of the 
transgene whereas cell-type-specific promoters (e.g., synapsin for neurons) tend to be less 
active. The experimenter should empirically determine the appropriate expression levels 
for each plasmid. Transform bacteria and grow stocks in bacterial media with the 
appropriate antibiotic. Remove commercially obtained competent cells from -80 °C and 
thaw on ice for 20 min. Mix DNA (100 pg – 100 ng) into 30 μL of competent cells and 
incubate the mixture on ice for 20 min. Transform the cells with heat shock by incubating 




1,000 μL of LB media to the transformed competent cells and grow for 45 min at 37°C 
on a shaking incubator. Plate 200 μL of the transformed cells into an LB agar plate 
containing the appropriate antibiotic and incubate the plate overnight at 37°C. The next 
day, incubate one bacterial colony in 200 mL of LB broth with the appropriate antibiotic 
at 37°C on a shaking incubator overnight. Purify plasmid DNA using a maxiprep kit. 
Follow instructions given in obtained maxiprep kit. For elution step, do not elute DNA 
into elution buffer. Instead, elute DNA using either 200 μL sterile PBS (1X) or molecular 
grade water. Ensure that the final concentration of the DNA is greater than 1 μg/µL. If the 
plasmid containing the gene of interest does not contain a reporter gene, then also prepare 
a plasmid to co-transfect with a reporter molecule, such as green fluorescent protein 
(GFP), to allow for the visualization of transfected cells. Prepare DNA solution for 
surgery by diluting the plasmid DNA into PBS (1X) so that the final concentration of 
each plasmid is 1 µg/µL. Add fast green dye so that the final concentration in the DNA 
solution is 0.1%. For bilateral injections, prepare 60 µL of solution per dam (for 
approximately 10 pups). 
In the days and weeks before the surgery, plan to order or breed timed-pregnant 
mice. If ordering timed-pregnant mice, order mice to arrive on gestation day (E) 13 or 
earlier to allow the dams adequate time to acclimate to animal housing.  This will reduce 
animal stress and lead to a higher survival rate of the pups. Here, we used CD-1 outbred 
mice for all experiments since they tend to have more offspring per litter. If breeding 
timed-pregnant mice, pair female mice with a male overnight, once a week. The presence 




determined by monitoring the weight of the female mice. Different mouse strains have 
different weight increases through pregnancy, so determine typical weight gain for the 
mouse strain used. Whether ordering or breeding the mice, to reduce stress of the dams, 
place a nesting pad and mouse house in the cage. Reducing stress can help increase the 
survival rate of the pups. 
Design and assemble the three-prong electrode prior to surgery day and test that it 
is working. Briefly, to make the three-prong electrode, use grade 2 titanium sheets with a 
thickness of 0.063 in as stock material for electrode contacts. Using standard machining 
techniques or precision hand tools, make electrodes with the following dimensions: 20 
mm x 5 mm with a rounded tip and grooved back. Remove any rough edges or burrs 
using fine grit sandpaper. To wire the electrode contacts, wrap 22-gauge stranded copper 
wire around the grooves of the electrode and secure by soldering. Protect this joint using 
heat shrink tubing. Then, attach the connected electrode to autoclavable, non-conductive 
forceps using additional heat shrink tubing to make the two negative electrodes. Attach 
the single positive electrode to an autoclavable, non-conductive material (such as a 
toothbrush handle). The open end of the wire can be fitted with a standard banana plug. 
Test that the three-prong electrode is functioning properly before the start of surgery.  
6.2.2 Surgery preparation and in utero electroporation procedure 
Prepare for surgery by bringing the pregnant dams to the surgery area at least 30 
min prior to surgery to allow stress levels to reduce after transport from the animal 




ethanol. Sterilize autoclaved tools in a glass bead sterilizer. Prepare sterile PBS (1X) 
(about 50 mL per dam) in conical tubes and place in water bath heated to 38-40° C. 
Check the sterile saline temperature with a thermometer. Turn on water heating 
circulation pump so that it is warmed to 37° C prior to start of surgery. This will maintain 
the mouse’s body temperature for the duration of the surgery.  Turn on the pressure-
injector and electroporator and ensure proper function prior to surgery. Briefly spin DNA 
solution on a tabletop centrifuge and place on ice. Pull glass pipettes on a pipette puller 
so that the tip of the pulled-glass pipette is about 50 µm in diameter. Fill a pulled pipette 
with 20-40 µL of DNA solution. Set up all necessary items for surgery including hair 
removing lotion, iodine, 70% ethanol, cotton swaps, eye drops, sutures, gauze, etc. 
Prepare a surgery sheet and fill out necessary information. 
To perform in utero electroporation surgery, weigh the mouse prior to surgery and 
note this on the surgery sheet. Anesthetize a pregnant mouse (E16) by inhalation in an 
induction chamber with 4% (v/v) oxygen-isoflurane mixture. Once the mouse has been 
induced, move to a mask inhalation and maintain isoflurane at 1-1.5% (v/v) and monitor 
breathing throughout the surgery. Administer preoperative analgesics. Use hair removal 
cream or carefully use a razor to remove the fur from the abdomen. Sterilize the abdomen 
by swabbing with povidone-iodine and 70% ethanol and repeat this at least 3 times. 
Create a sterile field around the abdomen using sterile gauze. Make an incision in the 
abdominal skin, being sure to lift the skin up with forceps to avoid cutting through the 
muscle. Then cut through the muscle, again taking care to lift the muscle up to avoid 




place them gently onto the sterile field, making sure that the uterine horn is supported 
with padding and isn’t tugging too far away from the dam. From this point on, keep the 
uterine horn moistened throughout the rest of the surgery with the pre-warmed sterile 
PBS (1X). Position an embryo using either forceps or fingers and carefully insert the 
pulled glass pipette into the lateral vertical. Inject about 2-3 μL into each lateral ventricle 
by either inserting the pipette into one and then the other ventricle (recommended) or by 
injecting the DNA solution into one ventricle until it passes into both lateral ventricles. 
Note: The tip of the glass pipette could break during surgery. If this happens, replace the 
glass pipette, ensuring that the uterine horns are kept moistened while a new pipette is 
prepared and filled with the DNA solution. To transfect cells bilaterally in the frontal 
cortex, position the two negative electrodes on the sides of the embryos head just lateral 
and slightly caudal to the lateral ventricles and position the positive electrode between the 
eyes, just in front of the developing snout. Ensure the embryo is generously moistened 
before applying four square pulses (pulse duration: 50 ms, pulse amplitude: 36 V, 
interpulse interval: 500 ms). Inject and electroporate all embryos, going one-by-one so 
that each embryo is electroporated immediately after the DNA solution injection. Once 
all embryos have been electroporated, carefully insert the uterine horns back into the 
abdominal cavity. The abdominal cavity can be coated in sterile PBS (1X) to aid uterine 
horn placement. Fill the abdominal cavity with sterile PBS (1X) so that no air pockets 
remain after suturing is complete. Suture the muscle with absorbable sutures and the skin 
with silk non-absorbable sutures. Allow the dam to fully recover in a heated chamber for 




6.2.3 Assaying early and adult social behavior 
Perform the maternal homing behavior in postnatal mice born after the IUE 
surgery. For the maternal interaction I (MI1) task, ensure that cage bedding is not 
changed in the week before the task will be performed. Obtain or build an open field 
(OF) arena that can be easily cleaned (acrylic is recommended) with the following 
dimensions: 50 x 50 x 30 cm (length-width-height). Lighting conditions during 
performance of behaviors can vary depending on experimental question and can 
influence levels of arousal and anxiety-like behavior. Record behavioral experiments 
under a dim light (approximately 20 lux) positioned over the center of the arena. For two 
days prior to behavior testing, acclimate the dam to the arena by placing it beneath a 
mesh wire cup (such as a pencil cup) in a corner of the arena for five min per day. On 
testing day, which can be from postnatal day (P) 18-21, before mice have been weaned, 
clean the arena thoroughly with sanitizing wipes and 70% ethanol. Set up the arena with 
two opposing corners both containing clean bedding and one corner containing soiled 
nest bedding from the pup’s home cage. Allow each pup to explore the arena for 3 min, 
placing each pup in the neutral, empty corner at the start. Record behavior with a video 
camera at 30 fps. Thoroughly clean the arena between every pup, and replace the fresh 
bedding. Alternate which corner is the fresh versus nest bedding as a control to avoid 
corner preference due to other reasons (i.e., ambient noise or light). If running multiple 
litters across the P18-21 developmental window, run behavioral experiments at the same 
time between days. Also ensure that during a given day, control and experimental groups 




Perform the maternal social interaction in the maternal interaction II (MI2) task 
immediately after the MI1 task. Set up the arena so that one corner contains an empty 
wire mesh cup and the opposing corner contains the dam under a mesh wire cup. If the 
mice are able to move the cup, weigh the cup down with a weight that can be taped to the 
top of the cup to prevent movement. Put soiled nest bedding from home cage in another 
corner. Run the MI2 task. Place the pup in the empty corner and record behavior for five 
min at 30 fps, allowing the pup to explore. Run each pup separately and thoroughly clean 
the entire arena and wire mesh cups between every pup.  
Follow the following instructions to perform the adult social behavior task. Adult 
social behavior can be run in the same mice post weaning. Handle the adult mice for 3 
consecutive days to allow habituation to the experimenter. Ensure that only 
experimenters that have been familiarized to the mice run behavior experiments, ideally 
the same person will run all tasks. Habituate mice to the OF arena for 3 days for 5 min 
each day. Assay behavior in a novel object recognition task to measure general 
locomotion and interest in a novel object. This will allow more meaningful interpretation 
of social behavior if mice have a specific deficit in social interactions. Novel object 
interaction is performed by placing mice in the arena for 5 min with a novel object (small 
plastic toy with smooth, cleanable surfaces) in one corner of the arena. Clean the arena 
thoroughly between mice with 70% ethanol. For novel object recognition, place the 
previously exposed ‘novel object’, which is now familiar, in one corner and place a new 
novel object in the opposing corner. For all tasks, switch the corners between trials as a 




matched and are acclimated to the mesh wire cup for 2 consecutive days for 5 min each 
day. For each trial, place a novel mouse under a mesh wire cup and in the opposing 
corner place an empty mesh wire cup. Let the experimental mice explore the arena for 5 
min while recording behavior with a video camera. Clean the arena and mesh wire cups 
thoroughly between each trial. 
To analyze behavioral data, we used DeepLabCut (Mathis et al. 2018) to perform 
basic body part tracking. Detailed notes on how to install and use DeepLabCut can be 
found on its GitHub page. We also used a custom python-based library 'dlc_utils' 
(https://github.com/balajisriram/dlc_utils) for further analysis of the data after basic body 
parts tracking was completed. More details about how to use this library can be found in 
the GitHub page. Briefly, install DeepLabCut using the anaconda installation process. 
Install a GUI capable CPU-only version of DeepLabCut as well as the GPU-enabled 
version for training the network. Follow the instructions to create a project for tracking 
body parts, choose a sample of frames from our data set, manually mark the relevant 
body parts in these sampled frames, train the DeepLabCut network to predict the body 
parts and verify that the trained network performs adequately.  
For the purposes of tracking body position and identifying simple interactions in 
an open field, identify the centroid of the animal, the head (operationally defined as the 
midpoint between the ears), the left and right ears as well as the snout and the base of the 
tail. Having multiple body parts tracked allows for appropriate substitution when some 
body parts are missing in the frame due to occlusion. Apart from animal body parts, track 




allow for repeatable estimation of such points across multiple sessions - even if the 
position of the camera slightly changes between sessions. After tracking the body parts 
from the behavioral data, take care to filter the predicted body part locations based on the 
confidence associated with the prediction on each frame of the video. Low confidence 
predictions are usually associated with occluded body parts. For such predictions, 
substitute a given body part with another (if such substitution is appropriate) or use the 
locations of other body parts to predict where the relevant body part is likely to be. For 
most open field applications, the centroid of the rodents' body is rarely occluded and can 
be predicted with high accuracy and precision. Use the predicted location of the centroid 
as well as the location of the tracked points in the environment to estimate a number of 
features of the animal's behavior. For example, in the open field data, the time derivative 
of the position can be used to calculate the speed of the animal. All statistical tests are 
designed to test an equal number of animals between groups. To avoid bias, perform all 
experiments “blind” with respect to the experimental group when possible, particularly 
when there is any subjective element in assessing the results. The effect of sex 
differences on the main experimental outcomes can be tested by the separating of data 
into male and female groups. 
6.2.4 Post hoc cell counting to characterize extent of cell transfection 
The number of cells transfected must be determined per mouse since not all mice 
will have successful transfection and there will be variation in the number of transfected 
cells. One method to achieve this involves counting the number of transfected neurons in 




transfected cells. For this, image and count every other coronal section (50 μm). For the 
frontal cortex, count cells within +2.75 and + 1.35 mm from Bregma. These coordinates 
contain frontal cortical areas and includes part of somatosensory cortex (S1).  Using this 
method, there were no observed transfected cells in more caudal cortical regions or 
subcortical areas. Be sure to denote the left from right hemisphere, such as marking one 
hemisphere with a needle hole during sectioning, and count cells bilaterally. Use an 
automated cell counting software or count cells manually, confirming the presence of a 
cell body using DAPI. 
Once cell counts are obtained, a threshold can be set for inclusion. For example, 
only include mice that are bilaterally electroporated in analysis. For further analysis, 
correlate number of cells transfected with behavioral responses to see if there is an 
association. This technique will target multiple brain areas so it is necessary to provide 
information on which brain regions have been genetically manipulated. It is possible that 
manipulating certain genes could alter neuronal migration, specification and/or death. 
Ensure during cell counting that brain anatomy is examined and each transfected neuron 
is within the layer that was supposedly transfected (i.e. L2/3). Gross anatomical 
measurements such as cortical thickness can also be quantified by measuring the distance 






6.3.1 Successful development and implementation of a custom-built electroporator and 
triple electrode 
For IUEs, an inexpensive custom-built electroporator was built based on a 
previously described design (Bullmann et al. 2015) (Figure 6.1, A). A three prong 
electrode was made (Szczurkowska et al. 2016, dal Maschio et al .2012) using plastic 
forceps with 2 negative electrodes attached to the tips of the prongs and the positive 
electrode was attached to the end of toothbrush handle (Figure 6.1). The electroporator 
and three prong electrode were tested to ensure proper function. IUE was performed by 
exposing the uterine horns, injecting plasmid DNA and electroporating each embryo 
(Figure 6.1, C). The three prong electrode can be held fairly easily in two hands as shown 
(Figure 6.1, B, right), using the prongs to stabilize the embryo’s head. L2/3 PFC 
pyramidal somas and their processes were labeled with GFP via IUE, thus confirming the 









6.3.2 Targeting a large population of neurons bilaterally in the frontal cortex of mice 
Figure 6.1: In utero electroporation using a custom-built electroporator and a 
three prong electrode. 
(A) Image of the custom-built electroporator (left) and its internal circuit (right). 1: 
Power Indicator. 2: Power Switch. 3: Pulse Indicator. 4: Test Mode Switch.  5: Voltage 
Selector. 6: Pulse Width Control. 7: Electrode (+). 8: External Trigger (TTL).  9: 
Electrode (-). (B) Image of the custom-built three prong electrode (left) and the 
recommended method to hold the three prong electrode during the IUE (right). (C) Left: 
Diagram depicting IUE surgery performed in E16 dams. Right: representative 20X 
confocal image of IUE with GFP targeted to L2/3 mPFC. Yellow asterisk: L2/3 GFP(+) 
neurons. Left panel scale bar = 250 µm. Right panel scale bar = 75 µm. Note: Data 
obtained and figure made by Ashley Comer. Figures and data adapted from Comer et 





The total number of transfected cells and the distribution of transfected neurons 
can be quantified for both juvenile and adult mice5. Using this bilateral IUE method, 
about 4000-6000 L2/3 pyramidal neurons were transfected (Figure 6.1). Additionally, 
most of these cells were localized to frontal cortical regions including the frontal 
association cortex, motor association areas, prelimbic and infralimbic cortex and the 
orbital and anterior cingulate cortex (Figure 6.1). A representative example shows the 
rostral-caudal distribution of transfected neurons in an adult control mouse (P60, Figure 
6.1). This confirms the ability of bilateral IUEs to target and genetically label large 
populations of L2/3 pyramidal neurons in the frontal cortex. 
 
6.3.3 Social behavior in juvenile and adult mice 
The first part of the maternal interaction task tested the ability of control P18 
transfected mice (IUE with pCAG-GFP) to find nest bedding (maternal interaction 1 
[MI1]). Control mice spent more time exploring their nest bedding than exploring fresh 
bedding. Thus suggesting that, as expected, these mice have intact sensorimotor abilities 
and exploratory behavior (Figure 6.2). The second part of the task (MI2) takes advantage 
of the tendency of mice to be motivated to interact with and be near their mother. In this 
task, pups spent most of their time near their mother while spending significantly less 
time exploring the empty cup or nest bedding (Figure 6.2). These results suggest that IUE 




Adult control mice (P60) spent approximately 35% of the time exploring a novel 
object (total time spent in the arena = 5 min, Figure 6.4). When presented with a novel 
and familiar object, adult mice spent more time exploring the novel object, suggesting 
intact interest in novelty (Figure 6.4). In the sociability task, control adult mice spent 
similar amounts of time exploring a novel mouse and empty cup (Figure 6.4). This 
behavior was automatically tracked using the freely available DeepLabCut software 
(Mathias et al. 2018). DeepLabCut was also used to determine when mice were rearing 
by examining the length of the mouse’s body, since this distance becomes shorter when 
the mouse rears. 
 
6.4 Discussion 
Herein, a pipeline is described that combines the manipulation of novel genes of 
interest in large populations of frontal cortical neurons with behavioral assays in mice. 
Moreover, this pipeline allows for the longitudinal study of behavior in the same mice 
both during early postnatal development and in adulthood. This technique bypasses the 
need to rely on genetic animal models that can be costly in terms of time and expenses. 
The strength of this protocol is that it can be used to study neurodevelopmental and 
neuropsychiatric disorders for which recent genome-wide association studies have 
discovered novel genetic associations (Li et al. 2017, Ripke et al. 2013). Although this 
method provides cell-type specific transfection of excitatory neurons, one limitation is 




However, multiple studies suggest a modified approach to target other brain cell-types 
(De Marco Garcia & Fishell 2014, Borrell et al. 2005). Additionally, by modifying the 
position of the electrodes relative to the embryo’s head and changing the timing of the 
IUE, other brain regions can be bilaterally transfected including the hippocampus, 
amygdala, cerebellum, and the visual, somatosensory and motor cortices (dal Maschio et 
al. 2015, Soma et al. 2009). Additionally, different cortical layers can be targeted by 
performing IUE at different developmental stages.  
Although IUE can have a high success rate, there are critical steps and 
troubleshooting of the method that is required at times. It is necessary that plasmids are 
carefully designed and validated in cell lines. As with all cloning, care must be taken to 
ensure proper gene expression such as confirming the sequence is in frame. Additionally, 
the effect of gene manipulation (e.g., overexpression or silencing) should be confirmed 
taking into consideration that expression levels could vary across the developmental time 
course of the mouse. Western blot and qPCR can be used to determine the extent of 
genetic overexpression (Comer et al. 2020). It is recommended to co-electroporate a 
reporter gene, such as GFP, in a separate plasmid since proteins tagged with GFP can be 
mis-folded or lose their function. Alternatively, if a reporter is not used the experimenter 
can use in situ hybridization, qPCR or western blot to determine expression levels of the 
gene of interest (Comer et al. 2020).  If plasmids have been verified but there are no 
animals that appear to be positive for transfection, thoroughly check all equipment, 
especially the electroporator, to ensure proper function. When delivering voltage pulses 




electrodes should produce bubbles upon generation of the voltage pulse. If no bubbles are 
present when the voltage is delivered, there is likely a problem with the electroporator.  
Alternatively, the cDNA might not have been injected properly into the ventricle. When 
cDNA is injected properly into the lateral ventricle, the fast green dye will be visible in 
the shape of a crescent. Lastly, the position of the electrodes is important. If the 
electrodes are positioned slightly incorrectly, cells might not be transfected in the region 
of interest. Therefore, when checking for successful transfection, save some more caudal 
brain sections to see if perhaps the wrong brain region was transfected. Once this method 
has been practiced, an experienced surgeon can expect to achieve a success rate of nearly 
90%. This protocol can be modified to target other brain regions of interest. For example, 
it is possible to target most cortical regions bilaterally and even certain subcortical 
regions, including the hippocampus (Szczurkowska et al. 2016). It is also possible to 
further cut down costs by building a custom electroporator, which was used in the data 
presented here (Comer et al. 2020, Bullmann et al. 2015).  
Future studies could make use of this method to understand the role of newly 
discovered gene candidates in various neurological diseases. The presented pipeline 
offers a relatively quick assay to test the effects of specific genetic manipulations on early 
postnatal development and behavior into adulthood. Future efforts using this method have 
the potential to discover which genes play a causative role in certain brain disorders, 






Concluding remarks and future directions 
We showed here that overexpression of C4 in the mPFC can perturb circuit 
development. We demonstrated that, during normal early postnatal development, 
excitatory neurons in the mouse mPFC express low levels of C4. Moreover, 
overexpression of C4 in these cells led to spine dysgenesis that was evident through a 
transient decrease in filopodia and medium-sized spine density during the third week of 
postnatal development. We also showed that C4-dependent spine abnormalities were 
accompanied by a decrease in excitatory synaptic drive onto pyramidal cells in the 
mPFC. C4 overexpression caused microglia to engulf more PSD-95 from transfected 
neuron’s apical dendrites in L1, where spine loss was observed. Lastly, increased 
expression of C4 in the frontal cortex was sufficient to reduce social interactions in 
juvenile (P18) and adult (P60–70) mice. Our findings implicate C4 in shaping the 
developmental trajectory of cortical circuits and provide a causal link between increased 
C4 levels and PFC dysfunction. These data show for the first time, to our knowledge, that 
C4-driven circuit dysfunction in the PFC drives cellular and behavioral phenotypes 
observed in SCZ rather than merely being a consequence of disease and/or 
pharmacological treatment. 
Our morphological characterization of L2/3 mPFC neurons revealed that C4-
mediated connectivity deficits are both circuit and spine-type specific. That is, 




of L2/3 neurons. These data provide evidence that C4-driven synaptic alterations in the 
mPFC are cortical layer and/or input specific. Interestingly, previous data have shown 
that exposure to repeated stress in adolescent rats can reduce connectivity in superficial 
L1 of the mPFC (Negrón-Oyarzo et al. 2015), suggesting that this layer is susceptible to 
genetic and environmental perturbations during development. In SCZ, dendritic spine 
changes are most prominent in L2/3 of the mPFC (Glantz & Lewis 2000); therefore, we 
focused on how overexpression of mC4 causes anatomical and functional changes in this 
region. However, imaging studies have reported structural changes in a variety of brain 
regions in SCZ, including the frontal and temporal lobes and hippocampus (DeLisi 2008). 
It remains unknown whether mC4 overexpression in other brain regions leads to a 
decrease in spine density or other abnormalities. This question could be answered by 
targeting other brain regions using IUE or generating a global mC4-overexpressing 
transgenic mouse. 
When we further investigated which spine types were affected by C4 
overexpression, we found a specific loss of filopodia and medium-sized spines, whereas 
the density of mature mushroom spines were intact. This is in line with previous 
observations that complement-mediated pruning is activity dependent (Schafer et al. 
2012). Large mushroom and stubby spines are also associated with an accumulation of 
extracellular matrix proteins, which could protect them from synaptic elimination by 
microglia (Levy et al. 2014). Future studies could shed light on the molecular 
mechanisms of input-specific plasticity by identifying “eat me”/“don’t eat me” signals 




differentially present in large mushroom versus filopodia spine types. For example, the 
protective “don’t eat me” signal CD47 and its receptor SIRPα have been found to protect 
synapses from microglia-mediated engulfment and can be regulated by activity to allow 
for input-specific elimination (Lehrman et al. 2018). Further study of signals that promote 
or hinder phagocytosis, such as Fc and complement receptors or C-type lectin and 
phosphatidylserine receptors (respectively) (Galloway et al. 2019), will likely be critical 
to understand the dynamic and complex role of microglia in synapse elimination.  
Major contributors to synaptogenesis are dendritic filopodia, which are thin, 
specialized postsynaptic structures that orchestrate synapse formation by dynamically 
sampling potential presynaptic partners, thus optimizing circuit wiring (Bonhoeffer & 
Yuste 2002, Ozcan 2017). It is possible that C4 contributes to aberrant synaptic wiring by 
reducing the ability of developing circuits to form appropriate connections. At its 
simplest, increased levels of C4 may underlie PFC pathology and dysfunction by 
specifically altering filopodia-dependent synapse formation during early development. 
This interpretation would suggest that subsequent aberrant synaptic elimination in SCZ is 
a consequence of suboptimal circuit wiring. Transient deficits in dendritic spines and 
filopodia are seen in several mouse models of neurodevelopmental disorders (Del Pino et 
al. 2018). Similar to these models, our data suggest that there are sensitive developmental 
periods during which cortical circuitry is especially susceptible to altered expression of 
C4. It is well-established that there are critical windows of development and that 
alterations through genetic or environmental perturbations during these times can have 




might be more sensitive to perturbations such as increased C4 expression due to 
increased plasticity of circuits during critical windows and the presence of homeostatic 
signals. For example, in typical brain development the human prefrontal cortex 
undergoes significant wiring changes including synaptic elimination and refinement that 
continues into early adulthood until about age 25 (Meredith et al. 2012). Insults during 
this time might have the potential to impact circuit development since the cellular 
machinery and expression profile is already in place to remove synapses. Therefore, the 
factors that initiate the complement cascade in the brain might only be present or might 
be present at higher levels during these critical windows of brain development. Notably, 
the factors that initiate the complement cascade in the brain are still not clear. In the 
periphery, C1q initiates the complement cascade by recognizing invading pathogens 
(Dunkelberger and Song 2010). Future work should aim to identify the binding partners 
of C1q specifically in the brain as this work would likely be valuable in determining the 
mechanism of complement-mediated synapse removal. 
In our experiments, we did not observe a significant difference in apical tuft 
protrusion density between adult (P60) control and C4 conditions. However, in human 
SCZ postmortem tissue, spine loss of PFC cortical L3 neurons persists into adulthood 
(Glantz & Lewis 2000). Notably, our genetic manipulation targeted a single gene, C4, 
whereas SCZ results from polygenetic mechanisms (Salleh 2004), implicating a 
multitude of genes. It is possible that the mechanisms that allow for the compensation of 
spine density in P60 mice are also impaired in SCZ. Therefore, our data suggest that the 




stimulate compensatory plasticity mechanisms not present in SCZ. Additionally, there 
may be differences in how human and mouse pyramidal neurons respond to increased 
levels of C4, which could explain the discrepancy in adult dendritic spine density 
between mice and humans. Importantly, our qPCR and western blot data show that C4 
levels at P60 were not increased in the mC4 condition mice. Therefore, the fact that spine 
density in C4 conditions recovered to control levels by P60 could simply be due to the 
lack of C4 overexpression at P60. Although spine density in C4-overexpressing neurons 
returned to control levels by P60, our behavioral data in adult mice suggest that the 
underlying circuitry remains aberrant in mice overexpressing C4 in the frontal cortex. It 
remains to be determined whether increased expression of C4 can lead to other abnormal 
changes in circuitry (i.e., L2/3 output to deeper cortical layers or PFC network properties) 
that were not measured in this study that persist into adulthood. 
Our electrophysiological data strengthen our morphological findings and provide 
additional insight into the functional abnormalities caused by C4 overexpression. 
Previous studies have shown that microglia are able to trogocytose—or “nibble” and 
phagocytose—small volumes of neurons and synapses (Weinhard et al. 2018). It is 
possible that microglia trogocytose some of the PSD without fully eliminating synapses, 
thus causing a reduction in synaptic strength due to a loss of glutamate receptors. In our 
experiments, the decrease in excitatory synaptic drive caused by C4 overexpression could 
be the result of an increase in phagocytosis of synapses by microglia. Alternatively, 
microglia trogocytosis of synaptic material could trigger synaptic elimination mediated 




Ertürk 2014). On the other hand, C4 did not induce a change in the frequency or 
amplitude of mIPSCs, which is in line with previous observations showing that 
complement does not target GABAergic synapses in mouse and cellular models of 
Alzheimer’s disease (Dejanovic et al. 2018). The slowed kinetics of inhibitory 
transmission could be mediated through a loss of excitatory dendritic spines, which has 
been shown to alter inhibitory synapse location since there is local coordination of 
excitatory and inhibitory synaptic localization (Chen et al. 2012). It is possible that the 
loss of excitatory synapses of distal apical dendrites could alter the localization of 
inhibitory synapse localization, leading to changes in the kinetics of inhibitory 
transmission, however future work is required to understand how C4 overexpression 
might alter inhibitory connectivity.   
In addition to being the brain’s resident macrophage, microglia can influence 
brain development by playing roles in synapse formation, elimination, and maintenance 
(Schafer et al. 2015, Wu et al. 2015, Bohlen et al 2019). Our data show that increased C4 
expression led to morphological changes in lysosomes and enhanced phagocytic activity. 
Since microglia are the only cells in the brain parenchyma that express CR3 and are 
poised to engulf synapses (as opposed to brain border macrophages which express CR3 
but are not positioned for synapse engulfment) (Schafer et al. 2015), they are equipped to 
recognize material that has been tagged by the complement cascade to initiate 
phagocytosis. Indeed, previous work has shown that in normal brain development, 
microglia phagocytose synaptic material and that this process of synapse elimination is 




consistent with and expand upon previous studies in the retinogeniculate pathway that 
show microglia engulf synapses in a complement-dependent manner (Schafer et al. 2012, 
Bialas et al. 2013), which suggests that complement-dependent circuit wiring is necessary 
for normal development and contributes to pathology when mis-regulated. 
Importantly, the mechanisms of microglia-mediated synaptic pruning is still not 
well-understood. It remains to be determined whether microglia target the pre- or post-
synapse, or both. There is evidence suggesting that microglia target and engulf pre-
synaptic material (Schafer et al. 2012, Weinhard et al. 2018, Lehrman et al. 2018, Vasek 
et al. 2016). However, there is also evidence for microglial engulfment of post-synaptic 
material (Comer et al. 2020, Hong et al.2016, He et al. 2019, Vainchtein et al. 2018) and 
evidence suggesting that microglia interact with and engulf both pre- and post-synaptic 
material (Paolicelli et al. 2011, Wake et al. 2009, Tremblay 2012, Tremblay et al. 2010, 
Sellgren et al. 2019). One study isolated synaptosomes and found that C1q, the initiator 
of the complement cascade, tagged a subset of synapses that where positive for apoptotic-
like markers such as cleaved caspase-3 (Györffy et al. 2018). In this study, C1q was 
present in both pre- and post-synaptic fractions but was greater localized to the pre-
synaptic element (Györffy et al. 2018). Another study suggested that rather than 
phagocytosing synaptic material, microglia engulf smaller volumes of synaptic material 
(< 1 µm3), termed trogocytosis (Weinhard et al. 2018).  This study used EM and imaging 
in organotypic hippocampal cultures and found evidence for complete microglial 
inclusions of synaptic material (Weinhard et al. 2018). The authors concluded that 




in microglia using electron microscopy, only 2 of these inclusions were identified as 
presynaptic by the presence of vesicles. The remaining 15 inclusions were not able to be 
characterized as pre or post-synaptic material (Weinhard et al. 2018). This study 
highlights the need to conduct real-time imaging experiments in vivo to better understand 
microglial interactions at the synapse. Since there is evidence for both pre- and post-
synaptic elimination, there are likely circumstances where either the pre or post-synapse, 
or both are targeted. This could be disease specific in which in some instances either the 
pre- or post-synaptic element is differentially targeted. In vivo time-lapse imaging will 
likely be necessary, as opposed to in vitro methods, to gain further insight into the 
mechanisms of microglial-dependent synapse removal, with the possibility for different 
mechanisms in different contexts (homeostatic vs pathological pruning, differences 
between different disease states, etc.).  
It is important to note that other immune pathways, outside of the complement 
system, have been implicated in synaptic pruning. For example, the chemokine 
fractalkine receptor CX3CR1expressed by microglia is critical and its neuronal ligand 
CX3CL1 is critical for proper synaptic pruning (Zhan et al. 2014, Paolicelli et al. 2011). 
Mice that are deficient for CX3CR1 prune less synapses than typically developing mice 
and this lack of sufficient pruning causes functional connectivity alterations and 
behavioral deficits (Zhan et al. 2014, Paolicelli et al. 2011). Additionally, the protective 
immune molecule CD47 and its receptor SIRPα are expressed in synapses, are activity 
dependent, and protect synapses from microglia-mediated engulfment (Lehrman et al. 




in phagocytosis, is necessary for homeostatic synaptic elimination and contributes to 
disease states when misregulated (Jay et al. 2019, Filipello et al. 2018, Zheng et al. 2018, 
Konishi et al. 2018). Other immune molecules, such as TGF-β, interact with complement 
proteins and play a role in synaptic refinement that occurs during development (Bialas et 
al. 2013). The role of the immune system in synapse development has only recently been 
explored, and likely many factors of the immune system regulate processes such as 
synaptic pruning through the coordination of both pro- and anti-inflammatory regulators 
that are able to finely orchestrate synapse removal based on activity-dependent 
mechanisms.  
Social deficits in individuals with SCZ are an early feature of this disease, and 
poorer social functioning is associated with worse functional outcome in adults with SCZ 
(Green 2016, Velthorst et al. 2017). Therefore, investigating the causes of early social 
deficits could reveal potential targets for early therapeutic interventions in SCZ. In L1, 
the apical dendrites of pyramidal cells in multiple cortical layers interact with projections 
from higher-order areas (Douglas & Martin 2007). It is thought that cortical “feedback” 
that inputs to L1 exerts “top-down” control that is important for higher-order cognitive 
processes (Sjöström & Häusser 2006); therefore, the vulnerability of this layer to C4 
overexpression could provide a cellular substrate for social dysfunction. The changes that 
we observed in connectivity and behavior parallel known SCZ phenotypes in humans 
(Green 2006, Velthorst et al. 2017, Vita et al. 2012, Glantz & Lewis 2000, Thompson et 




could interrogate the role of C4 in other SCZ-relevant phenotypes such as deficits in 
memory function (Donohoe et al. 2018). 
Previous work has shown that mice deficient for various complement proteins, 
including C3R, C1q, C3, and C4, have a reduced pruning of synaptic terminals in the 
visual system during development (Sekar et al. 2016, Stevens et al. 2007, Schafer et al. 
2012). Since it has been shown that other complement proteins play a role in 
developmental pruning, it is possible that C4 exerts its effects through the activation of 
the complement cascade. However, C4 might act on other pathways in neurons to alter 
connectivity, independent of the complement cascade. Future work could aim to elucidate 
noncanonical pathways that C4 could interact with by performing proteomics or 
transcriptomics in neurons. 
Although polygenetic mechanisms underlie SCZ (Schizophrenia Working Group 
of the Psychiatric Genomics Consortium 2014), we provide evidence that altering 
expression of a single gene, C4, in mPFC neurons is sufficient to cause cellular and 
behavioral phenotypes that resemble SCZ pathology. We propose that mPFC neurons 
express low levels of C4 during normal brain development, which makes them especially 
susceptible to genetic and environmental risk factors that increase C4 expression, which 
are associated with SCZ. In summary, we have identified a critical developmental 
window during which prefrontal cortical circuits are susceptible to alterations in C4 
expression. thus opening the possibility for therapeutic intervention to either alter the 




 This work is compelling when considering that complement proteins are not just 
relevant to schizophrenia, but have also been implicated in synapse remodeling in other 
diseases including multiple neurodegenerative disorders, spinal cord and brain injuries, 
autism spectrum disorder and in normal aging (Magdalon et al. 2020). Additionally, 
complement system dysregulation is associated with multiple environmental risk factors, 
such as MIA and exposure to pollution, which contribute to the risk of developing 
multiple nervous system disorders (Magdalon et al. 2020). Therefore, the studies 
presented here (Comer et al. 2020) have the potential to be useful in understanding the 
pathogenesis in multiple diseases. Interestingly, evidence suggests that SCZ has both 
neurodevelopmental and neurodegenerative components (Gupta et al. 2010). Our method 
for experimentally overexpressing C4 did not stably increase C4 levels throughout 
adulthood (Comer et al. 2020), therefore methods that allow stable overexpression, such 
as transgenic mouse models, could allow for greater understanding of how complement 
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